| Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
|---|---|---|---|---|---|---|---|
| 1. | Maintenance therapy of melioidosis with ciprofloxacin plus azithromycin compared with cotrimoxazole plus doxycycline. | Chetchotisakd, P Chaowagul, W Mootsikapun, P Budhsarawong, D Thinkamrop, B |
0 | ||||
| 2. | Rhinocerebral mucormycosis: A report of eleven cases | Chetchotisakd, P Boonma, P Sookpranee, M Pairojkul, C |
1991 | ||||
| 3. | Hospital acquired Janthinobacterium lividum septicemia in Srinagarind Hospital. | Wilailackana, C. Lumbiganon, P. Noppawinyoowong, C. Boonma, P. Sitthikesorn, J. Chetchotisakd, P. Simajareuk, K. |
1992 | ||||
| 4. | Human pythiosis in Srinagarind Hospital: one year's experience. | Chetchotisakd, P. Pairojkul, C. Porntaveevudhi, O. Sathapatayavongs, B. Mairiang, P. Nuntirooj, K. Patjanasoontorn, B. Saew, O.T. Chaiprasert, A.K. Haswell, M.R. |
1992 | ||||
| 5. | Assessment of bacterial cross-transmission as a cause of infections in patients in intensive care units. | Chetchotisakd, P. | 1994 | ||||
| 6. | Methicillin – resistant Staphylococcus aureus (MRSA) Outbreaks in Srinagarind Hospital | JANPEN JAROONTUM PLOENCHAN CHETCHOTISAKD NANTAKA KHUNTIKEO PAGAKRONG LUMBIGANON WEERACHAI KOSUWON WIPAWADEE MANMONTRI PUNNIPA SIRIERMPOOL |
1994 | ||||
| 7. | Typing of sequential bacterial isolates by pulsed-field gel electrophoresis | Hartstein, AI Chetchotisakd, P Phelps, CL LeMonte, AM |
1995 | ||||
| 8. | Pulmonary infections in HIV infected patients. | Mootsikapun, P. Chetchotisakd, P. Intarapoka, B. |
1996 | ||||
| 9. | Cefoperazone/sulbactam + co-trimoxazole vs ceftazidime + co-trimoxazole in the treatment of severe melioidosis: a randomized, double-blind, controlled study. | Thamprajamchit, S. Chetchotisakd, P. Thinkhamrop, B. |
1998 | ||||
| 10. | Sweet's syndrome associated with non-tuberculous mycobacterial infection: A report of five cases | Choonhakarn, C Chetchotisakd, P Jirarattanapochai, K Mootsikapun, P |
1998 | ||||
| 11. | Antilipopolysaccharide II: An antibody protective against fatal melioidosis | Charuchaimontri, C Suputtamongkol, Y Nilakul, C Chaowagul, W Chetchotisakd, P Lertpatanasuwun, N Intaranongpai, S Brett, PJ Woods, DE |
1999 | ||||
| 12. | Efficacy and safety of twice daily administration of cefpirome in the empiric treatment of sepsis. | Bowonwatanuwong, C. Rajanuwong, A. Chetchotisakd, P. |
1999 | ||||
| 13. | Risk factors for melioidosis and bacteremic melioidosis. | Suputtamongkol, Y. Chaowagul, W. Chetchotisakd, P. Lertpatanasuwun, N. Intaranongpai, S. Ruchutrakool, T. Budhsarawong, D. Mootsikapun, P. Wuthiekanun, V.R. Lulitanond, V. Lulitanond, A. |
1999 | ||||
| 14. | Comparision between the Antimicrobial Susceptibility of Burkholderia pseudomallei to Trimethoprim-Sulfamethoxazole by Standard Disk Diffusion Method and by Minimal Inhibitory Concentration Determination | Lumbiganon, P. Tattawasatra, U. Chetchotisakd, P. Wongratanacheewin, S. Thinkhamrop, B. |
2000 | ||||
| 15. | Comparison between the antimicrobial susceptibility of Burkholderia pseudomallei to trimethoprim-sulfamethoxazole by standard disk diffusion method and by minimal inhibitory concentration determination. | Lumbiganon, P Tattawasatra, U Chetchotisakd, P Wongratanacheewin, S Thinkhamrop, B |
2000 | ||||
| 16. | Disseminated infection due to rapidly growing mycobacteria in immunocompetent hosts presenting with chronic lymphadenopathy: a previously unrecognized clinical entity. | Chetchotisakd, P. Mootsikapun, P. Anunnatsiri, S. Jirarattanapochai, K. Choonhakarn, C. Chaiprasert, A.K. Davis, T.E. |
2000 | ||||
| 17. | Factors associated with severe manifestations of histoplasmosis in AIDS | Wheat, LJ Chetchotisakd, P Williams, B Connolly, P Shutt, K Hajjeh, R |
2000 | ||||
| 18. | Maintenance therapy of melioidosis with ciprofloxacin plus azithromycin compared with cotrimoxazole plus doxycycline | Chetchotisakd, P. Chaowagul, W. Mootsikapun, P. Budhsarawong, D. Thinkamrop, B. |
2001 | ||||
| 19. | Randomized, double-blind, controlled study of cefoperazone-sulbactam plus cotrimoxazole versus ceftazidime plus cotrimoxazole for the treatment of severe melioidosis | Chetchotisakd, P Porramatikul, S Mootsikapun, P Anunnatsiri, S Thinkhamrop, B |
2001 | ||||
| 20. | A randomized, open-label, comparative trial of BID and TID dosing of saquinavir enhanced oral formulation as part of a triple therapy for advanced AIDS patients | Chetchotisakd, P Anunnatsiri, S Wankun, J Mootsikapun, P Boonyaprawit, P |
2002 | ||||
| 21. | Clinical outcome of native valve infective endocarditis in Khon Kaen: 1990-1999. | Pachirat, O. Klungboonkrong, V. Tantisirin, C. Taweesangsuksakul, P. Tasanavivat, P. Chetchotisakd, P. Limwattananon, S. |
2002 | ||||
| 22. | Infective endocarditis: prevalence, characteristics and mortality in Khon Kaen, 1990-1999. | Pachirat, O. Chetchotisakd, P. Klungboonkrong, V. Taweesangsuksakul, P. Tantisirin, C. Loapiboon, M. |
2002 | ||||
| 23. | The role of cefoperazone-sulbactam for treatment of severe melioidosis [4] (multiple letters) | Chetchotisakd, P. Porramatikul, S. Mootsikapun, P. Anunnatsiri, S. Thinkhamrop, B. |
2002 | ||||
| 24. | The role of cefoperazone-sulbactam for treatment of severe melioidosis - Reply | P Chetchotisakd S Porramatikul P Mootsikapun S Anunnatsiri B Thinkhamrop |
2002 | ||||
| 25. | Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study. | Sungkanuparph, S. Mootsikapun, P. Chetchotisakd, P. Bowonwatanuwong, C. |
2003 | ||||
| 26. | Efavirenz-based regimen as treatment of advanced AIDS with cryptococcal meningitis. | S Sungkanuparph A Vibhagool J Mootsikapun P Chetchotisakd S Tansuphaswaswadikul C Bowonwatanuwong W Chantratita |
2003 | ||||
| 27. | Efavirenz-based regimen as treatment of advanced AIDS with cryptococcal meningitis [4] | Sungkanuparph, S. Mootsikapun, P. Chetchotisakd, P. Bowonwatanuwong, C. Chantràtita, W. |
2003 | ||||
| 28. | Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial. | Ananworanich, J. le Braz, M. Chetchotisakd, P. Wicharuk, S. Ruxrungtham, K. Cooper, D.A. |
2003 | ||||
| 29. | Opportunistic infections after the initiation of highly active antiretroviral therapy in advanced AIDS patients in an area with a high prevalence of tuberculosis | Sungkanuparph, S Vibhagool, A Mootsikapun, P Chetchotisakd, P Tansuphaswaswadikul, S Bowonwatanuwong, C |
2003 | ||||
| 30. | The efficacy of fluconazole 600 mg/day versus itraconazole 600 mg/day as consolidation therapy of cryptococcal meningitis in AIDS patients | Mootsikapun, P Chetchotisakd, P Anunnatsiri, S Choksawadphinyo, K |
2003 | ||||
| 31. | A multicentre, randomized, double-blind, placebo-controlled trial of primary cryptococcal meningitis prophylaxis in HIV-infected patients with severe immune deficiency. | Chetchotisakd, P. Sungkanuparph, S. Thinkhamrop, B. Mootsikapun, P. Boonyaprawit, P. |
2004 | ||||
| 32. | A prospective study of efficacy and safety of once-daily saquinavir/ritonavir plus two nucleoside reverse transcriptase inhibitors in treatment-naive Thai patients | Ananworanich, J Hill, A Siangphoe, U Ruxrungtham, K Prasithsirikul, W Chetchotisakd, P Kiertiburanakul, S Munsakul, W Raksakulkarn, P Tansuphasawadikul, S Nuesch, R Cooper, DA Hirschel, B , |
2005 | ||||
| 33. | Body composition in adults infected with human immunodeficiency virus in Khon Kaen, Thailand | Hendricks, K.M. Chetchotisakd, P. Mootsikapun, P. Anunnatsiri, S. |
2005 | ||||
| 34. | Effect of changes in diagnosis and management of active infective endocarditis on the clinical outcome at Srinagarind Hospital. | Pachirat, O. Kiatchoosakun, S. Chetchotisakd, P. Tantisirin, C. Limwattananon, S. |
2005 | ||||
| 35. | Efficacy and safety of indinavir/ritonavir 400/100 mg twice daily plus two nucleoside analogues in treatment-naive HIV-1-infected patients with CD4 + T-cell counts <200 cells/mm3: 96-Week outcomes | P Mootsikapun P Chetchotisakd S Anunnatsiri P Boonyaprawit |
2005 | ||||
| 36. | Factors associated with treatment outcomes in pulmonary tuberculosis in northeastern Thailand | Anunnatsiri, S Chetchotisakd, P Wanke, C |
2005 | ||||
| 37. | Two randomized controlled trials of ceftazidime alone versus ceftazidime in combination with trimethoprim-sulfamethoxazole for the treatment of severe melioidosis | W Chierakul S Anunnatsiri JM Short B Maharjan P Mootsikapun AJH Simpson D Limmathurotsakul AC Cheng K Stepniewska PN Newton W Chaowagul NJ White SJ Peacock NP Day P Chetchotisakd |
2005 | ||||
| 38. | Absence of resistance mutations in antiretroviral-naive patients treated with ritonavir-boosted saquinavir | Ananworanich, J Hirschel, B Sirivichayakul, S Ubolyam, S Jupimai, T Prasithsirikul, W Chetchotisakd, P Kiertiburanakul, S Munsakul, W Raksakulkarn, P Tansuphasawadikul, S Schutz, M Snowden, W Ruxrungtham, K , |
2006 | ||||
| 39. | CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial | Ananworanich, J Gayet-Ageron, A Le Braz, M Prasithsirikul, W Chetchotisakd, P Kiertiburanakul, S Munsakul, W Raksakulkarn, P Tansuphasawasdikul, S Sirivichayakul, S Cavassini, M Karrer, U Genné, D Nüesch, R Vernazza, P Bernasconi, E Leduc, D Satchell, C Yerly, S Perrin, L Hill, A Perneger, T Phanuphak, P Furrer, H Cooper, D Ruxrungtham, K Hirschel, B , , |
2006 | ||||
| 40. | Clinical and epidemiological analyses of human pythiosis in Thailand | Sathapatayavongs, B. Chaiprasert, A.K. Saipetch, M. Mootsikapun, P. Chetchotisakd, P. Supparatpinyo, K. Chaiwarith, R. Srisiri, S. Somkaew, S. |
2006 | ||||
| 41. | High rate multiple drug resistances in HIV-infected patients failing nonnucleoside reverse transcriptase inhibitor regimens in Thailand, where subtype A/E is predominant | Chetchotisakd, P Anunnatsiri, S Kiertiburanakul, S Sutthent, R Anekthananon, T Bowonwatanuwong, C Kowadisaiburana, B Supparatpinyo, K Horsakulthai, M Chasombat, S Ruxrungtham, K , , , , , , , , |
2006 | ||||
| 42. | Addition of trimethoprim-sulfamethoxazole to ceftazidime during parenteral treatment of melioidosis is not associated with a long-term outcome benefit | Chierakul, W Anunnatsiri, S Chaowagul, W Peacock, SJ Chetchotisakd, P Day, NP |
2007 | ||||
| 43. | Addition of trimethoprim-sulfamethoxazole to ceftazidime during parenteral treatment of melioidosis is not associated with a long-term outcome benefit [4] | Anunnatsiri, S. Chaowagul, W. Peacock, S.J. Chetchotisakd, P. Day, N. |
2007 | ||||
| 44. | A rapidly fatal case of Panton-valentine leukocidin positive Staphylococcus aureus necrotizing pneumonia in an HIV-infected patient. | Chetchotisakd, P. Anunnatsiri, S. Puapermpoonsiri, S. Prariyachatgul, C. Chumpol, J. |
2007 | ||||
| 45. | Disseminated nontuberculous mycobacterial infection in patients who are not infected with HIV in Thailand. | Ploenchan Chetchotisakd Sasisopin Kiertiburanakul Piroon Mootsikapun Susun Assanasen Romanee Chaiwarith Siriluck Anunnatsiri |
2007 | ||||
| 46. | Efficacy and tolerability of a double boosted protease inhibitor (lopinavir plus saquinavir/ritonavir) regimen in HIV-infected patients who failed treatment with nonnucleoside reverse transcriptase inhibitors | Chetchotisakd, P Anunnatsiri, S Mootsikapun, P Kiertiburanakul, S Anekthananon, T Bowonwatanuwong, C Kowadisaiburana, B Supparatpinyo, K Ruxrungtham, K , , , , , , , , |
2007 | ||||
| 47. | Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial. | Ernst-Ruediger Kuse Ploenchan Chetchotisakd Clovis Arns da Cunha Markus Ruhnke Carlos Barrios Digumarti Raghunadharao Jagdev Singh Sekhon Antonio Freire Venkatasubramanian Ramasubramanian Ignace Demeyer Marcio Nucci Amorn Leelarasamee Frederique Jacobs Johan Decruyenaere Didier Pittet Andrew J. Ullmann Luis Ostrosky-Zeichner Olivier Lortholary Sonja Koblinger Heike Diekmann-Berndt Oliver A. Cornely |
2007 | ||||
| 48. | No change in calculated creatinine clearance after tenofovir initiation among Thai patients | Gayet-Ageron, A. Ananworanich, J. Jupimai, T. Chetchotisakd, P. Prasithsirikul, W. le Braz, M. Ruxrungtham, K. |
2007 | ||||
| 49. | Non-HACEK gram-negative bacillus endocarditis | Morpeth, S.C. Nacinovich, F. Fernández-Hidalgo, N. De Oliveira Ramos, A.I. Klein, J.L. Giannitsioti, E. Giamarellou, H.J. Paré, C. Armero, Y. Kanj-Sharara, S. Ravasio, V. Bernard, Y.F. Lambert, P.A. Trivi, M.S. Chambers, S.T. Lalani, T. Chaiworramukkun, J. Pachirat, O. Chetchotisakd, P. Suwanich, T. Raoult, D.M. Kumar, A.S. McBryde, E.S. Ryan, S. Ionac, A. Imazio, M. Bukovski, S. Bayer, A.S. |
2007 | ||||
| 50. | Predictors of CD4 count change over 8 months of follow up in HIV-1-infected patients with a CD4 count >= 300 cells/mu L who were assigned to 7.5 MIU interleukin-2 | Zoe Fox Andrew N. Phillips Schlomo Staszewski Donald I. Abrams David A. Cooper Janet H. Darbyshire William R. Duncan H. Clifford Lane Jens D. Lundgren James D. Neaton Liliana Aguilar Eleonora Betina Angel Silvia Aquilia Jorge Benetucci Victor Bittar Pedro Cahn Arnaldo Casiro Jorge Contarelli Jorge Corral Lucia Daciuk Daniel David Ines Ferrari Diego Fridman Viviana Galache Graciela Guaragna Silvina Ivalo Hector Laplume Isabel Lanusse Maria B. Lasala Roberta Lattes Jaime Lasovsky Gustavo Lopardo Marcelo Losso Leonardo Lourtau Sergio Lupo Aldo Maranzana Cristina Marson Lucila Massera Marisa del Lujan Sanchez Carla Somenzini Mariel Tocci Sally Algar Jonathan Anderson David Baker Kathy Blavius Mark Bloch Michael Boyle David Bradford Phillip Britton Leah Carrall Andrew Carr John Chuah Michael Curry Clive D'Arcy-Evans Pauline Dobson Nicholas Doong Cari Egan Wendy Ferguson Robert Finlayson Martyn French Anthony Frater Julian Gold Philip Habel Kay Haig Rohan Holland Natalie Hyland Jennifer Hoy Jeff Hudson Robyn James Jenny Leung Kaye Lowe Karen MacRae Marilyn McMurchie Nicholas Medland Samantha Miller Jo Murray Rosie Newman David Orth Julie Patching Ruth Primrose Hugo Ree Robyn Richardson Gary Rogers Janine Roney Norman Roth Jeganathan Sarangapany David Shaw Carol Silberberg Jenny Skett Leah Williams Tuck Meng Soo David Sowden Alan Street Robyn Vale Claudio Villella Alan Walker Ashley Watson Ngaire Wendt Helen Wood David Youds Alexander Aichelburg Armin Rieger Norbert Vetter Nathan Clumeck Stephane De Wit Kabamba Kabeya Elizabeth O'Doherty Cristiane de Sales Amorim Caritas Relva Basso David Salamao Lewi Luiz Carlos Pereira Mariliza da Silva Tamara Newman Lobato Souza Jonathan Angel Pierrette-Rolande Bouchard Fran Clark Jeff Cohen Mimose Dambreville Michele Ellis Stephan Fiset Andrea Foster Christopher Fraser Susan Gagnon Janet Gilmour Richard Guenette Heather Haldane Nanci Hawley-Foss Susan Hyndman Lynn Johnston Nathalie Jubinville Francoise Juneau Lynn Kelleher Lyne LaPointe Judy Latendre-Paquette Adeline Lindemulder Laura Mashinter Eric Lefebvre Nancy McFarland Chantal Morisseau Robert O'Neill Alain Piche Edward Ralph Danielle Rouleau Jean-Pierre Routy Roger Sandre Shelley Schmidt Stephen Shafran Fiona Smaill Dale Stromberg Jean-Marc Trepanier Sylvie Trottier Susanne Veal Sharon Walmsley Karl Weiss Kurt Williams Mavis Young Barbara Zaleschuk Don Zarowny Bente Baadegaard Finn Black Kirsten Boedker Jan Gerstoft Lene Jensen Lars Mathiesen Henrik Nielsen Court Pedersen Dorthe Petersen Jean-Pierre Aboulker Adyb Baakili Nafissa Bengrait Maryse Bensalem Huguette Berthe Martin Bloche Claude Bazin Francois Boue Elisabeth Bouvet Christiane Brancon Catherine Capitant Carole Ceppi Christine Cheneau Anne Coutellier Jean Marie Chennebault Fabienne Coquet Pierre De Truchis Anne-Marie Delavalle Veronique Frixon-Marin Jean-Albert Gastaut Francois Delfraissy Muriel Eliaszeicz Herve Gallais Jean-Albert Gataut Jacques Gilquin Gustavo Gonzalez-Canali Chrisiane Gaudebout Cecile Goujard Bruno Hoen Patricia Honore Bernard Jarousse Jean-Marie Lang Benedict Lefebvre Yves Levy Jocelyne Loison Aline Maignan Jean-Luc Meynard Christophe Michon Martin Mole Laurence Marsal Sophie Matheron Emmanuel Mortier Eric Oksenhendler Sandrine Poirier Catherine Picard-Dahan Isabelle Ravaux Francois Raffi Gilles Raguin Jacque Reynes Willy Rozenbaum Dominique Salmon Anne Simon Gabriella Spiridon Jean-Paul Viard Michele Vidal Laurence Weiss David Zucman Frank Bergmann Norbert Brockmeyer Gerd Faetkenheuer Stefan Fenske Daniela Gey Frank-Detlef Goebel Martina Goetsch Martin Hartmann Hartwig Klinker Gisela Kremer Kathleen Mantzsch Stefan Mauss Juergen Rockstroh Jessica Rotty Ellen Rund Katrin Schneider Dirk Schuermann Schlomo Staszweski Klaus Tilmann Martin Vogel Zvi Bentwich Goldstain Drora Eynat Kedem Ruth Lang Itzic Levi Shlomo Maayan Eli Magen Merav Mamorsky Anat Pilpul Shimon Pollack Zev Sthoeger Hadas Vered Israel Yust Fiona Mulcahy Fernando Auiti Gioacchino Angarano Davide Bertelli Teresa Bini Raffaele Bruno Gian Pietro Cadeo Giampietro Carosi Antonella D'Arminio Monforte Sergio Del Giacco Massimo Di Pietro Roberto Esposito Gaetano Filice Gabriella Gavazzeni Giovanni Guaraldi Francesco Indiveri Adriano Lazzarin Francesco Mazzotta Lorenzo Minolli Maria Montroni Mauro Moroni Silvia Nozza Guiseppe Pastor Guido Poli Enzo Raise Sergio Romagnani Vega Rusconi Paolo Sacchi Fredy Suter Giuseppe Tambussi Umberto Tirelli Helen Fraser Aikichi Iwamoto Yoshida Kikuchi Masahiko Mori Tetsuya Nakamura Takashi Odawara Shinichi Oka Takuma Shirasaka Misao Takano Junichiro To Chisato Ueta W. Blok J. Borleffs B. Bravenboer W. Bronveld F. Claessen Maurice Duurvoort J. Ferwerda P. Frissen Nicolette Hulshoff Job Juttman R. Kauffmann P. Koopmans F. Kroon Selwyn Lowe M. Leemhuis P. Meenhorst Lieselotte Posthuma de Boer Peter Reiss S. Reinders-Folmer C. Richter Rick Santegoets Marijke Schoemaker G. Schrey Herman Sprenger Jacob Ten Veen Judith Tessalaar M. van der Ende H. van der Vall Arne van Eeden Remko van Leeuwen Joost Vermeulen Reinier W. ten Kate Renee van Boxtel Arne van Eden Bernadette van de Ven Piet van der Meulen C. ten Napei R. Vriesendrop Johann Bruun Elzbieta Bakowska Marek Beniowski Anna Boron-Kaczmarska Jacek Gasiorowski Andrzej Gxadysz Andrzej Horban Brygida Knysz Elzbieta Mularska Magdelena Pynka Aleksandra Szymczak Isabel Aldir Francisco Antunes Manuela Doroana Luis Duque Kamal Mansinho Inez Pinto Emilia Valadas Jose Vera Estelle Foo Anushia Panchalingham Poh Lian Lim Nick Paton Bernard Peperstraete Angela Quek Rosario Alcazar-Caballero Julio Arrizabalaga Emilio Bouza Concepcion Cepeda Xabier de Barron Miguel Cervero Jimenez Bonaventura Clotet Luis Cortes Pere Domingo Pompeyo Fernandez Eduardo Fernandez-Cruz Montserrat Fuster Jose Gatell Paloma Gijon Ignacio Gil Juan Gonzales-Lahoz Alicia Gonzalez Manuel Hernandez Jose Iribarren Miguel Jimenez Hernando Knobel Agathe Leon Juan Carlos Lopez Angeles Lozano Paco Lopez Jose Moreno Rosa Munoz Belen Padilla Angeles Parras Antoni Pastor Jose Pedreira Julio Pristo Jose Pena Victor Roca Rafael Rubio Jose Sanchez de Rivera Jesus Sanz Lara Tamargo Rafael Torres Pehr O. Pehrson Eric Sandstrom Enos Bernasconi Vanina Gurtner Lorenzo Magenta Uangarun Ampunpong Chureeratana Bowonwatnuwong Patimoaporn Chanchai Ploenchan Chetchotisakd Thesinee Chuenyam Chris Duncombe Mannassinee Horsakulthai Pacharee Kantipong John Liddy Praphan Phanuphak Vithaya Pongsurachet Kiat Ruxrungtham Samroeng Seekaew Areerat Sonjai Nuramon Subsri Surapol Suwanagool Wichai Techasathit Jaturaporn Wankoon Aderonke Adebiyi Diana Aldam Ian Alexander Tristan Barber Sue Bonnington Chris Care Anne Carroll David Cornforth Oscar Donaldson Laurance Druiff Philippa Easterbrook Beverley Edwards Chris Ellis Ikbale Erradey Kamal El Filali Martin Fisher Ray Fox Brian Gazzard Allan Harrison Sandra Herman Lisa Heald Christopher Higgs Hakima Himmich Isabelle Jendrulek Margaret Johnson Lucy Judges Fatimah Karim George Kinghorn Julie Laurenti Christine Lee Clifford Leen Ken Legg Fiona Lyons Raymond Maw Alisdair MacConachie Sinead McKernan Lorna McLean Andrew McMillan Sifiso Mguni Sheila Morris Fiona Mulchay Dee Mullan Scott Mullaney Maurice Murphy Andrew Nunn Edmund Ong Maxine Owen Adrian Palfreeman Nicky Perry Barry Peters Anton Pozniak Annette Rochford Agnes Ronan Cecilia Skinner Carol Stroud Martin Takawira Norbert Tamm Rachel Thomas Thynn Thynn Yee An Vanthuyne Mark Wansborough-Jones Jonathan Weber David White Ed Wilkins Martin Wiselka Ian Williams Mike Waugh Joyce Wotherspoon Mike Youle Margaret Doyle Roberta Luskin-Hawk Rita Verheggen John Baxter C. Lynn Besch Carroll Child David Cohn Pam Cooper Martha Farrough Evelyn Fisher Luis Fuentes Edward Goodwin Carol Graeber Jay Kostman Kelly Lattanzi Rodger MacArthur Linda Makohon Norman P. Markowitz Diane Mastro-Polak Vinnie Mitchell David Mushatt Kathryn Patterson George Perez Corey Rosmarin Jack R. Rouff Jennifer Saldanha Robert Sawyer James Sullivan Bentley Sweeton Ellen Tedaldi Melanie Thompson Patricia Valencia Gwen Verlinghieri Janice Walker Vicky Watson Bruce Williams Adam Armstrong Susan Banks David Blazes Anthony Barile Linda Coelho Marilyn Dennis Hannah Flaks Joyce Gilcrest Kathleen Gittens Shelia Hopper M. J. Humphries Katherine Spooner Cindy L. Tamminga Jean Vita Scott A. Wegner Glenn Wortmann Nicole Bisby William Blake Sheldon Brown Phillippe Chilliade Teresa Cole Katherine Elliot Christiane Geisler Matthew Goetz Elizabeth Gomez-Perez Fred Gordin Jami Helman Nancy Klimas Ann Labriola Ronald Nahass Dirk LeFlore Barbara Marston Maria Obregon Jennifer Petrolati David L. Pitrak Robert Roland Carol Rosa Barbara Rossman Susan Schlueter Wirtz Suzanne Schuck Tiffany Scretchings Gary Simon Mack Smith Barbara Standridge Kimberley Summers Mary Jo Werhane Roberto Arduino Brian Bell Katherine Breaux Hilda Cuervo Carl Hale Stanley Lewis Mark Mall Fransisco Mora Martine M. Diez Pablo Okhuysen Maria Rodriguez-Barradas Shannon R. Schrader Lynn Healy Chris Kaszubski Michael Kolber Tom Tanner Joann Armstrong Jennifer Dahlke Leonard Johnson Patricia Kaminski Cheryl Shoden Zelalem Temesgen Marcy Urbanich Sharon Valenti Marcus Zervos Rick Davey Bill Barrick Doreen Chaitt Barbara Hahn Cliff Lane Dennis Martell Laura McNay Julia Metcalf April Powers Jorge A. Tavel Karen Loveless Norma Martinez Sue Peterson James Sampson Suzanne Sweek Donald Abrams Helmut Albrecht Nicole Antoine Mary Ellen Kelly Paula Pell Waldo Belloso Jose Maria Gatell Jenny Hoy Court Pederson Frank Rhame Wafaa El-Sadr Liselotte Borup Ulrik Bak Dragsted Anne Fau Greve Karoline Jensen Jens Lundgren David Mollerup Mary Pearson Andrew Phillips Jamila Aboulhab Brian Angus Abdel Babiker Brooke Cordwell Janet Darbyshire Lisa Hack Malcolm Hooker Yolanda Moraes Douglas Newberry Harriet Nuwagaba-Biribonwoha Fionna van Hooff Eileen Denning Leslie Holland Klemme Cate Carey Fonnie Chan David Cooper David Courtney-Rodgers Fraser Drummond Sean Emery Simone Jacoby Matthew Law Morgan Stewart Sarah Pett Zarina Alloo Judy Bebchuk Patty Bollenbeck Alain G. DuChene Lisa Fosdick Merrie Harrison Eric Krum Gregg Larson Alan Lifson Sue Meger James Neaton Ray Nelson Siu-Fun L. Quan Terri Schultz Susan Telke Lisa Thackeray Greg Thompson Deborah Wentworth Nicole Wyman William Duncan Elaine Ferguson Lawrence Fox Nikki Gettinger Janet Herrera Sandra Lehrman Mary Anne Luzar Mieko Maeshiro Ana Martinez Karen Oseekey Greg Baigent William Capra Anne-Marie Duliege Linda Fitzgerald Marthin Kwakkelstein Jean Maral Mary O'Hara David Sahner Claire Weber Christine Adam-Perchec Nigel Barron Mary Louise Bell Sandra Dolan Julie Eckstrand Steven Hicks George McAuley Sharon Beck Shawn Brown Adam Rupert |
2007 | ||||
| 51. | Consensus guidelines for dosing of amoxicillin-clavulanate in melioidosis. | Cheng, AC Chierakul, W Chaowagul, W Chetchotisakd, P Limmathurotsakul, D Dance, DA Peacock, SJ Currie, BJ |
2008 | ||||
| 52. | Fungemia in Non-HIV-infected Patients: A 5-Year Review | S. Anunnatsiri P. Chetchotisakd P. Mootsikapun |
2008 | ||||
| 53. | Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents: the recommendations of the Thai AIDS Society (TAS) 2008. | Sungkanuparph, S. Anekthananon, T. Bowonwatanuwong, C. Supparatpinyo, K. Mootsikapun, P. Chetchotisakd, P. Kiertiburanakul, S. Tantisiriwat, W. Ruxrungtham, K. |
2008 | ||||
| 54. | IMPACT OF PATIENT-HEALTH CARE PROVIDER COMMUNICATION: THE HIV/AIDS PATIENTS' PERSPECTIVES | M. R. Layton S. J. Kerr P. Chetchotisakd |
2008 | ||||
| 55. | Interruptions of tenofovir/emtricitabine-based antiretroviral therapy in patients with HIV/hepatitis B virus co-infection | Nüesch, R Ananworanich, J Srasuebkul, P Chetchotisakd, P Prasithsirikul, W Klinbuayam, W Mahanontharit, A Jupimai, T Ruxrungtham, K Hirschel, B |
2008 | ||||
| 56. | Long-term efficacy and safety of first-line therapy with once-daily saquinavir/ritonavir | Jintanat Ananworanich Angele Gayet-Ageron Kiat Ruxrungtham Ploenchan Chetchotisakd Wisit Prasithsirikul Sasisopin Kiertiburanakul Warangkana Munsakul Phitsanu Rakasakulkarn Somboon Tansuphasawadikul Michelle LeBraz Thidarat Jupimai Sasiwimol Ubolyam Malte Schutz Bernard Hirschel |
2008 | ||||
| 57. | Low-dose, once-daily atazanavir/ritonavir (200/100): an effective treatment for HIV-infected patients in Thailand. | Ploenchan Chetchotisakd Siriluck Anunnatsiri |
2008 | ||||
| 58. | Mycotic aneurysm in northeast Thailand: The importance of Burkholderia pseudomallei as a causative pathogen | Anunnatsiri, S Chetchotisakd, P Kularbkaew, C |
2008 | ||||
| 59. | Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study | Molina, JM Andrade-Villanueva, J Echevarria, J Chetchotisakd, P Corral, J David, N Moyle, G Mancini, M Percival, L Yang, R Thiry, A McGrath, D , |
2008 | ||||
| 60. | Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and erntricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study | Jean-Michel Molina Jaime Andrade-Villanueva Juan Echevarria Ploenchan Chetchotisakd Jorge Corral Neal David Graeme Moyle Marco Mancini Lisa Percival Rong Yang Alexandra Thiry Donnie McGrath |
2008 | ||||
| 61. | Short report: Consensus guidelines for dosing of amoxicillin-clavulanate in melioidosis | Allen C. Cheng Wirongrong Chierakul Wipada Chaowagul Ploenchan Chetchotisakd Direk Limmathurotsakul David A. B. Dance Sharon J. Peacock Bart J. Currie |
2008 | ||||
| 62. | A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis. | Peter G. Pappas Ploenchan Chetchotisakd Robert A. Larsen Weerawat Manosuthi Michele I. Morris Thomansak Anekthananon Somnuek Sungkanuparph Khauncahi Supparatpinyo Tracy L. Nolen Louise O. Zimmer Amy S. Kendrick Phillip Johnson Jack D. Sobel Scott G. Filler |
2009 | ||||
| 63. | Cryptococcal Immune Reconstitution Inflammatory Syndrome after Antiretroviral Therapy in AIDS Patients with Cryptococcal Meningitis: A Prospective Multicenter Study | Sungkanuparph, S. Chetchotisakd, P. Nolen, T.L. Anekthananon, T. Morris, M.I. Supparatpinyo, K. Kendrick, A.S. Johnson, P.C. |
2009 | ||||
| 64. | Effect of high-dose fluconazole on QT interval in patients with human immunodeficiency virus (HIV)-associated cryptococcal meningitis | Weerawat Manosuthi Somnuek Sungkanuparph Thanomsak Anekthananon Khuanchai Supparatpinyo Tracy L. Nolen Louise O. Zimmer Peter G. Pappas Robert A. Larsen Scott G. Filler Ploenchan Chetchotisakd |
2009 | ||||
| 65. | Fungemia in non-HIV-infected patients: a five-year review. | Siriluck Anunnatsiri Ploenchan Chetchotisakd Piroon Mootsikapun |
2009 | ||||
| 66. | Phenotypic and functional characterization of human memory T cell responses to Burkholderia pseudomallei. | Tippayawat, P. Saenwongsa, W. Mahawantung, J. Suwannasaen, D. Chetchotisakd, P. Limmathurotsakul, D. Peacock, S.J. Felgner, P.L. Atkins, H.S. Titball, R.W. Bancroft, G.J. Lertmemongkolchai, G. |
2009 | ||||
| 67. | Phenotypic and Functional Characterization of Human Memory T Cell Responses to to Burkholderia pseudomallei | Patcharaporn Tippayawat Wipawee Saenwongsa Jirawan Mahawantung Duangchan Suwannasaen Ploenchan Chetchotisakd Direk Limmathurotsakul Sharon J. Peacock Philip L. Felgner Helen S. Atkins Richard W. Titball Gregory J. Bancroft Ganjana Lertmemongkolchai |
2009 | ||||
| 68. | The CASTLE study: Atazanavir/r versus lopinavir/r in antiretroviral-naive patients | Chetchotisakd, P | 2009 | ||||
| 69. | The impact of combination antiretroviral therapy and its interruption on anxiety, stress, depression and quality of life in thai patients | Nüesch, R Gayet-Ageron, A Chetchotisakd, P Prasithsirikul, W Kiertiburanakul, S Munsakul, W Raksakulkarn, P Tansuphasawasdikul, S Chautrakarn, S Ruxrungtham, K Hirschel, B Anaworanich, J , |
2009 | ||||
| 70. | Use of a low-dose steroid as an adjunct in the treatment, in mice, of severe sepsis caused by Burkholderia pseudomallei. | P. Panomket P. Chetchotisakd R. W. Sermswan P. Pannengpetch S. Wongratanacheewin |
2009 | ||||
| 71. | Effects of intermittent IL-2 alone or with peri-cycle antiretroviral therapy in early HIV infection: The STALWART study | Gey, D.C. López, J.C.A. Munroe, D.L. Ruxrungtham, K. Wentworth, D. Wyman, N. Grarup, J. Reilev, S. Braimah, N. Horton, J. Cooper, D.A. Courtney-Rodgers, D. Nelson, R. Haerry, D.H.U. Meulbroek, M. Watson, J. Chaisson, R.E. Kim, K. Kelly, M.D. Chetchotisakd, P. Winston, A. Nixon, D.E. |
2010 | ||||
| 72. | Increasing Incidence of Human Melioidosis in Northeast Thailand | Limmathurotsakul, D Wongratanacheewin, S Teerawattanasook, N Wongsuvan, G Chaisuksant, S Chetchotisakd, P Chaowagul, W Day, NP Peacock, SJ |
2010 | ||||
| 73. | International collaboration between US and Thailand on a clinical trial of treatment for HIV-associated cryptococcal meningitis. | L. O. Zimmer T. L. Nolen S. Pramanpol D. Wallace M. E. Walker P. Pappas P. Chetchotisakd |
2010 | ||||
| 74. | Melioidosis pericarditis mimicking tuberculous pericarditis. | Chetchotisakd, P. Anunnatsiri, S. Kiatchoosakun, S. Kularbkaew, C. |
2010 | ||||
| 75. | Monitoring and impact of fluconazole serum and cerebrospinal fluid concentration in HIV-associated cryptococcal meningitis-infected patients | Chetchotisakd, P. Nolen, T.L. Sungkanuparph, S. Anekthananon, T. Supparatpinyo, K. |
2010 | ||||
| 76. | Once-daily atazanavir/ritonavir compared with twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 96-week efficacy and safety results of the CASTLE study. | Jean-Michel Molina Jaime Andrade-Villanueva Juan Echevarria Ploenchan Chetchotisakd Jorge Corral Neal David Graeme Moyle Marco Mancini Lisa Percival Rong Yang Victoria Wirtz Max Lataillade Judith Absalon Donnie McGrath |
2010 | ||||
| 77. | Etravirine and rilpivirine resistance in HIV-1 subtype CRF01-AE-infected adults failing non-nucleoside reverse transcriptase inhibitor-based regimens | Bunupuradah, T. Ananworanich, J. Chetchotisakd, P. Jirajariyavej, S. Munsakul, W. Prasithsirikul, W. Sungkanuparph, S. Bowonwattanuwong, C. Klinbuayaem, V. Bhakeecheep, S. Ruxrungtham, K. |
2011 | ||||
| 78. | Etravirine and rilpivirine resistance in HIV-1 subtype CRF01_AE-infected adults failing non-nucleoside reverse transcriptase inhibitor-based regimens. | Torsak Bunupuradah Jintanat Ananworanich Ploenchan Chetchotisakd Pacharee Kantipong Supunnee Jirajariyavej Sunee Sirivichayakul Warangkana Munsakul Wisit Prasithsirikul Somnuek Sungkanuparph Chureeratana Bowonwattanuwong Virat Klinbuayaem Kathy Petoumenos Bernard Hirschel Sorakij Bhakeecheep Kiat Ruxrungtham |
2011 | ||||
| 79. | Predictors of poor clinical outcome of cryptococcal meningitis in HIV-infected patients | Anekthananon, T Manosuthi, W Chetchotisakd, P Kiertiburanakul, S Supparatpinyo, K Ratanasuwan, W Pappas, PG Filler, SG Kopetskie, HA Nolen, TL Kendrick, AS Larsen, RA , |
2011 | ||||
| 80. | Adult-onset immunodeficiency in Thailand and Taiwan | Sarah K. Browne Peter D. Burbelo Ploenchan Chetchotisakd Yupin Suputtamongkol Sasisopin Kiertiburanakul Pamela A. Shaw Jennifer L. Kirk Kamonwan Jutivorakool Rifat Zaman Li Ding Amy P. Hsu Smita Y. Patel Kenneth N. Olivier Viraphong Lulitanond Piroon Mootsikapun Siriluck Anunnatsiri Nasikarn Angkasekwinai Boonmee Sathapatayavongs Po-Ren Hsueh Chi-Chang Shieh Margaret R. Brown Wanna Thongnoppakhun Reginald Claypool Elizabeth P. Sampaio Charin Thepthai Duangdao Waywa Camilla Dacombe Yona Reizes Adrian M. Zelazny Paul Saleeb Lindsey B. Rosen Allen Mo Michael Iadarola Steven M. Holland |
2012 | ||||
| 81. | A randomized comparison of second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir in patients failing NNRTI regimens: The HIV STAR study | Torsak Bunupuradah Ploenchan Chetchotisakd Jintanat Ananworanich Warangkana Munsakul Supunnee Jirajariyavej Pacharee Kantipong Wisit Prasithsirikul Somnuek Sungkanuparph Chureeratana Bowonwatanuwong Virat Klinbuayaem Stephen J. Kerr Jiratchaya Sophonphan Sorakij Bhakeecheep Bernard Hirschel Kiat Ruxrungtham |
2012 | ||||
| 82. | A randomized comparison of second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir in patients failing NNRTI regimens: The HIV STAR study (Antiviral Therapy (2012) DOI: 10.3851/IMP2443) | Bunupuradah, T. Chetchotisakd, P. Ananworanich, J. Munsakul, W. Jirajariyavej, S. Prasithsirikul, W. Sungkanuparph, S. Bowonwatanuwong, C. Klinbuayaem, V. Sophonphan, J. Bhakeecheep, S. Ruxrungtham, K. |
2012 | ||||
| 83. | Assessing adherence in Thai patients taking combination antiretroviral therapy | Kerr, SJ Avihingsanon, A Putcharoen, O Chetchotisakd, P Layton, M Ubolyam, S Ruxrungtham, K Cooper, DA Phanuphak, P Duncombe, C |
2012 | ||||
| 84. | Cobicistat versus ritonavir as pharmacoenhancers in combination with atazanavir plus tenofovir disoproxil fumarate/emtricitabine: phase 3 randomized, double blind, active-controlled trial, week 48 results | J. Gallant E. Koenig J. Andrade-Villanueva P. Chetchotisakd E. Dejesus F. Antunes K. Arasteh G. Moyle G. Rizzardini J. Fehr Y-P. Liu L. Zhong C. Callebaut S. Ramanathan J. Szwarcberg M. Rhee A. Cheng |
2012 | ||||
| 85. | Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the phase III randomized, double-blind ECHO and THRIVE trials | Clumeck, N.N. Abusamra, L. Ceriotto, M. Henry, K. Leider, J.M. Ortiz, R. Scribner, A.N. Sloan, L.M. Martínez, P.G. Vetter, N. Pilotto, J.H.S. Rangel, F. Boissonnault, M. Macleod, J. Winston, A. David, N. Botes, M.E. Mohapi, L. Chetchotisakd, P. Sungkanuparph, S. Hodder, S.L. Wilkin, A.M. Wu, H. |
2012 | ||||
| 86. | Emergence of NDM-1-and IMP-14a-producing Enterobacteriaceae in Thailand | Rimrang, B. Chanawong, A. Lulitanond, A. Lulitanond, V. Wilailuckana, C. Charoensri, N. Sribenjalux, P. Phumsrikaew, W. Wonglakorn, L. Kerdsin, A. Chetchotisakd, P. |
2012 | ||||
| 87. | Neurocognitive impairment in patients randomized to second-line lopinavir/ritonavir-based antiretroviral therapy vs. lopinavir/ritonavir monotherapy | Torsak Bunupuradah Ploenchan Chetchotisakd Supunnee Jirajariyavej Victor Valcour Chureeratana Bowonwattanuwong Warangkana Munsakul Virat Klinbuayaem Wisit Prasithsirikul Jiratchaya Sophonphan Apicha Mahanontharit Bernard Hirschel Sorakij Bhakeecheep Kiat Ruxrungtham Jintanat Ananworanich |
2012 | ||||
| 88. | New Delhi metallo-beta-lactamase-1 (NDM-1)-producing Enterobacteriaceae: first report in Thailand | B. Rimrang A. Chanawong A. Lulitanond C. Wilailuckana N. Charoensri P. Sribenjalux W. Phumsrikaew L. Wonglakorn P. Chetchotisakd |
2012 | ||||
| 89. | Pooled Week 96 efficacy and safety results from the double-blind, randomised, Phase III trials comparing rilpivirine (RPV;TMC278) versus efavirenz (EFV) in treatment-naive, HIV-1-infected adults | C. Orkin C. Cohen J-M Molina I. Cassetti P. Chetchotisakd A. Lazzarin F. Rhame H. J. Stellbrink L. Taisheng H. Crauwels L. Rimsky S. Vanveggel P. Williams K. Boven |
2012 | ||||
| 90. | Cobicistat versus ritonavir as a pharmacoenhancer of atazanavir plus emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV type 1-infected patients: week 48 results. | Joel E. Gallant Ellen Koenig Jaime Andrade-Villanueva Ploenchan Chetchotisakd Edwin DeJesus Francisco Antunes Keikawus Arasteh Graeme Moyle Giuliano Rizzardini Jan Fehr Yapei Liu Lijie Zhong Christian Callebaut Javier Szwarcberg Martin S. Rhee Andrew K. Cheng |
2013 | ||||
| 91. | Week 96 efficacy and safety of rilpivirine in treatment-naive, HIV-1 patients in two Phase III randomized trials | Calvin J. Cohen Jean-Michel Molina Isabel Cassetti Ploenchan Chetchotisakd Adriano Lazzarin Chloe Orkin Frank Rhame Hans-Juergen Stellbrink Taisheng Li Herta Crauwels Laurence Rimsky Simon Vanveggel Peter Williams Katia Boven |
2013 | ||||
| 92. | Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): A randomised, double-blind, placebo-controlled, non-inferiority trial | Cooper, D.A. Phanuphak, P.P. Winston, A. Clarke, A.T. Delfino, M. Kaew-On, P. Taylor, J.L. Calanni, L. Chetchotisakd, P. Contarelli, J. Kelly, M.D. Messina, O.G. Mohapi, L. Supparatpinyo, K. Smith, D.E. Kelleher, T. Yeung, J. Shaik, A. Dunn, D. |
2014 | ||||
| 93. | Ergotism in Thailand caused by increased access to antiretroviral drugs: a global warning. | Avihingsanon, A. Suwanpimolkul, G. Chetchotisakd, P. Bowonwatanuwong, C. Jirajariyavej, S. Tantipong, H. Ohata, J. Ruxrungtham, K. Burger, D.M. |
2014 | ||||
| 94. | Linezolid in the treatment of disseminated nontuberculous mycobacterial infection in anti-interferon-gamma autoantibody-positive patients. | Chetchotisakd, P. Anunnatsiri, S. |
2014 | ||||
| 95. | Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial | Chetchotisakd, P Chierakul, W Chaowagul, W Anunnatsiri, S Phimda, K Mootsikapun, P Chaisuksant, S Pilaikul, J Thinkhamrop, B Phiphitaporn, S Susaengrat, W Toondee, C Wongrattanacheewin, S Wuthiekanun, V Chantratita, N Thaipadungpanit, J Day, NP Limmathurotsakul, D Peacock, SJ |
2014 | ||||
| 96. | Atazanavir/ritonavir 200/100 mg is non-inferior to atazanavir/ritonavir 300/100 mg in virologic suppressed HIV-infected Thai adults: a multicentre, randomized, open-label trial: LASA | Torsak Bunupuradah Sasisopin Kiertiburanakul Anchalee Avihingsanon Ploenchan Chetchotisakd Malee Techapornroong Niramon Leerattanapetch Pacharee Kantipong Chureeratana Bowonwatanuwong Sukit Banchongkit Virat Klinbuayaem Sripetcharat Mekviwattanawan Sireethorn Nimitvilai Supunnee Jirajariyavej Wisit Prasithsirikul Warangkana Munsakul Sorakij Bhakeecheep Sushada Chaivooth Praphan Phanuphak David A. Cooper Tanakorn Apornpong Stephen J. Kerr Sean Emery Kiat Ruxrungtham |
2015 | ||||
| 97. | Brief Report: Cobicistat Compared With Ritonavir as a Pharmacoenhancer for Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate: Week 144 Results. | Gallant, JE Koenig, E Andrade-Villanueva, JF Chetchotisakd, P DeJesus, E Antunes, F Arastéh, K Rizzardini, G Fehr, J Liu, HC Abram, ME Cao, H Szwarcberg, J |
2015 | ||||
| 98. | Cerebrospinal fluid exposure of efavirenz and its major metabolites when dosed at 400 mg and 600 mg once daily: A randomized controlled trial | Alan Winston Janaki Amin Amanda Clarke Laura Else Alieu Amara Andrew Owen Tristan Barber Heiko Jessen Anchalee Avinghsanon Ploenchan Chetchotisakd Saye Khoo David A. Cooper Sean Emery Rebekah Puls |
2015 | ||||
| 99. | Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection: A case control study | Grarup, J. Reilev, S. Angus, B.J. Horton, J. Courtney-Rodgers, D. Chaisson, R.E. Angel, E.B. Aquilia, S. Bittar, V. Contarelli, J. Daciuk, L. Galache, V. Guaragna, G. Ivalo, S.A. Lourtau, L.D. Marson, C. Massera, L. Somenzini, C. Tocci, M. Blavius, K. Carrall, L. D'Arcy-Evans, C. Johnston, C. Lowe, K. Patching, J. Price, S. Primrose, R. Prone, I. Roney, J. Sarangapany, J. Smith, D.E. Vale, R. Clumeck, N.N. Montes, M.L. Bowonwatanuwong, C. Chetchotisakd, P. Kelly, M.D. Delfino, M. Nelson, R. Donohue, W. Silvers, J.E. Phanuphak, P.P. Pumpradit, W. Kiertiburanakul, S. Klinbuayaem, V. Mootsikapun, P. Nonenoy, S. Piyavong, B. Prasithsirikul, W. Raksakulkarn, P. Hodder, S.L. Nixon, D.E. |
2015 | ||||
| 100. | Cobicistat Compared With Ritonavir as a Pharmacoenhancer for Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate: Week 144 Results | Chetchotisakd, P. Arastéh, K. Cao, H. |
2015 | ||||
| 101. | Cost-effectiveness analysis of parenteral antimicrobials for acute melioidosis in Thailand | Hantrakun, V Chierakul, W Chetchotisakd, P Anunnatsiri, S Currie, BJ Peacock, SJ Day, NP Cheah, PY Limmathurotsakul, D Lubell, Y |
2015 | ||||
| 102. | Cost-effectiveness analysis of parenteral antimicrobials for acute melioidosis in Thailand (vol 109, pg 416, 2015) | Viriya Hantrakun Wirongrong Chierakul Ploenchan Chetchotisakd Siriluck Anunnatsiri Bart J. Currie Sharon J. Peacock Nicholas P. J. Day Phaik Yeong Cheah Direk Limmathurotsakul Yoel Lubell |
2015 | ||||
| 103. | Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study | Stephen Becker Marta Boffi To Chris Duncombe Andrew Hill Tim Read Jim Rooney Kim Schaff Er Cecilia Abela Janaki Amin Anchalee Avihingsanon Mark Boyd Dianne Carey Amanda Clarke Kymme Courtney-Vega Marina Delfi No Anna Donaldson Sean Emery Natalie Espinosa Tanya Johannesen Enmoore Lin Alejandra Moricz Sarah Pett Praphan Phanupak Rebekah Puls Kanitta Pussadee Parinya Sutheerasak Louise Tomlins Sasiwimol Ubolyam Waldo Belloso Raja Iskandar Shah bin Raja Azwa Emiliano Bissio Liliana Calanni Ploenchan Chetchotisakd David Cooper Brenda Crabtree-Ramirez Nicholas Doong Julian Elliott Sharne Foulkes Brian Gazzard Heiko Jessen Mark Kelly Suresh Kumar Hector Laplume Man-Po Lee Marcelo Losso Norma del Carmen Luna Sergio Lupo Oscar Garcia Messina Lerato Mohapi Richard Moore David Nolan Chidi Nwizu Catherine Orrell Carlos Perez Praphan Phanuphak Tim Read Juergen Rockstroh Diane Rowling Eduardo Shahar Khuanchai Supparatpinyo Don Smith Jaime Andrade Villanueva Emanuel Vlahakis Alan Winston Marcelo Wolff Barnaby Young Tony Kelleher Philip Cunningham Kate Merlin Julie Yeung Ansari Shaik Bertha Fsadni Alex Carrera Melanie Lograsso Roy Gulick David Dunn Matthew Dolan |
2015 | ||||
| 104. | Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2014, Thailand. | Weerawat Manosuthi Sumet Ongwandee Sorakij Bhakeecheep Manoon Leechawengwongs Kiat Ruxrungtham Praphan Phanuphak Narin Hiransuthikul Winai Ratanasuwan Ploenchan Chetchotisakd Woraphot Tantisiriwat Sasisopin Kiertiburanakul Anchalee Avihingsanon Akechittra Sukkul Thanomsak Anekthananon |
2015 | ||||
| 105. | Pilot study of a non-return catheter valve for reducing catheter-associated urinary tract infections in critically ill patients. | Panitchote, A. Charoensri, S. Chetchotisakd, P. Hurst, C.P. |
2015 | ||||
| 106. | Safety of tenofovir alafenamide in renal impairment | A. Pozniak J. Arribas S. Gupta F. Post A. Avihingsanon G. Crofoot K. Lichtenstein M. Ramgopa P. Chetchotisakd P. Benn M. W. Fordyce |
2015 | ||||
| 107. | Serological diagnosis of pulmonary Mycobacterium tuberculosis infection by LIPS using a multiple antigen mixture | Burbelo, PD Keller, J Wagner, J Klimavicz, JS Bayat, A Rhodes, CS Diarra, B Chetchotisakd, P Suputtamongkol, Y Kiertiburanakul, S Holland, SM Browne, SK Siddiqui, S Kovacs, JA |
2015 | ||||
| 108. | Anti-IFN-γ autoantibodies are strongly associated with HLA-DR∗15:02/16:02 and HLA-DQ∗05:01/05:02 across Southeast Asia | Ku, CL Lin, CH Chang, SW Chan, JF Kong, XF Lee, CH Rosen, EA Ding, JY Lee, WI Bustamante, J Witte, T Shih, HP Kuo, CY Chetchotisakd, P Kiertiburanakul, S Suputtamongkol, Y Yuen, KY Casanova, JL Holland, SM Doffinger, R Browne, SK Chih, CY |
2016 | ||||
| 109. | Antiretroviral Resistance After First-Line Antiretroviral Therapy Failure in Diverse HIV-1 Subtypes in the SECOND-LINE Study. | Edward P. Lam Cecilia L. Moore Eduardo Gotuzzo Chidi Nwizu Adeeba Kamarulzaman Ploenchan Chetchotisakd Jean van Wyk Hedy Teppler Nagalingeswaran Kumarasamy Jean-Michel Molina Sean Emery David A. Cooper Mark A. Boyd |
2016 | ||||
| 110. | A qualitative assessment of barriers and facilitators to antiretroviral adherence in Thai patients. | Melissa Phuphanich Maneerat Rattanamahattana Anchalee Avihingsanon Ploenchan Chetchotisakd Opass Putcharoen Monica Gandhi Annette H. Sohn John Imrie Praphan Phanuphak Stephen J. Kerr |
2016 | ||||
| 111. | Clinical features and outcomes of Sweet's syndrome associated with non-tuberculous mycobacterial infection and other associated diseases. | Chaowattanapanit, S. Choonhakarn, C. Chetchotisakd, P. Sawanyawisuth, K. |
2016 | ||||
| 112. | Comparison of community-onset Staphylococcus argenteus and Staphylococcus aureus sepsis in Thailand: A prospective multicentre observational study | Chantratita, N Wikraiphat, C Tandhavanant, S Wongsuvan, G Ariyaprasert, P Suntornsut, P Thaipadungpanit, J Teerawattanasook, N Jutrakul, Y Srisurat, N Chaimanee, P Anukunananchai, J Phiphitaporn, S Srisamang, P Chetchotisakd, P West, TE Peacock, SJ |
2016 | ||||
| 113. | COST-UTILITY ANALYSIS OF ATAZANAVIR/RITONAVIR 200/100 MG VERSUS ATAZANAVIR/RITONAVIR 300/100 MG IN THAI ADULTS WITH VIROLOGIC SUPPRESSION | S. Taychakhoonavudh N. Maneesawangwong T. Bunupuradah S. Kiertiburanakul T. Worrathammasorn P. Hadnorntun A. Avihingsanon P. Chetchotisakd S. Emery K. Ruxrungtham |
2016 | ||||
| 114. | Early Antiretroviral Therapy at High CD4 Counts Does Not Improve Arterial Elasticity: A Substudy of the Strategic Timing of AntiRetroviral Treatment (START) Trial. | Baker, JV Hullsiek, KH Engen, NW Nelson, R Chetchotisakd, P Gerstoft, J Jessen, H Losso, M Markowitz, N Munderi, P Papadopoulos, A Shuter, J Rappoport, C Pearson, MT Finley, E Babiker, A Emery, S Duprez, D , |
2016 | ||||
| 115. | Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in treatment-naive Asian adults | Shinichi Oka Ploenchan Chetchotisakd Amanda Clarke Khuanchai Supparatpinyo Sasisopin Kiertiburanakul Julie Ryu David Piontkowsky Susan Guo Thai Nguyen-Cleary Moupali Das Scott McCallister |
2016 | ||||
| 116. | High-level carbapenem-resistant OXA-48-producing Klebsiella pneumoniae with a novel OmpK36 variant and low-level, carbapenem-resistant, non-porin-deficient, OXA-181-producing Escherichia coli from Thailand | Lunha, K Chanawong, A Lulitanond, A Wilailuckana, C Charoensri, N Wonglakorn, L Saenjamla, P Chaimanee, P Angkititrakul, S Chetchotisakd, P |
2016 | ||||
| 117. | Improvement of lipid profiles when switching from efavirenz to rilpivirine in HIV-infected patients with dyslipidemia. | Chetchotisakd, P. Anunnatsiri, S. Mootsikapun, P. |
2016 | ||||
| 118. | Isavuconazole treatment for mucormycosis: A single-arm open-label trial and case-control analysis | Francisco M. Marty Luis Ostrosky-Zeichner Oliver A. Cornely Kathleen M. Mullane John R. Perfect George R. Thompson George J. Alangaden Janice M. Brown David N. Fredricks Werner J. Heinz Raoul Herbrecht Nikolai Klimko Galina Klyasova Johan A. Maertens Sameer R. Melinkeri Ilana Oren Peter G. Pappas Zdenek Racil Galia Rahav Rodrigo Santos Stefan Schwartz J. Janne Vehreschild Jo-Anne H. Young Ploenchan Chetchotisakd Sutep Jaruratanasirikul Souha S. Kanj Marc Engelhardt Achim Kaufh Masanori Ito Misun Lee Carolyn Sasse Rochelle M. Maher Bernhardt Zeiher Maria J. G. T. Vehreschild |
2016 | ||||
| 119. | Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): a randomised, open-label, non-inferiority trial. | Torsak Bunupuradah Sasisopin Kiertiburanakul Anchalee Avihingsanon Ploenchan Chetchotisakd Malee Techapornroong Niramon Leerattanapetch Pacharee Kantipong Chureeratana Bowonwatanuwong Sukit Banchongkit Virat Klinbuayaem Sripetcharat Mekviwattanawong Sireethorn Nimitvilai Supunnee Jirajariyavej Wisit Prasithsirikul Warangkana Munsakul Sorakij Bhakeecheep Suchada Chaivooth Praphan Phanuphak David A. Cooper Tanakorn Apornpong Stephen J. Kerr Sean Emery Kiat Ruxrungtham |
2016 | ||||
| 120. | Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study | Avihingsanon, A. Chetchotisakd, P. |
2016 | ||||
| 121. | Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study | Boyd, MA Amin, J Mallon, PW Kumarasamy, N Lombaard, J Wood, R Chetchotisakd, P Phanuphak, P Mohapi, L Azwa, I Belloso, WH Molina, JM Hoy, J Moore, CL Emery, S Cooper, DA , |
2017 | ||||
| 122. | Cryptococcosis in Anti-Interferon-Gamma Autoantibody-Positive Patients: a Different Clinical Manifestation from HIV-Infected Patients. | Ploenchan Chetchotisakd Siriluck Anunnatsiri Arnone Nithichanon Ganjana Lertmemongkolchai |
2017 | ||||
| 123. | Imipenem-hydrolyzing beta-lactamase-1 (IMI-1)-producing Enterobacter cloacae isolates from Thailand | K. Lunha A. Chanawong A. Lulitanond C. Wilailuckana N. Charoensri L. Wonglakorn W. Kuvadjanakoon P. Chetchotisakd |
2017 | ||||
| 124. | Molecular Characterization of Carbapenemase-Nonproducing Clinical Isolates of Escherichia coli (from a Thai University Hospital) with Reduced Carbapenem Susceptibility. | Chanawong, A. Sangka, A. Wilailuckana, C. Angkititrakul, S. Charoensri, N. Wonglakorn, L. Chaimanee, P. |
2017 | ||||
| 125. | Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial | Suwanpimolkul, G. Ruxrungtham, K. |
2017 | ||||
| 126. | Patient Characteristics, Management, and Predictors of Outcome from Severe Community-Onset Staphylococcal Sepsis in Northeast Thailand: A Prospective Multicenter Study | West, TE Wikraiphat, C Tandhavanant, S Ariyaprasert, P Suntornsut, P Okamoto, S Mahavanakul, W Srisamang, P Phiphitaporn, S Anukunananchai, J Chetchotisakd, P Peacock, SJ Chantratita, N |
2017 | ||||
| 127. | Superior efficacy of dolutegravir (DTG) plus 2 nucleoside reverse transcriptase inhibitors (NRTIs) compared with lopinavir/ritonavir (LPV/RTV) plus 2 NRTIs in second-line treatment: interim data from the DAWNING study | M. Aboud R. Kaplan J. Lombaard F. Zhang J. Hidalgo E. Mamedova M. Losso P. Chetchotisakd J. Sievers D. Brown J. Hopking M. Underwood M. C. Nascimento M. Gartland K. Smith |
2017 | ||||
| 128. | Thailand national guidelines for the prevention of mother-to-child transmission of HIV 2016 | Chokephaibulkit, K. Phanuphak, N. |
2017 | ||||
| 129. | TLR4 genetic variation is associated with inflammatory responses in Gram-positive sepsis. | Chantratita, N. Srisurat, N. Chaimanee, P. Wongratanacheewin, S. Chetchotisakd, P. Peacock, S.J. |
2017 | ||||
| 130. | Analysis of drug-susceptibility patterns and gene sequences associated with clarithromycin and amikacin resistance in serial Mycobacterium abscessus isolates from clinical specimens from Northeast Thailand | Ananta, P Kham-Ngam, I Chetchotisakd, P Chaimanee, P Reechaipichitkul, W Namwat, W Lulitanond, V Faksri, K |
2018 | ||||
| 131. | Differentiation between persistent infection/colonization and re-infection/re-colonization of Mycobacterium abscessus isolated from patients in Northeast Thailand. | Kham-Ngam, I Chetchotisakd, P Ananta, P Chaimanee, P Reechaipichitkul, W Lulitanond, V Namwat, W Faksri, K |
2018 | ||||
| 132. | Epidemiology of and risk factors for extrapulmonary nontuberculous mycobacterial infections in Northeast Thailand | Chetchotisakd, P. Chaimanee, P. Reechaipichitkul, W. Faksri, K. |
2018 | ||||
| 133. | Haemophilus influenzae infected atrial myxoma: A case report | Thinnakrit Sasiprapha Ploenchan Chetchotisakd |
2018 | ||||
| 134. | Immune Control of Burkholderia pseudomallei-Common, High-Frequency T-Cell Responses to a Broad Repertoire of Immunoprevalent Epitopes | Nithichanon, A. Rinchai, D. Buddhisa, S. Kewcharoenwong, C. Kessler, B. Khaenam, P. Chetchotisakd, P. Robinson, J.H. Reynolds, C.J. Altmann, D.M. Lertmemongkolchai, G. |
2018 | ||||
| 135. | Immune Control of--Common, High-Frequency T-Cell Responses to a Broad Repertoire of Immunoprevalent Epitopes. | Nithichanon, A Rinchai, D Buddhisa, S Saenmuang, P Kewcharoenwong, C Kessler, B Khaenam, P Chetchotisakd, P Maillere, B Robinson, J Reynolds, CJ Boyton, RJ Altmann, DM Lertmemongkolchai, G |
2018 | ||||
| 136. | Implementation of a Test, Treat, and Prevent HIV program among men who have sex with men and transgender women in Thailand, 2015-2016 | Ongwandee, S. Lertpiriyasuwat, C. Khawcharoenporn, T. Chetchotisak, P. Thiansukhon, E. Leerattanapetch, N. Leungwaranan, B. Manopaiboon, C. Phoorisri, T. Visavakum, P. Jetsawang, B. Poolsawat, M. Nookhai, S. Vasanti-Uppapokakorn, M. Karuchit, S. Kittinunvorakoon, C. Mock, P. Prybylski, D. Sukkul, A.C. Roels, T. Martin, M. |
2018 | ||||
| 137. | Increased indoleamine-2,3-dioxygenase activity is associated with poor clinical outcome in adults hospitalized with influenza in the INSIGHT FLU003Plus study | Wentworth, D. Delfino, M. López, P.F. Ruxrungtham, K. Wyman, N. Daciuk, L. Chetchotisakd, P. Clumeck, N.N. |
2018 | ||||
| 138. | Intravenous cyclophosphamide therapy for anti-IFN-gamma autoantibody-associated mycobacterium abscessus infection | Ploenchan Chetchotisakd Siriluck Anunnatsiri Ratanavadee Nanagara Arnone Nithichanon Ganjana Lertmemongkolchai |
2018 | ||||
| 139. | Melioidosis in Thailand: Present and Future | Soawapak Hinjoy Viriya Hantrakun Somkid Kongyu Jedsada Kaewrakmuk Tri Wangrangsimakul Siroj Jitsuronk Weerawut Saengchun Saithip Bhengsri Thantapat Akarachotpong Somsak Thamthitiwat Ornuma Sangwichian Siriluck Anunnatsiri Rasana W. Sermswan Ganjana Lertmemongkolchai Chayada Sitthidet Tharinjaroen Kanya Preechasuth Ratchadaporn Udpaun Poomin Chuensombut Nisarat Waranyasirikul Chanihcha Anudit Surapong Narenpitak Yaowaruk Jutrakul Prapit Teparrukkul Nittaya Teerawattanasook Kittisak Thanvisej Alisa Suphan Punchawee Sukbut Kritchavat Ploddi Poolsri Sirichotirat Bongkoch Chiewchanyon Kamolchanok Rukseree Maliwan Hongsuwan Gumphol Wongsuwan Pornpan Sunthornsut Vanaporn Wuthiekanun Sandy Sachaphimukh Prapass Wannapinij Wirongrong Chierakul Claire Chewapreecha Janjira Thaipadungpanit Narisara Chantratita Sunee Korbsrisate Apichai Taunyok Susanna Dunachie Prasit Palittapongarnpim Stitaya Sirisinha Rungrueng Kitphati Sopon Iamsirithaworn Wipada Chaowagul Ploenchan Chetchotisak Toni Whistler Surasakdi Wongratanacheewin Direk Limmathurotsakul |
2018 | ||||
| 140. | Ocular involvement in melioidosis: a 23-year retrospective review | Yaisawang, S Asawaphureekorn, S Chetchotisakd, P Wongratanacheewin, S Pakdee, P |
2018 | ||||
| 141. | Predictive Validity of qSOFA for Sepsis Among Patients with Community-Onset Staphylococcal Infection and SIRS in Northeast Thailand | S. Gupta K. E. Rudd C. Wikraiphat S. Tandhavanant G. Wongsuwan P. Ariyaprasert P. Suntornsut N. Teerawattanasook Y. Jutrakul N. Srisurat P. Chaimanee J. Anukunananchai S. Phiphitaporn P. Srisamang P. Chetchotisakd C. W. Seymour D. C. Angus S. J. Peacock N. Chantratita T. E. West |
2018 | ||||
| 142. | Differentiation between persistent infection/colonization and re-infection/re-colonization of Mycobacterium abscessus isolated from patients in Northeast Thailand | Chetchotisakd, P. Chaimanee, P. Reechaipichitkul, W. Lulitanond, V. Namwat, W. Faksri, K. |
2019 | ||||
| 143. | Dolutegravir versus ritonavir-boosted lopinavir both with dual nucleoside reverse transcriptase inhibitor therapy in adults with HIV-1 infection in whom first-line therapy has failed (DAWNING): an open-label, non-inferiority, phase 3b trial | Aboud, M Kaplan, R Lombaard, J Zhang, F Hidalgo, JA Mamedova, E Losso, MH Chetchotisakd, P Brites, C Sievers, J Brown, D Hopking, J Underwood, M Nascimento, MC Punekar, Y Gartland, M Smith, K |
2019 | ||||
| 144. | Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in Asian participants with human immunodeficiency virus 1 infection: A sub-analysis of phase 3 clinical trials. | Yeon-Sook Kim Shinichi Oka Ploenchan Chetchotisakd Amanda Clarke Khuanchai Supparatpinyo Anchalee Avihingsanon Winai Ratanasuwan Sasisopin Kiertiburanakul Kiat Ruxrungtham SangYoun Yang Susan Guo YaPei Liu Moupali Das Do Tran Damian McColl Roberto Corales Chris Nguyen David Piontkowsky |
2019 | ||||
| 145. | Influence of and polymorphisms on atazanavir/r concentrations in Thai HIV-infected patients. | Singkham, N Avihingsanon, A Thammajaruk, N Ruxrungtham, K Bunupuradah, T Kiertiburanakul, S Chetchotisakd, P Burger, DM Emery, S Punyawudho, B |
2019 | ||||
| 146. | Influence of CYP3A5 and SLCO1B1 polymorphisms on atazanavir/r concentrations in Thai HIV-infected patients | Ruxrungtham, K. Bunupuradah, T. Kiertiburanakul, S. Chetchotisakd, P. Burger, D.M. Punyawudho, B. |
2019 | ||||
| 147. | Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial. | Rahav, G. Chetchotisakd, P. Lademacher, C. |
2019 | ||||
| 148. | Longer-term (96-week) efficacy and safety of switching to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in women | C. Kityo D. Hagins E. Koenig A. Avihingsanon P. Chetchotisakd K. Supparatpinyo N. Gankina V. Pokrovsky E. Voronin J. L. Stephens E. DeJesus H. Wang R. Acosta D. Brainard H. Martin T. A. Makadzange |
2019 | ||||
| 149. | Natural History of Anti-Interferon-gamma Autoantibody-associated Immunodeficiency Syndrome in Thailand | Gloria H. Hong Ploenchan Chetchotisakd Siriluck Anunnatsiri Piroon Mootsikapun Lindsey B. Rosen Christa S. Zerbe Steven M. Holland |
2019 | ||||
| 150. | Predictive validity of the qSOFA score for sepsis in adults with community-onset staphylococcal infection in Thailand | Supaksh Gupta Kristina E. Rudd Sarunporn Tandhavanant Pornpan Suntornsut Ploenchan Chetchotisakd Derek C. Angus Sharon J. Peacock Narisara Chantratita Timothy Eoin West |
2019 | ||||
| 151. | Switching to Fixed-Dose Bictegravir, Emtricitabine, and Tenofovir Alafenamide (B/F/TAF) in Virologically Suppressed HIV-1 Infected Women: A Randomized, Open-Label, Multicenter, Active-Controlled, Phase 3, Noninferiority Trial | Cissy Kityo Debbie Hagins Ellen Koenig Anchalee Avihingsanon Ploenchan Chetchotisakd Khuanchai Supparatpinyo Natalya Gankina Vadim Pokrovsky Evgeny Voronin Jeffrey L. Stephens Edwin DeJesus Hui Wang Rima K. Acosta Huyen Cao Erin Quirk Hal Martin Tariro Makadzange |
2019 | ||||
| 152. | Diagnosis of NTM active infection in lymphadenopathy patients with anti-interferon-gamma auto-antibody using inhibitory ELISA vs. indirect ELISA | Nithichanon, A Chetchotisakd, P Matsumura, T Takahashi, Y Ato, M Sakagami, T Lertmemongkolchai, G |
2020 | ||||
| 153. | Evaluation of plasma anti-GPL-core IgA and IgG for diagnosis of disseminated non-tuberculous mycobacteria infection. | Arnone Nithichanon Waraporn Samer Ploenchan Chetchotisakd Chidchamai Kewcharoenwong Manabu Ato Ganjana Lertmemongkolchai |
2020 | ||||
| 154. | Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15-25 years: A phase IV randomized comparative study | Folschweiller, N Teixeira, J Joshi, S Goldani, LZ Supparatpinyo, K Basu, P Chotpitayasunondh, T Chetchotisakd, P Ruxrungtham, K Roteli-Martins, C Grinsztejn, B Quintana, SM Kumarasamy, N Poongulali, S Kulkarni, V Lin, L Datta, SK Descamps, D Dodet, M Dubin, G Friel, D Hezareh, M Karkada, N Meric Camilleri, D Poncelet, S Salaun, B Tavares-da-Silva, F Thomas-Jooris, F Struyf, F |
2020 | ||||
| 155. | Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15–25 years: A phase IV randomized comparative study | Supparatpinyo, K. Basu, P.S.A. Chetchotisakd, P. Ruxrungtham, K. Poongulali, S. |
2020 | ||||
| 156. | Natural history and evolution of anti-interferon-? autoantibody-associated immunodeficiency syndrome in Thailand and the United States | Chetchotisakd, P. Mootsikapun, P. Rosen, L.B. |
2020 | ||||
| 157. | Natural History and Evolution of Anti-Interferon-gamma Autoantibody-Associated Immunodeficiency Syndrome in Thailand and the United States | Hong, GH Ortega-Villa, AM Hunsberger, S Chetchotisakd, P Anunnatsiri, S Mootsikapun, P Rosen, LB Zerbe, CS Holland, SM |
2020 | ||||
| 158. | A Comparison Between 12 Versus 20 Weeks of Trimethoprim-sulfamethoxazole as Oral Eradication Treatment for Melioidosis: An Open-label, Pragmatic, Multicenter, Non-inferiority, Randomized Controlled Trial | Anunnatsiri, S Chaowagul, W Teparrukkul, P Chetchotisakd, P Tanwisaid, K Khemla, S Narenpitak, S Pattarapongsin, M Kongsawasd, W Pisuttimarn, P Thipmontree, W Mootsikapun, P Chaisuksant, S Chierakul, W Day, NPJ Limmathurotsakul, D |
2021 | ||||
| 159. | Antibiotic Prophylaxis Prior to Urodynamic Study in Patients with Neurogenic Bladder and Asymptomatic Bacteriuria: A Randomized Controlled Trial | Chetchotisakd, P. Kharmwan, S. |
2021 | ||||
| 160. | Antibiotic susceptibility of clinical burkholderia pseudomallei isolates in northeast thailand from 2015 to 2018 and the genomic characterization of β-lactam-resistant isolates | Shirley Yi Fen Hii Sarunporn Tandhavanant Rungnapa Phunpang Peeraya Ekchariyawat Natnaree Saiprom Claire Chewapreecha Rathanin Seng Ekkachai Thiansukhon Chumpol Morakot Narongchai Sangsa Sunee Chayangsu Somchai Chuananont Kittisak Tanwisaid Wirayut Silakun Noppol Buasi Seksan Chaisuksant Tanin Hompleum Ploenchan Chetchotisakd Nicholas P. J. Day Wasun Chantratita Ganjana Lertmemongkolchai T. Eoin West Narisara Chantratita |
2021 | ||||
| 161. | Assessment of in vitro activities of novel modified antimicrobial peptides against clarithromycin resistant Mycobacterium abscessus. | Sirichoat, A. Chetchotisakd, P. Kanthawong, S. Faksri, K. |
2021 | ||||
| 162. | Factors Associated with Microbiological Outcomes to Colistin in Patients with Multidrug-resistant Gram-Negative Bacterial Infections | Anutrakulchai, S. Chetchotisakd, P. |
2021 | ||||
| 163. | Pharmacogenetics-based population pharmacokinetic analysis for dose optimization of ritonavir-boosted atazanavir in Thai adult HIV-infected patients. | Noppaket Singkham Anchalee Avihingsanon Richard C. Brundage Angela K. Birnbaum Narukjaporn Thammajaruk Kiat Ruxrungtham Torsak Bunupuradah Sasisopin Kiertiburanakul Ploenchan Chetchotisakd Baralee Punyawudho |
2021 | ||||
| 164. | Reducing antibiotic treatment duration for ventilator-associated pneumonia (REGARD-VAP): a trial protocol for a randomised clinical trial. | West, E.E. Chetchotisakd, P. Tambyah, P.A.N. Limmathurotsakul, D. |
2021 | ||||
| 165. | High rate of reinfection and possible transmission of complex in Northeast Thailand. | Boonjetsadaruhk, W Kaewprasert, O Nithichanon, A Ananta, P Chaimanee, P Salao, K Phoksawat, W Laohaviroj, M Sirichoat, A Fong, Y Wongwajana, S Namwat, W Lulitanond, V Chetchotisakd, P Faksri, K |
2022 | ||||
| 166. | High rate of reinfection and possible transmission of Mycobacterium avium complex in Northeast Thailand | Nithichanon, A. Ananta, P. Chaimanee, P. Salao, K. Phoksawat, W. Laohaviroj, M. Sirichoat, A. Wongwajana, S. Namwat, W. Lulitanond, V. Chetchotisakd, P. Faksri, K. |
2022 | ||||
| 167. | Pharmacogenetics-based population pharmacokinetic analysis for dose optimization of ritonavir-boosted atazanavir in Thai adult HIV-infected patients | Ruxrungtham, K. Bunupuradah, T. Kiertiburanakul, S. Chetchotisakd, P. Punyawudho, B. |
2022 | ||||
| 168. | Rank correlation inferences for clustered data with small sample size | Chetchotisakd, P. | 2022 | ||||
| 169. | Varicella zoster meningitis following COVID-19 vaccination: a report of two cases. | Kotruchin, P. Mootsikapun, P. Chetchotisakd, P. |
2022 | ||||
| 170. | Virological outcomes and metabolic effects after switching from ritonavir-boosted protease inhibitors to a dolutegravir-based regimen in virologically suppressed patients living with HIV. | Sribenjalux, W Nuntawit, T Meesing, A Chetchotisakd, P |
2022 | ||||
| 171. | Whole-Genome Sequencing and Drug-Susceptibility Analysis of Serial Mycobacterium abscessus Isolates from Thai Patients | Kaewprasert, O. Nonghanphithak, D. Chetchotisakd, P. Namwat, W. Ong, R.T.-H. Faksri, K. |
2022 | ||||
| 172. | Antibiotic susceptibility of clinical Burkholderia pseudomallei isolates in northeast Thailand during 2015-2018 and the genomic characterization of β-lactam-resistant isolates | Fen, S.H.Y. Tandhavanant, S. Phunpang, R. |
2023 | ||||
| 173. | Characteristics and one year outcomes of melioidosis patients in Northeastern Thailand: a prospective, multicenter cohort study | Chantratita, N. Phunpang, R. Yarasai, A. Dulsuk, A. Yimthin, T. Onofrey, L.A. Coston, T.D. Thiansukhon, E. Chaisuksant, S. Tanwisaid, K. Chuananont, S. Morakot, C. Sangsa, N. Chayangsu, S. Silakun, W. Buasi, N. Chetchotisakd, P. Day, N.P.J. Lertmemongkolchai, G. West, T.E. |
2023 | ||||
| 174. | Efficacy and safety of switching to bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed Asian adults living with HIV: A pooled analysis from three international phase III randomized trials | Avihingsanon, A Chetchotisakd, P Kiertiburanakul, S Ratanasuwan, W Siripassorn, K Supparatpinyo, K Martin, H Wang, H Wong, T Wang, HY |
2023 | ||||
| 175. | Evaluating anti-GPL-core IgA as a diagnostic tool for non-tuberculous mycobacterial infections in Thai patients with high antibody background | Manbenmad, V So-Ngern, A Chetchotisakd, P Faksri, K Ato, M Nithichanon, A Lertmemongkolchai, G |
2023 | ||||
| 176. | Intra-abdominal Abscesses due to Melioidosis: Clinical Course and Outcomes | Anunnatsiri, S. Chetchotisakd, P. |
2023 | ||||
| 177. | Lipid profiles of people with human immunodeficiency virus with dyslipidemia after switching from efavirenz to dolutegravir. | Khemla, S Meesing, A Sribenjalux, W Chetchotisakd, P |
2023 | ||||
| 178. | MALDI-TOF MS analysis of Burkholderia pseudomallei and closely related species isolated from soils and water in Khon Kaen, Thailand. | Nithimongkolchai, N Hinwan, Y Kaewseekhao, B Chareonsudjai, P Reungsang, P Kraiklang, R Chareonsudjai, S Wonglakorn, L Chetchotisakd, P Sirichoat, A Nithichanon, A Faksri, K |
2023 | ||||
| 179. | Treatment Outcomes After Switching to Second-Line Anti-Retroviral Therapy: Results From the Thai National Treatment Program. | Sudsila, P Teeraananchai, S Kiertiburanakul, S Lertpiriyasuwat, C Triamwichanon, R Gatechompol, S Putcharoen, O Chetchotisakd, P Avihingsanon, A Kerr, SJ Ruxrungtham, K |
2023 | ||||
| 180. | Virological outcomes and metabolic effects after switching from ritonavir-boosted protease inhibitors to a dolutegravir-based regimen in virologically suppressed patients living with HIV | Sribenjalux, W. Nuntawit, T. Meesing, A. Chetchotisakd, P. |
2023 | ||||
| 181. | Analysis of fine-scale phylogeny of Burkholderia pseudomallei in relation to regional geography and drug susceptibility in Thailand. | Hinwan, Y Chareonsudjai, P Reungsang, P Kraiklang, R Chetchotisakd, P Chareonsudjai, S Sirichoat, A Nithichanon, A Wonglakorn, L Sermswan, RW Blair, D Faksri, K |
2024 | ||||
| 182. | Increased Inflammatory Responses in Patients With Active Disseminated Non-Tuberculous Mycobacterial Infection and High Anti-Interferon-Gamma Autoantibodies. | Srisai, P Hongsa, C Hinwan, Y Manbenmad, V Chetchotisakd, P Anunnatsiri, S Faksri, K Techo, T Salao, K Edwards, SW Nithichanon, A |
2024 | ||||
| 183. | Individualised, short-course antibiotic treatment versus usual long-course treatment for ventilator-associated pneumonia (REGARD-VAP): a multicentre, individually randomised, open-label, non-inferiority trial. | Mo, Y Booraphun, S Li, AY Domthong, P Kayastha, G Lau, YH Chetchotisakd, P Limmathurotsakul, D Tambyah, PA Cooper, BS , |
2024 | ||||
| 184. | Lack of Association of TLR1 and TLR5 Coding Variants with Mortality in a Large Multicenter Cohort of Melioidosis Patients. | Yimthin, T Phunpang, R Wright, SW Thiansukhon, E Chaisuksant, S Chetchotisakd, P Tanwisaid, K Chuananont, S Morakot, C Sangsa, N Silakun, W Chayangsu, S Buasi, N Lertmemongkolchai, G Chantratita, N West, TE |
2024 | ||||
| 185. | Statin Use and Reduced Risk of Pneumonia in Patients with Melioidosis: A Lung-Specific Statin Association. | Coston, T.D. Wright, S.W. Phunpang, R. Dulsuk, A. Thiansukhon, E. Chaisuksant, S. Tanwisaid, K. Chuananont, S. Morakot, C. Sangsa, N. Chayangsu, S. Silakun, W. Buasi, N. Chetchotisakd, P. |
2024 | ||||
| 186. | Cause of death in people living with HIV who initiated antiretroviral therapy after enrolling to the Thai National AIDS Program from 2008 to 2021. | Lertpiriyasuwat, C Kerr, SJ Noknoy, S Namahoot, P Punsuwan, N Apornpong, T Sophonphan, J Hiranburana, N Chetchotisakd, P Putcharoen, O Ruxrungtham, K Avihingsanon, A |
2025 | ||||
| 187. | Efficacy and Safety of Long-Acting Subcutaneous Lenacapavir in Heavily Treatment-Experienced People with Multidrug-Resistant HIV-1: Week 104 Results of a Phase 2/3 Trial. | Ogbuagu, O Molina, JM Chetchotisakd, P Ramgopal, MN Sanchez, W Brunetta, J Castelli, F Crofoot, GE Hung, CC Ronot-Bregigeon, S Margot, NA Wang, H Dvory-Sobol, H Rhee, MS Segal-Maurer, S |
2025 | ||||
| 188. | Rapid detection of antibiotic resistance in Burkholderia pseudomallei using MALDI-TOF mass spectrometry. | Nithimongkolchai, N Hinwan, Y Trisakul, K Wonglakorn, L Chetchotisakd, P Sirichoat, A Nithichanon, A Chareonsudjai, S Chareonsudjai, P Phelan, J Clark, TG Faksri, K |
2025 | ||||
| 189. | Risk of severe bacterial infections including TB before and after immediate or deferred antiretroviral therapy: a multicenter, prospective, cohort study. | Jensen, T.O. Sharma, S. Avihingsanon, A. Lutaakome, J. Brar, I. Burman, W. Chetchotisakd, P. de Castro, N. Galán-Herrera, J.F. Kumarasamy, N. Paredes, R. Ridzon, R. Sciaudone, M. Singh, K. Uriel, A. Lundgren, J. Reilly, C. Matthews, G. |
2025 | ||||
| 190. | Whole-genome sequencing analysis of Burkholderia pseudomallei comparing drug-resistant and pan-susceptible isolates reveals novel biomarkers for drug resistance. | Hinwan, Y Nithimongkolchai, N Trisakul, K Kaewseekhao, B Wonglakorn, L Chetchotisakd, P Chareonsudjai, S Sirichoat, A Nithichanon, A Phelan, J Clark, TG Faksri, K |
2025 | Count | 142 | 132 | 105 | 1 |
| Title | Authors | Year | Publication name | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total | ||||||
| 1. | Rhinocerebral mucormycosis: A report of eleven cases | Chetchotisakd, P. Boonma, P. Sookpranee, M. Pairojkul, C. |
1991 |
Southeast Asian Journal of Tropical Medicine and Public Health 2 (22), pp. 268-275 |
||||||||
| 2. | Hospital acquired Janthinobacterium lividum septicemia in Srinagarind Hospital | Wilailackana, C. Lumbiganon, P. Noppawinyoowong, C. Boonma, P. Sitthikesorn, J. Chetchotisakd, P. Simajareuk, K. |
1992 |
Journal of the Medical Association of Thailand SUPPL. 2 (75), pp. 6-10 |
||||||||
| 3. | Human pythiosis in Srinagarind Hospital: one year's experience. | Chetchotisakd, P. Pairojkul, C. Porntaveevudhi, O. Sathapatayavongs, B. Mairiang, P. Nuntirooj, K. Patjanasoontorn, B. Saew, O.T. Chaiprasert, A.K. Haswell, M.R. |
1992 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 4 (75), pp. 248-254 |
||||||||
| 4. | Assessment of bacterial cross-transmission as a cause of infections in patients in intensive care units | Chetchotisakd, P. | 1994 |
Clinical Infectious Diseases 6 (18), pp. 929-937 |
||||||||
| 5. | Typing of sequential bacterial isolates by pulsed-field gel electrophoresis | Chetchotisakd, P. | 1995 |
Diagnostic Microbiology and Infectious Disease 4 (22), pp. 309-314 |
||||||||
| 6. | Pulmonary infections in HIV infected patients. | Mootsikapun, P. Chetchotisakd, P. Intarapoka, B. |
1996 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 8 (79), pp. 477-485 |
||||||||
| 7. | Cefoperazone/Sulbactam + Co-trimoxazole vs Ceftazidime + Co-trimoxazole in the Treatment of Severe Melioidosis: A Randomized, Double-Blind, Controlled Study | Thamprajamchit, S. Chetchotisakd, P. Thinkhamrop, B. |
1998 |
Journal of the Medical Association of Thailand 4 (81), pp. 265-271 |
||||||||
| 8. | Sweet's syndrome associated with non-tuberculous mycobacterial infection: A report of five cases | Choonhakarn, C. Chetchotisakd, P. Jirarattanapochai, K. Mootsikapun, P. |
1998 |
British Journal of Dermatology 1 (139), pp. 107-110 |
||||||||
| 9. | Antilipopolysaccharide II: An antibody protective against fatal melioidosis | Charuchaimontri, C. Suputtamongkol, Y. Nilakul, C. Chaowagul, W. Chetchotisakd, P. Lertpatanasuwun, N. Intaranongpai, S. Brett, P.J. Woods, D.E. |
1999 |
Clinical Infectious Diseases 4 (29), pp. 813-818 |
||||||||
| 10. | Efficacy and safety of twice daily administration of cefpirome in the empiric treatment of sepsis | Bowonwatanuwong, C. Rajanuwong, A. Chetchotisakd, P. |
1999 |
Journal of the Medical Association of Thailand 7 (82), pp. 648-652 |
||||||||
| 11. | Risk factors for melioidosis and bacteremic melioidosis | Suputtamongkol, Y. Chaowagul, W. Chetchotisakd, P. Lertpatanasuwun, N. Intaranongpai, S. Ruchutrakool, T. Budhsarawong, D. Mootsikapun, P. Wuthiekanun, V.R. Lulitanond, V. Lulitanond, A. |
1999 |
Clinical Infectious Diseases 2 (29), pp. 408-413 |
||||||||
| 12. | Comparision between the Antimicrobial Susceptibility of Burkholderia pseudomallei to Trimethoprim-Sulfamethoxazole by Standard Disk Diffusion Method and by Minimal Inhibitory Concentration Determination | Lumbiganon, P. Tattawasatra, U. Chetchotisakd, P. Wongratanacheewin, S. Thinkhamrop, B. |
2000 |
Journal of the Medical Association of Thailand 8 (83), pp. 856-860 |
||||||||
| 13. | Disseminated infection due to rapidly growing mycobacteria in immunocompetent hosts presenting with chronic lymphadenopathy: A previously unrecognized clinical entity | Chetchotisakd, P. Mootsikapun, P. Anunnatsiri, S. Jirarattanapochai, K. Choonhakarn, C. Chaiprasert, A.K. Davis, T.E. |
2000 |
Clinical Infectious Diseases 1 (30), pp. 29-34 |
||||||||
| 14. | Factors associated with severe manifestations of histoplasmosis in AIDS | Chetchotisakd, P. | 2000 |
Clinical Infectious Diseases 6 (30), pp. 877-881 |
||||||||
| 15. | Maintenance therapy of melioidosis with ciprofloxacin plus azithromycin compared with cotrimoxazole plus doxycycline | Chetchotisakd, P. Chaowagul, W. Mootsikapun, P. Budhsarawong, D. Thinkamrop, B. |
2001 |
American Journal of Tropical Medicine and Hygiene 1-2 (64), pp. 24-27 |
||||||||
| 16. | Randomized, double-blind, controlled study of cefoperazone-sulbactam plus cotrimoxazole versus ceftazidime plus cotrimoxazole for the treatment of severe melioidosis | Chetchotisakd, P. Porramatikul, S. Mootsikapun, P. Anunnatsiri, S. Thinkhamrop, B. |
2001 |
Clinical Infectious Diseases 1 (33), pp. 29-34 |
||||||||
| 17. | A randomized, open-label, comparative trial of BID and TID dosing of saquinavir enhanced oral formulation as part of a triple therapy for advanced AIDS patients | Chetchotisakd, P. Anunnatsiri, S. Wankun, J. Mootsikapun, P. Boonyaprawit, P. |
2002 |
Journal of the Medical Association of Thailand 5 (85), pp. 590-596 |
||||||||
| 18. | Clinical outcome of native valve infective endocarditis in Khon Kaen: 1990-1999 | Pachirat, O. Klungboonkrong, V. Tantisirin, C. Taweesangsuksakul, P. Tasanavivat, P. Chetchotisakd, P. Limwattananon, S. |
2002 |
Journal of the Medical Association of Thailand 2 (85), pp. 139-146 |
||||||||
| 19. | Infective Endocarditis : Prevalence, Characteristics and Mortality in Khon Kaen, 1990-1999 | Pachirat, O. Chetchotisakd, P. Klungboonkrong, V. Taweesangsuksakul, P. Tantisirin, C. Loapiboon, M. |
2002 |
Journal of the Medical Association of Thailand 1 (85), pp. 1-10 |
||||||||
| 20. | The role of cefoperazone-sulbactam for treatment of severe melioidosis [4] (multiple letters) | Chetchotisakd, P. Porramatikul, S. Mootsikapun, P. Anunnatsiri, S. Thinkhamrop, B. |
2002 |
Clinical Infectious Diseases 5 (34), pp. 721-723 |
||||||||
| 21. | Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: A prospective, multicenter, randomized study | Sungkanuparph, S. Mootsikapun, P. Chetchotisakd, P. Bowonwatanuwong, C. |
2003 |
Clinical Infectious Diseases 10 (36), pp. 1329-1331 |
||||||||
| 22. | Efavirenz-based regimen as treatment of advanced AIDS with cryptococcal meningitis [4] | Sungkanuparph, S. Mootsikapun, P. Chetchotisakd, P. Bowonwatanuwong, C. Chantràtita, W. |
2003 |
Journal of Acquired Immune Deficiency Syndromes 1 (33), pp. 118-119 |
||||||||
| 23. | Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial | Ananworanich, J. le Braz, M. Chetchotisakd, P. Wicharuk, S. Ruxrungtham, K. Cooper, D.A. |
2003 |
AIDS 15 (17), pp. F33-F37 |
||||||||
| 24. | Opportunistic infections after the initiation of highly active antiretroviral therapy in advanced AIDS patients in an area with a high prevalence of tuberculosis | Sungkanuparph, S. Mootsikapun, P. Chetchotisakd, P. Bowonwatanuwong, C. |
2003 |
AIDS 14 (17), pp. 2129-2131 |
||||||||
| 25. | The efficacy of fluconazole 600 mg/day versus itraconazole 600 mg/day as consolidation therapy of cryptococcal meningitis in AIDS patients | Mootsikapun, P. Anunnatsiri, S. Chetchotisakd, P. |
2003 |
Journal of the Medical Association of Thailand 4 (86), pp. 293-298 |
||||||||
| 26. | A multicentre, randomized, double-blind, placebo-controlled trial of primary cryptococcal meningitis prophylaxis in HIV-infected patients with severe immune deficiency | Chetchotisakd, P. Sungkanuparph, S. Thinkhamrop, B. Mootsikapun, P. Boonyaprawit, P. |
2004 |
HIV Medicine 3 (5), pp. 140-143 |
||||||||
| 27. | A prospective study of efficacy and safety of once-daily saquinavir/ritonavir plus two nucleoside reverse transcriptase inhibitors in treatment-naive Thai patients | Ananworanich, J. Ruxrungtham, K. Prasithsirikul, W. Chetchotisakd, P. Kiertiburanakul, S. Munsakul, W. Raksakulkarn, P. Tansuphasawadikul, S. Cooper, D.A. |
2005 |
Antiviral Therapy 6 (10), pp. 761-767 |
||||||||
| 28. | Body composition in adults infected with human immunodeficiency virus in Khon Kaen, Thailand | Hendricks, K.M. Chetchotisakd, P. Mootsikapun, P. Anunnatsiri, S. |
2005 |
American Journal of Tropical Medicine and Hygiene 4 (73), pp. 815-819 |
||||||||
| 29. | Effect of changes in diagnosis and management of active infective endocarditis on the clinical outcome at Srinagarind Hospital | Pachirat, O. Kiatchoosakun, S. Chetchotisakd, P. Tantisirin, C. Limwattananon, S. |
2005 |
Journal of the Medical Association of Thailand 4 (88), pp. 498-504 |
||||||||
| 30. | Efficacy and safety of indinavir/ritonavir 400/100 mg twice daily plus two nucleoside analogues in treatment-naive HIV-1-infected patients with CD4 + T-cell counts <200 cells/mm3: 96-Week outcomes | Mootsikapun, P. Chetchotisakd, P. Anunnatsiri, S. Boonyaprawit, P. |
2005 |
Antiviral Therapy 8 (10), pp. 911-916 |
||||||||
| 31. | Factors associated with treatment outcomes in pulmonary tuberculosis in northeastern Thailand | Anunnatsiri, S. Chetchotisakd, P. |
2005 |
Southeast Asian Journal of Tropical Medicine and Public Health 2 (36), pp. 324-330 |
||||||||
| 32. | Two randomized controlled trials of ceftazidime alone versus ceftazidime in combination with trimethoprim-sulfamethoxazole for the treatment of severe melioidosis | Anunnatsiri, S. Mootsikapun, P. Simpson, A.J.H. Limmathurotsakul, D. Chaowagul, W. Peacock, S.J. Day, N. Chetchotisakd, P. |
2005 |
Clinical Infectious Diseases 8 (41), pp. 1105-1113 |
||||||||
| 33. | Absence of resistance mutations in antiretroviral-naive patients treated with ritonavir-boosted saquinavir | Ananworanich, J. Jupimai, T. Prasithsirikul, W. Chetchotisakd, P. Kiertiburanakul, S. Munsakul, W. Raksakulkarn, P. Tansuphasawadikul, S. Schütz, M. Ruxrungtham, K. |
2006 |
Antiviral Therapy 5 (11), pp. 631-635 |
||||||||
| 34. | CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial | Ananworanich, J. Gayet-Ageron, A. le Braz, M. Prasithsirikul, W. Chetchotisakd, P. Kiertiburanakul, S. Munsakul, W. Raksakulkarn, P. Tansuphasawasdikul, S. Phanuphak, P.P. Cooper, D.A. Ruxrungtham, K. |
2006 |
Lancet 9534 (368), pp. 459-465 |
||||||||
| 35. | Clinical and epidemiological analyses of human pythiosis in Thailand | Sathapatayavongs, B. Chaiprasert, A.K. Saipetch, M. Mootsikapun, P. Chetchotisakd, P. Supparatpinyo, K. Chaiwarith, R. Srisiri, S. Somkaew, S. |
2006 |
Clinical Infectious Diseases 5 (43), pp. 569-576 |
||||||||
| 36. | High rate multiple drug resistances in HIV-infected patients failing nonnucleoside reverse transcriptase inhibitor regimens in Thailand, where subtype A/E is predominant | Chetchotisakd, P. Anunnatsiri, S. Kiertiburanakul, S. Sutthent, R. Anekthananon, T. Bowonwatanuwong, C. Kowadisaiburana, B. Supparatpinyo, K. Horsakulthai, M. Chasombat, S. Ruxrungtham, K. |
2006 |
Journal of the International Association of Physicians in AIDS Care 4 (5), pp. 152-156 |
||||||||
| 37. | Addition of trimethoprim-sulfamethoxazole to ceftazidime during parenteral treatment of melioidosis is not associated with a long-term outcome benefit [4] | Anunnatsiri, S. Chaowagul, W. Peacock, S.J. Chetchotisakd, P. Day, N. |
2007 |
Clinical Infectious Diseases 4 (45), pp. 521-523 |
||||||||
| 38. | A rapidly fatal case of Panton-valentine leukocidin positive Staphylococcus aureus necrotizing pneumonia in an HIV-infected patient | Chetchotisakd, P. Anunnatsiri, S. Puapermpoonsiri, S. Prariyachatgul, C. Chumpol, J. |
2007 |
Southeast Asian Journal of Tropical Medicine and Public Health 4 (38), pp. 690-694 |
||||||||
| 39. | Disseminated nontuberculous mycobacterial infection in patients who are not infected with HIV in Thailand | Chetchotisakd, P. Kiertiburanakul, S. Mootsikapun, P. Assanasen, S. Chaiwarith, R. Anunnatsiri, S. |
2007 |
Clinical Infectious Diseases 4 (45), pp. 421-427 |
||||||||
| 40. | Efficacy and tolerability of a double boosted protease inhibitor (lopinavir + saquinavir/ritonavir) regimen in HIV-infected patients who failed treatment with nonnucleoside reverse transcriptase inhibitors | Chetchotisakd, P. Anunnatsiri, S. Mootsikapun, P. Kiertiburanakul, S. Anekthananon, T. Bowonwatanuwong, C. Kowadisaiburana, B. Supparatpinyo, K. Ruxrungtham, K. |
2007 |
HIV Medicine 8 (8), pp. 529-535 |
||||||||
| 41. | Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial | Chetchotisakd, P. Barrios, C.H.E. Sekhon, J.S. Decruyenaere, J.M.A. Lortholary, O. Koblinger, S. Diekmann-Berndt, H. |
2007 |
Lancet 9572 (369), pp. 1519-1527 |
||||||||
| 42. | No change in calculated creatinine clearance after tenofovir initiation among Thai patients | Gayet-Ageron, A. Ananworanich, J. Jupimai, T. Chetchotisakd, P. Prasithsirikul, W. le Braz, M. Ruxrungtham, K. |
2007 |
Journal of Antimicrobial Chemotherapy 5 (59), pp. 1034-1037 |
||||||||
| 43. | Non-HACEK gram-negative bacillus endocarditis | Morpeth, S.C. Nacinovich, F. Fernández-Hidalgo, N. De Oliveira Ramos, A.I. Klein, J.L. Giannitsioti, E. Giamarellou, H.J. Paré, C. Armero, Y. Kanj-Sharara, S. Ravasio, V. Bernard, Y.F. Lambert, P.A. Trivi, M.S. Chambers, S.T. Lalani, T. Chaiworramukkun, J. Pachirat, O. Chetchotisakd, P. Suwanich, T. Raoult, D.M. Kumar, A.S. McBryde, E.S. Ryan, S. Ionac, A. Imazio, M. Bukovski, S. Bayer, A.S. |
2007 |
Annals of Internal Medicine 12 (147), pp. 829-835 |
||||||||
| 44. | Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents: The recommendations of the thai AIDS society (TAS) 2008 | Sungkanuparph, S. Anekthananon, T. Bowonwatanuwong, C. Supparatpinyo, K. Mootsikapun, P. Chetchotisakd, P. Kiertiburanakul, S. Tantisiriwat, W. Ruxrungtham, K. |
2008 |
Journal of the Medical Association of Thailand 12 (91), pp. 1925-1936 |
||||||||
| 45. | Interruptions of tenofovir/emtricitabine-based antiretroviral therapy in patients with HIV/hepatitis B virus co-infection | Ananworanich, J. Srasuebkul, P. Chetchotisakd, P. Prasithsirikul, W. Klinbuayam, W. Mahanontharit, A. Jupimai, T. Ruxrungtham, K. |
2008 |
AIDS 1 (22), pp. 152-154 |
||||||||
| 46. | Long-term efficacy and safety of first-line therapy with once-daily saquinavir/ritonavir | Ananworanich, J. Gayet-Ageron, A. Ruxrungtham, K. Chetchotisakd, P. Prasithsirikul, W. Kiertiburanakul, S. Munsakul, W. Raksakulkarn, P. Tansuphasawadikul, S. LeBraz, M. Jupimai, T. Schütz, M. |
2008 |
Antiviral Therapy 3 (13), pp. 375-380 |
||||||||
| 47. | Low-dose, once-daily atazanavir/ritonavir (200/100): An effective treatment for HIV-infected patients in Thailand | Chetchotisakd, P. Anunnatsiri, S. |
2008 |
Journal of Acquired Immune Deficiency Syndromes 2 (49), pp. 230-231 |
||||||||
| 48. | Mycotic aneurysm in northeast Thailand: The importance of Burkholderia pseudomallei as a causative pathogen | Anunnatsiri, S. Chetchotisakd, P. Kularbkaew, C. |
2008 |
Clinical Infectious Diseases 11 (47), pp. 1436-1439 |
||||||||
| 49. | Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study | Chetchotisakd, P. Corral, J. David, N. Mancini, M. Percival, L.D. Mcgrath, D. |
2008 |
The Lancet 9639 (372), pp. 646-655 |
||||||||
| 50. | Short report: Consensus guidelines for dosing of amoxicillin-clavulanate in melioidosis | Chaowagul, W. Chetchotisakd, P. Limmathurotsakul, D. Peacock, S.J. Currie, B.J. |
2008 |
American Journal of Tropical Medicine and Hygiene 2 (78), pp. 208-209 |
||||||||
| 51. | A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis | Chetchotisakd, P. Morris, M.I. Sungkanuparph, S. Supparatpinyo, K. Nolen, T.L. Zimmer, L.O. Kendrick, A.S. Johnson, P.C. |
2009 |
Clinical Infectious Diseases 12 (48), pp. 1775-1783 |
||||||||
| 52. | Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: A prospective multicenter study | Sungkanuparph, S. Chetchotisakd, P. Nolen, T.L. Anekthananon, T. Morris, M.I. Supparatpinyo, K. Kendrick, A.S. Johnson, P.C. |
2009 |
Clinical Infectious Diseases 6 (49), pp. 931-934 |
||||||||
| 53. | Effect of high-dose fluconazole on QT interval in patients with human immunodeficiency virus (HIV)-associated cryptococcal meningitis | Sungkanuparph, S. Anekthananon, T. Supparatpinyo, K. Nolen, T.L. Zimmer, L.O. Chetchotisakd, P. |
2009 |
International Journal of Antimicrobial Agents 5 (34), pp. 494-496 |
||||||||
| 54. | Fungemia in non-HIV-infected patients: a five-year review | Anunnatsiri, S. Chetchotisakd, P. Mootsikapun, P. |
2009 |
International Journal of Infectious Diseases 1 (13), pp. 90-96 |
||||||||
| 55. | Phenotypic and functional characterization of human memory T cell responses to Burkholderia pseudomallei | Tippayawat, P. Saenwongsa, W. Mahawantung, J. Suwannasaen, D. Chetchotisakd, P. Limmathurotsakul, D. Peacock, S.J. Felgner, P.L. Atkins, H.S. Titball, R.W. Bancroft, G.J. Lertmemongkolchai, G. |
2009 |
PLoS Neglected Tropical Diseases 4 (3), pp. |
||||||||
| 56. | The CASTLE study: Atazanavir/r versus lopinavir/r in antiretroviral-naive patients | Chetchotisakd, P. | 2009 |
Expert Review of Anti-Infective Therapy 7 (7), pp. 801-805 |
||||||||
| 57. | The impact of combination antiretroviral therapy and its interruption on anxiety, stress, depression and quality of life in thai patients | Gayet-Ageron, A. Chetchotisakd, P. Prasithsirikul, W. Kiertiburanakul, S. Munsakul, W. Raksakulkarn, P. Tansuphasawasdikul, S. Chautrakarn, S. Ruxrungtham, K. Anaworanich, J. Phanuphak, P.P. Saenawat, S. Wicharuk, S. Nonenoy, S. Wannachai, N. Chuenyam, T. Mahanontharit, A. Sankonte, J. Piyavong, B. Piroj, V. Seekaow, N. Karakte, W. Putthwong, S. Liganonsakul, S. Sanchiem, W. Boonchoo, P. Suannum, M. Bunyaprawit, P. Kaewmarg, R. Penglimoon, Y. Khongsawad, S. |
2009 |
Open AIDS Journal (3), pp. 38-45 |
||||||||
| 58. | Use of a low-dose steroid as an adjunct in the treatment, in mice, of severe sepsis caused by Burkholderia pseudomallei | Panomket, P. Chetchotisakd, P. Sermswan, R.W.O. Pannengpetch, P. Wongratanacheewin, S. |
2009 |
Annals of Tropical Medicine and Parasitology 7 (103), pp. 635-646 |
||||||||
| 59. | Effects of intermittent IL-2 alone or with peri-cycle antiretroviral therapy in early HIV infection: The STALWART study | Gey, D.C. López, J.C.A. Munroe, D.L. Ruxrungtham, K. Wentworth, D. Wyman, N. Grarup, J. Reilev, S. Braimah, N. Horton, J. Cooper, D.A. Courtney-Rodgers, D. Nelson, R. Haerry, D.H.U. Meulbroek, M. Watson, J. Chaisson, R.E. Kim, K. Kelly, M.D. Chetchotisakd, P. Winston, A. Nixon, D.E. |
2010 |
PLoS ONE 2 (5), pp. |
||||||||
| 60. | Increasing incidence of human melioidosis in northeast Thailand | Limmathurotsakul, D. Wongratanacheewin, S. Chaisuksant, S. Chetchotisakd, P. Chaowagul, W. Day, N. Peacock, S.J. |
2010 |
American Journal of Tropical Medicine and Hygiene 6 (82), pp. 1113-1117 |
||||||||
| 61. | International collaboration between US and Thailand on a clinical trial of treatment for HIV-associated cryptococcal meningitis | Zimmer, L.O. Nolen, T.L. Pramanpol, S. Chetchotisakd, P. |
2010 |
Contemporary Clinical Trials 1 (31), pp. 34-43 |
||||||||
| 62. | Melioidosis pericarditis mimicking tuberculous pericarditis | Chetchotisakd, P. Anunnatsiri, S. Kiatchoosakun, S. Kularbkaew, C. |
2010 |
Clinical Infectious Diseases 5 (51), pp. e46-e49 |
||||||||
| 63. | Monitoring and impact of fluconazole serum and cerebrospinal fluid concentration in HIV-associated cryptococcal meningitis-infected patients | Chetchotisakd, P. Nolen, T.L. Sungkanuparph, S. Anekthananon, T. Supparatpinyo, K. |
2010 |
HIV Medicine 4 (11), pp. 276-281 |
||||||||
| 64. | Once-daily atazanavir/ritonavir compared with twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 96-week efficacy and safety results of the CASTLE study | Chetchotisakd, P. Corral, J. David, N. Mancini, M. Percival, L.D. Wirtz, V. Lataillade, M. Mcgrath, D. |
2010 |
Journal of Acquired Immune Deficiency Syndromes 3 (53), pp. 323-332 |
||||||||
| 65. | Etravirine and rilpivirine resistance in HIV-1 subtype CRF01-AE-infected adults failing non-nucleoside reverse transcriptase inhibitor-based regimens | Bunupuradah, T. Ananworanich, J. Chetchotisakd, P. Jirajariyavej, S. Munsakul, W. Prasithsirikul, W. Sungkanuparph, S. Bowonwattanuwong, C. Klinbuayaem, V. Bhakeecheep, S. Ruxrungtham, K. |
2011 |
Antiviral Therapy 7 (16), pp. 1113-1121 |
||||||||
| 66. | Predictors of poor clinical outcome of cryptococcal meningitis in HIV-infected patients | Anekthananon, T. Chetchotisakd, P. Kiertiburanakul, S. Supparatpinyo, K. Nolen, T.L. Kendrick, A.S. |
2011 |
International Journal of STD and AIDS 11 (22), pp. 665-670 |
||||||||
| 67. | Adult-onset immunodeficiency in Thailand and Taiwan | Chetchotisakd, P. Suputtamongkol, Y. Kiertiburanakul, S. Shaw, P.A. Jutivorakool, K. Lulitanond, V. Mootsikapun, P. Anunnatsiri, S. Sathapatayavongs, B. Shieh, C. Claypool, R.J. Saleeb, P.G. Rosen, L.B. Mo, A. |
2012 |
New England Journal of Medicine 8 (367), pp. 725-734 |
||||||||
| 68. | A randomized comparison of second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir in patients failing NNRTI regimens: The HIV STAR study | Bunupuradah, T. Chetchotisakd, P. Ananworanich, J. Munsakul, W. Jirajariyavej, S. Prasithsirikul, W. Sungkanuparph, S. Bowonwatanuwong, C. Klinbuayaem, V. Sophonphan, J. Bhakeecheep, S. Ruxrungtham, K. |
2012 |
Antiviral Therapy 7 (17), pp. 1351-1361 |
||||||||
| 69. | A randomized comparison of second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir in patients failing NNRTI regimens: The HIV STAR study (Antiviral Therapy (2012) DOI: 10.3851/IMP2443) | Bunupuradah, T. Chetchotisakd, P. Ananworanich, J. Munsakul, W. Jirajariyavej, S. Prasithsirikul, W. Sungkanuparph, S. Bowonwatanuwong, C. Klinbuayaem, V. Sophonphan, J. Bhakeecheep, S. Ruxrungtham, K. |
2012 |
Antiviral Therapy 7 (17), pp. 1389-1390 |
||||||||
| 70. | Assessing adherence in Thai patients taking combination antiretroviral therapy | Avihingsanon, A. Chetchotisakd, P. Layton, M.R. Ruxrungtham, K. Cooper, D.A. Phanuphak, P.P. |
2012 |
International Journal of STD and AIDS 3 (23), pp. 160-165 |
||||||||
| 71. | Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the phase III randomized, double-blind ECHO and THRIVE trials | Clumeck, N.N. Abusamra, L. Ceriotto, M. Henry, K. Leider, J.M. Ortiz, R. Scribner, A.N. Sloan, L.M. Martínez, P.G. Vetter, N. Pilotto, J.H.S. Rangel, F. Boissonnault, M. Macleod, J. Winston, A. David, N. Botes, M.E. Mohapi, L. Chetchotisakd, P. Sungkanuparph, S. Hodder, S.L. Wilkin, A.M. Wu, H. |
2012 |
Journal of Antimicrobial Chemotherapy 8 (67), pp. 2020-2028 |
||||||||
| 72. | Emergence of NDM-1- and IMP-14a-producing enterobacteriaceae in Thailand | Rimrang, B. Chanawong, A. Lulitanond, A. Lulitanond, V. Wilailuckana, C. Charoensri, N. Sribenjalux, P. Phumsrikaew, W. Wonglakorn, L. Kerdsin, A. Chetchotisakd, P. |
2012 |
Journal of Antimicrobial Chemotherapy 11 (67), pp. 2626-2630 |
||||||||
| 73. | Neurocognitive impairment in patients randomized to second-line lopinavir/ritonavir-based antiretroviral therapy vs. lopinavir/ritonavir monotherapy | Bunupuradah, T. Chetchotisakd, P. Jirajariyavej, S. Bowonwattanuwong, C. Munsakul, W. Klinbuayaem, V. Prasithsirikul, W. Sophonphan, J. Mahanontharit, A. Bhakeecheep, S. Ruxrungtham, K. Ananworanich, J. |
2012 |
Journal of NeuroVirology 6 (18), pp. 479-487 |
||||||||
| 74. | Cobicistat versus ritonavir as a pharmacoenhancer of atazanavir plus emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV type 1-infected patients: Week 48 results | Chetchotisakd, P. Liu, Y. |
2013 |
Journal of Infectious Diseases 1 (208), pp. 32-39 |
||||||||
| 75. | Week 96 efficacy and safety of rilpivirine in treatment-naive, HIV-1 patients in two Phase III randomized trials | Chetchotisakd, P. Crauwels, H.M. |
2013 |
AIDS 6 (27), pp. 939-950 |
||||||||
| 76. | Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): A randomised, double-blind, placebo-controlled, non-inferiority trial | Cooper, D.A. Phanuphak, P.P. Winston, A. Clarke, A.T. Delfino, M. Kaew-On, P. Taylor, J.L. Calanni, L. Chetchotisakd, P. Contarelli, J. Kelly, M.D. Messina, O.G. Mohapi, L. Supparatpinyo, K. Smith, D.E. Kelleher, T. Yeung, J. Shaik, A. Dunn, D. |
2014 |
The Lancet 9927 (383), pp. 1474-1482 |
||||||||
| 77. | Ergotism in thailand caused by increased access to antiretroviral drugs: A global warning | Avihingsanon, A. Suwanpimolkul, G. Chetchotisakd, P. Bowonwatanuwong, C. Jirajariyavej, S. Tantipong, H. Ohata, J. Ruxrungtham, K. Burger, D.M. |
2014 |
Topics in Antiviral Medicine 5 (21), pp. 165-168 |
||||||||
| 78. | Linezolid in the treatment of disseminated nontuberculous mycobacterial infection in anti-interferon-gamma autoantibody-positive patients | Chetchotisakd, P. Anunnatsiri, S. |
2014 |
The Southeast Asian journal of tropical medicine and public health 5 (45), pp. 1125-1131 |
||||||||
| 79. | Trimethoprim-sulfamethoxazole versus trimethoprimsulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): A multicentre, double-blind, non-inferiority, randomised controlled trial | Chetchotisakd, P. Chaowagul, W. Anunnatsiri, S. Mootsikapun, P. Chaisuksant, S. Thinkhamrop, B. Susaengrat, W. Wuthiekanun, V.R. Chantratita, N. Limmathurotsakul, D. Peacock, S.J. |
2014 |
The Lancet 9919 (383), pp. 807-814 |
||||||||
| 80. | Cerebrospinal fluid exposure of efavirenz and its major metabolites when dosed at 400 mg and 600 mg once daily: A randomized controlled trial | Winston, A. Clarke, A.T. Else, L.J. Barber, T. Avinghsanon, A. Chetchotisakd, P. Cooper, D.A. |
2015 |
Clinical Infectious Diseases 7 (60), pp. 1026-1032 |
||||||||
| 81. | Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection: A case control study | Grarup, J. Reilev, S. Angus, B.J. Horton, J. Courtney-Rodgers, D. Chaisson, R.E. Angel, E.B. Aquilia, S. Bittar, V. Contarelli, J. Daciuk, L. Galache, V. Guaragna, G. Ivalo, S.A. Lourtau, L.D. Marson, C. Massera, L. Somenzini, C. Tocci, M. Blavius, K. Carrall, L. D'Arcy-Evans, C. Johnston, C. Lowe, K. Patching, J. Price, S. Primrose, R. Prone, I. Roney, J. Sarangapany, J. Smith, D.E. Vale, R. Clumeck, N.N. Montes, M.L. Bowonwatanuwong, C. Chetchotisakd, P. Kelly, M.D. Delfino, M. Nelson, R. Donohue, W. Silvers, J.E. Phanuphak, P.P. Pumpradit, W. Kiertiburanakul, S. Klinbuayaem, V. Mootsikapun, P. Nonenoy, S. Piyavong, B. Prasithsirikul, W. Raksakulkarn, P. Hodder, S.L. Nixon, D.E. |
2015 |
PLoS ONE 10 (10), pp. |
||||||||
| 82. | Cobicistat Compared With Ritonavir as a Pharmacoenhancer for Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate: Week 144 Results | Chetchotisakd, P. Arastéh, K. Cao, H. |
2015 |
Journal of Acquired Immune Deficiency Syndromes 3 (69), pp. 338-340 |
||||||||
| 83. | Cost-effectiveness analysis of parenteral antimicrobials for acute melioidosis in Thailand | Chetchotisakd, P. Anunnatsiri, S. Currie, B.J. Peacock, S.J. Day, N.P.J. Limmathurotsakul, D. Lubell, Y. |
2015 |
Transactions of the Royal Society of Tropical Medicine and Hygiene 6 (109), pp. 416-418 |
||||||||
| 84. | Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study | Cooper, D.A. Winston, A. Avihingsanon, A. Clarke, A.T. Delfino, M. Calanni, L. Chetchotisakd, P. Kelly, M.D. Messina, O.G. Mohapi, L. Phanuphak, P.P. Supparatpinyo, K. Smith, D.E. Kelleher, T. Yeung, J. Shaik, A. Dunn, D. |
2015 |
The Lancet Infectious Diseases 7 (15), pp. 793-802 |
||||||||
| 85. | Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2014, Thailand | Ongwandee, S. Bhakeecheep, S. Ruxrungtham, K. Phanuphak, P.P. Chetchotisakd, P. Tantisiriwat, W. Kiertiburanakul, S. Avihingsanon, A. Sukkul, A. Anekthananon, T. |
2015 |
AIDS Research and Therapy 1 (12), pp. |
||||||||
| 86. | Pilot study of a non-return catheter valve for reducing catheter-associated urinary tract infections in critically ill patients | Panitchote, A. Charoensri, S. Chetchotisakd, P. Hurst, C.P. |
2015 |
Journal of the Medical Association of Thailand 2 (98), pp. 150-155 |
||||||||
| 87. | Serological diagnosis of pulmonary Mycobacterium tuberculosis infection by LIPS using a multiple antigen mixture | Chetchotisakd, P. Suputtamongkol, Y. Kiertiburanakul, S. |
2015 |
BMC Microbiology 1 (15), pp. |
||||||||
| 88. | Anti-IFN-γ autoantibodies are strongly associated with HLA-DR∗15:02/16:02 and HLA-DQ∗05:01/05:02 across Southeast Asia | Chetchotisakd, P. Kiertiburanakul, S. Suputtamongkol, Y. |
2016 |
Journal of Allergy and Clinical Immunology 3 (137), pp. 945-948.e8 |
||||||||
| 89. | Antiretroviral resistance after first-line antiretroviral therapy failure in diverse HIV-1 subtypes in the SECOND-LINE study | Moore, C.L. Chetchotisakd, P. Cooper, D.A. |
2016 |
AIDS Research and Human Retroviruses 9 (32), pp. 841-850 |
||||||||
| 90. | Clinical features and outcomes of Sweet's syndrome associated with non-tuberculous mycobacterial infection and other associated diseases | Chaowattanapanit, S. Choonhakarn, C. Chetchotisakd, P. Sawanyawisuth, K. |
2016 |
Journal of Dermatology 5 (43), pp. 532-536 |
||||||||
| 91. | Comparison of community-onset Staphylococcus argenteus and Staphylococcus aureus sepsis in Thailand: A prospective multicentre observational study | Chantratita, N. Chaimanee, P. Chetchotisakd, P. Peacock, S.J. |
2016 |
Clinical Microbiology and Infection 5 (22), pp. 458.e11-458.e19 |
||||||||
| 92. | High-level carbapenem-resistant OXA-48-producing Klebsiella pneumoniae with a novel OmpK36 variant and low-level, carbapenem-resistant, non-porin-deficient, OXA-181-producing Escherichia coli from Thailand | Chanawong, A. Wilailuckana, C. Charoensri, N. Wonglakorn, L. Chaimanee, P. Angkititrakul, S. Chetchotisakd, P. |
2016 |
Diagnostic Microbiology and Infectious Disease 2 (85), pp. 221-226 |
||||||||
| 93. | Improvement of lipid profiles when switching from efavirenz to rilpivirine in HIV-infected patients with dyslipidemia | Chetchotisakd, P. Anunnatsiri, S. Mootsikapun, P. |
2016 |
HIV Clinical Trials 1 (17), pp. 12-16 |
||||||||
| 94. | Isavuconazole treatment for mucormycosis: A single-arm open-label trial and case-control analysis | Rahav, G. Chetchotisakd, P. |
2016 |
The Lancet Infectious Diseases 7 (16), pp. 828-837 |
||||||||
| 95. | Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): a randomised, open-label, non-inferiority trial | Bunupuradah, T. Kiertiburanakul, S. Avihingsanon, A. Chetchotisakd, P. Bowonwatanuwong, C. Banchongkit, S. Klinbuayaem, V. Mekviwattanawong, S. Jirajariyavej, S. Prasithsirikul, W. Munsakul, W. Bhakeecheep, S. Phanuphak, P.P. Cooper, D.A. Ruxrungtham, K. |
2016 |
The Lancet HIV 8 (3), pp. e343-e350 |
||||||||
| 96. | Switching to tenofovir alafenamide, coformulated with elvitegravir, cobicistat, and emtricitabine, in HIV-infected patients with renal impairment: 48-week results from a single-arm, multicenter, open-label phase 3 study | Avihingsanon, A. Chetchotisakd, P. |
2016 |
Journal of Acquired Immune Deficiency Syndromes 5 (71), pp. 530-537 |
||||||||
| 97. | Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study | Mallon, P.W.G. Chetchotisakd, P. Phanuphak, P.P. Mohapi, L. Moore, C.L. Cooper, D.A. |
2017 |
The Lancet HIV 1 (4), pp. e13-e20 |
||||||||
| 98. | Cryptococcosis in anti-interferon-gamma autoantibody-positive patients: A different clinical manifestation from HIV-infected patients | Chetchotisakd, P. Anunnatsiri, S. Nithichanon, A. Lertmemongkolchai, G. |
2017 |
Japanese Journal of Infectious Diseases 1 (70), pp. 69-74 |
||||||||
| 99. | Molecular characterization of carbapenemase-nonproducing clinical isolates of Escherichia coli (from a Thai University Hospital) with reduced carbapenem susceptibility | Chanawong, A. Sangka, A. Wilailuckana, C. Angkititrakul, S. Charoensri, N. Wonglakorn, L. Chaimanee, P. |
2017 |
Japanese Journal of Infectious Diseases 6 (70), pp. 628-634 |
||||||||
| 100. | Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial | Suwanpimolkul, G. Ruxrungtham, K. |
2017 |
The Lancet Infectious Diseases 12 (17), pp. 1255-1265 |
||||||||
| 101. | Patient characteristics, management, and predictors of outcome from severe community-onset staphylococcal sepsis in northeast Thailand: A prospective multicenter study | Peacock, S.J. Chantratita, N. |
2017 |
American Journal of Tropical Medicine and Hygiene 5 (96), pp. 1042-1049 |
||||||||
| 102. | Thailand national guidelines for the prevention of mother-to-child transmission of HIV 2016 | Chokephaibulkit, K. Phanuphak, N. |
2017 |
Asian Biomedicine 2 (11), pp. 145-159 |
||||||||
| 103. | TLR4 genetic variation is associated with inflammatory responses in Gram-positive sepsis | Chantratita, N. Srisurat, N. Chaimanee, P. Wongratanacheewin, S. Chetchotisakd, P. Peacock, S.J. |
2017 |
Clinical Microbiology and Infection 1 (23), pp. 47.e1-47.e10 |
||||||||
| 104. | Analysis of drug-susceptibility patterns and gene sequences associated with clarithromycin and amikacin resistance in serial Mycobacterium abscessus isolates from clinical specimens from Northeast Thailand | Chetchotisakd, P. Chaimanee, P. Reechaipichitkul, W. Namwat, W. Lulitanond, V. Faksri, K. |
2018 |
PLoS ONE 11 (13), pp. |
||||||||
| 105. | Epidemiology of and risk factors for extrapulmonary nontuberculous mycobacterial infections in Northeast Thailand | Chetchotisakd, P. Chaimanee, P. Reechaipichitkul, W. Faksri, K. |
2018 |
PeerJ 8 (2018), pp. |
||||||||
| 106. | Haemophilus influenzae infected atrial myxoma: A case report | Chetchotisakd, P. | 2018 |
Southeast Asian Journal of Tropical Medicine and Public Health 3 (49), pp. 465-468 |
||||||||
| 107. | Immune control of Burkholderia pseudomallei--common, high-frequency T-cell responses to a broad repertoire of immunoprevalent epitopes | Nithichanon, A. Rinchai, D. Buddhisa, S. Kewcharoenwong, C. Kessler, B. Khaenam, P. Chetchotisakd, P. Robinson, J.H. Reynolds, C.J. Altmann, D.M. Lertmemongkolchai, G. |
2018 |
Frontiers in Immunology MAR (9), pp. |
||||||||
| 108. | Implementation of a Test, Treat, and Prevent HIV program among men who have sex with men and transgender women in Thailand, 2015-2016 | Ongwandee, S. Lertpiriyasuwat, C. Khawcharoenporn, T. Chetchotisak, P. Thiansukhon, E. Leerattanapetch, N. Leungwaranan, B. Manopaiboon, C. Phoorisri, T. Visavakum, P. Jetsawang, B. Poolsawat, M. Nookhai, S. Vasanti-Uppapokakorn, M. Karuchit, S. Kittinunvorakoon, C. Mock, P. Prybylski, D. Sukkul, A.C. Roels, T. Martin, M. |
2018 |
PLoS ONE 7 (13), pp. |
||||||||
| 109. | Increased indoleamine-2,3-dioxygenase activity is associated with poor clinical outcome in adults hospitalized with influenza in the INSIGHT FLU003Plus study | Wentworth, D. Delfino, M. López, P.F. Ruxrungtham, K. Wyman, N. Daciuk, L. Chetchotisakd, P. Clumeck, N.N. |
2018 |
Open Forum Infectious Diseases 1 (5), pp. |
||||||||
| 110. | Intravenous cyclophosphamide therapy for anti-IFN-gamma autoantibody-associated mycobacterium abscessus infection | Chetchotisakd, P. Nanagara, R. Nithichanon, A. Lertmemongkolchai, G. |
2018 |
Journal of Immunology Research (2018), pp. |
||||||||
| 111. | Melioidosis in Thailand: Present and Future | Hinjoy, S. Hantrakun, V. Kongyu, S. Kaewrakmuk, J. Thamthitiwat, S. Sangwichian, O. Anunnatsiri, S. Sermswan, R.W. Lertmemongkolchai, G. Narenpitak, S. Jutrakul, Y. Teparrukkul, P. Teerawattanasook, N. Hongsuwan, M. Wuthiekanun, V. Chewapreecha, C. Thaipadungpanit, J. Chantratita, N. Korbsrisate, S. Dunachie, S. Palittapongarnpim, P. Sirisinha, S. Iamsirithaworn, S. Chaowagul, W. Chetchotisak, P. Wongratanacheewin, S. Limmathurotsakul, D. |
2018 |
Tropical Medicine and Infectious Disease 2 (3), pp. |
||||||||
| 112. | Ocular involvement in melioidosis: a 23-year retrospective review | Asawaphureekorn, S. Chetchotisakd, P. Wongratanacheewin, S. |
2018 |
Journal of Ophthalmic Inflammation and Infection 1 (8), pp. |
||||||||
| 113. | Differentiation between persistent infection/colonization and re-infection/re-colonization of Mycobacterium abscessus isolated from patients in Northeast Thailand | Chetchotisakd, P. Chaimanee, P. Reechaipichitkul, W. Lulitanond, V. Namwat, W. Faksri, K. |
2019 |
Infection, Genetics and Evolution (68), pp. 35-42 |
||||||||
| 114. | Dolutegravir versus ritonavir-boosted lopinavir both with dual nucleoside reverse transcriptase inhibitor therapy in adults with HIV-1 infection in whom first-line therapy has failed (DAWNING): an open-label, non-inferiority, phase 3b trial | Chetchotisakd, P. | 2019 |
The Lancet Infectious Diseases 3 (19), pp. 253-264 |
||||||||
| 115. | Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in Asian participants with human immunodeficiency virus 1 infection: A sub-analysis of phase 3 clinical trials | Chetchotisakd, P. Supparatpinyo, K. Liu, Y. |
2019 |
HIV Research and Clinical Practice 3 (20), pp. 73-81 |
||||||||
| 116. | Influence of CYP3A5 and SLCO1B1 polymorphisms on atazanavir/r concentrations in Thai HIV-infected patients | Ruxrungtham, K. Bunupuradah, T. Kiertiburanakul, S. Chetchotisakd, P. Burger, D.M. Punyawudho, B. |
2019 |
Pharmacogenomics 7 (20), pp. 517-527 |
||||||||
| 117. | Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial | Rahav, G. Chetchotisakd, P. Lademacher, C. |
2019 |
Clinical Infectious Diseases 12 (68), pp. 1981-1989 |
||||||||
| 118. | Predictive validity of the qSOFA score for sepsis in adults with community-onset staphylococcal infection in Thailand | Tandhavanant, S. Chetchotisakd, P. Peacock, S.J. Chantratita, N. West, E.E. |
2019 |
Journal of Clinical Medicine 11 (8), pp. |
||||||||
| 119. | Switching to Fixed-Dose Bictegravir, Emtricitabine, and Tenofovir Alafenamide (B/F/TAF) in Virologically Suppressed HIV-1 Infected Women: A Randomized, Open-Label, Multicenter, Active-Controlled, Phase 3, Noninferiority Trial | Chetchotisakd, P. Supparatpinyo, K. Cao, H. |
2019 |
Journal of Acquired Immune Deficiency Syndromes 3 (82), pp. 321-328 |
||||||||
| 120. | Diagnosis of NTM active infection in lymphadenopathy patients with anti-interferon-gamma auto-antibody using inhibitory ELISA vs. indirect ELISA | Nithichanon, A. Chetchotisakd, P. Lertmemongkolchai, G. |
2020 |
Scientific Reports 1 (10), pp. |
||||||||
| 121. | Evaluation of plasma anti-GPL-core IgA and IgG for diagnosis of disseminated nontuberculous mycobacteria infection | Nithichanon, A. Chetchotisakd, P. Kewcharoenwong, C. Lertmemongkolchai, G. |
2020 |
PLoS ONE 11 November (15), pp. |
||||||||
| 122. | Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15–25 years: A phase IV randomized comparative study | Supparatpinyo, K. Basu, P.S.A. Chetchotisakd, P. Ruxrungtham, K. Poongulali, S. |
2020 |
EClinicalMedicine (23), pp. |
||||||||
| 123. | Natural history and evolution of anti-interferon-? autoantibody-associated immunodeficiency syndrome in Thailand and the United States | Chetchotisakd, P. Mootsikapun, P. Rosen, L.B. |
2020 |
Clinical Infectious Diseases 1 (71), pp. 53-62 |
||||||||
| 124. | A Comparison Between 12 Versus 20 Weeks of Trimethoprim-sulfamethoxazole as Oral Eradication Treatment for Melioidosis: An Open-label, Pragmatic, Multicenter, Non-inferiority, Randomized Controlled Trial | Anunnatsiri, S. Chaowagul, W. Teparrukkul, P. Chetchotisakd, P. Narenpitak, S. Pattarapongsin, M. Pisuttimarn, P. Thipmontree, W. Mootsikapun, P. Chaisuksant, S. Day, N.P.J. Limmathurotsakul, D. |
2021 |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 11 (73), pp. e3627-e3633 |
||||||||
| 125. | Antibiotic Prophylaxis Prior to Urodynamic Study in Patients with Neurogenic Bladder and Asymptomatic Bacteriuria: A Randomized Controlled Trial | Chetchotisakd, P. Kharmwan, S. |
2021 |
Journal of the Medical Association of Thailand (104), pp. S56-S62 |
||||||||
| 126. | Antibiotic susceptibility of clinical burkholderia pseudomallei isolates in northeast thailand from 2015 to 2018 and the genomic characterization of β-lactam-resistant isolates | Chaisuksant, S. Chetchotisakd, P. Chantràtita, W. Lertmemongkolchai, G. West, E.E. Chantratita, N. |
2021 |
Antimicrobial Agents and Chemotherapy 5 (65), pp. |
||||||||
| 127. | Assessment of in vitro activities of novel modified antimicrobial peptides against clarithromycin resistant Mycobacterium abscessus | Sirichoat, A. Chetchotisakd, P. Kanthawong, S. Faksri, K. |
2021 |
PLoS ONE November (16), pp. |
||||||||
| 128. | Factors Associated with Microbiological Outcomes to Colistin in Patients with Multidrug-resistant Gram-Negative Bacterial Infections | Anutrakulchai, S. Chetchotisakd, P. |
2021 |
Journal of the Medical Association of Thailand (104), pp. S126-S133 |
||||||||
| 129. | Reducing antibiotic treatment duration for ventilator-associated pneumonia (REGARD-VAP): A trial protocol for a randomised clinical trial | West, E.E. Chetchotisakd, P. Tambyah, P.A.N. Limmathurotsakul, D. |
2021 |
BMJ Open 5 (11), pp. |
||||||||
| 130. | High rate of reinfection and possible transmission of Mycobacterium avium complex in Northeast Thailand | Nithichanon, A. Ananta, P. Chaimanee, P. Salao, K. Phoksawat, W. Laohaviroj, M. Sirichoat, A. Wongwajana, S. Namwat, W. Lulitanond, V. Chetchotisakd, P. Faksri, K. |
2022 |
One Health (14), pp. |
||||||||
| 131. | Pharmacogenetics-based population pharmacokinetic analysis for dose optimization of ritonavir-boosted atazanavir in Thai adult HIV-infected patients | Ruxrungtham, K. Bunupuradah, T. Kiertiburanakul, S. Chetchotisakd, P. Punyawudho, B. |
2022 |
Expert Review of Clinical Pharmacology 1 (15), pp. 99-108 |
||||||||
| 132. | Rank correlation inferences for clustered data with small sample size | Chetchotisakd, P. | 2022 |
Statistica Neerlandica 3 (76), pp. 309-330 |
||||||||
| 133. | Varicella zoster meningitis following COVID-19 vaccination: a report of two cases | Kotruchin, P. Mootsikapun, P. Chetchotisakd, P. |
2022 |
International Journal of Infectious Diseases (119), pp. 214-216 |
||||||||
| 134. | Whole-Genome Sequencing and Drug-Susceptibility Analysis of Serial Mycobacterium abscessus Isolates from Thai Patients | Kaewprasert, O. Nonghanphithak, D. Chetchotisakd, P. Namwat, W. Ong, R.T.-H. Faksri, K. |
2022 |
Biology 9 (11), pp. |
||||||||
| 135. | Antibiotic susceptibility of clinical Burkholderia pseudomallei isolates in northeast Thailand during 2015-2018 and the genomic characterization of β-lactam-resistant isolates | Fen, S.H.Y. Tandhavanant, S. Phunpang, R. |
2023 |
Antimicrobial agents and chemotherapy 5 (95), pp. |
||||||||
| 136. | Characteristics and one year outcomes of melioidosis patients in Northeastern Thailand: a prospective, multicenter cohort study | Chantratita, N. Phunpang, R. Yarasai, A. Dulsuk, A. Yimthin, T. Onofrey, L.A. Coston, T.D. Thiansukhon, E. Chaisuksant, S. Tanwisaid, K. Chuananont, S. Morakot, C. Sangsa, N. Chayangsu, S. Silakun, W. Buasi, N. Chetchotisakd, P. Day, N.P.J. Lertmemongkolchai, G. West, T.E. |
2023 |
The Lancet Regional Health - Southeast Asia (9), pp. |
||||||||
| 137. | Efficacy and safety of switching to bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed Asian adults living with HIV: A pooled analysis from three international phase III randomized trials | Chetchotisakd, P. Kiertiburanakul, S. Siripassorn, K. Supparatpinyo, K. |
2023 |
HIV Medicine 3 (24), pp. 290-300 |
||||||||
| 138. | Evaluating anti-GPL-core IgA as a diagnostic tool for non-tuberculous mycobacterial infections in Thai patients with high antibody background | Manbenmad, V. So-ngern, A. Chetchotisakd, P. Faksri, K. Ato, M. Nithichanon, A. Lertmemongkolchai, G. |
2023 |
Scientific Reports 1 (13), pp. |
||||||||
| 139. | Intra-abdominal Abscesses due to Melioidosis: Clinical Course and Outcomes | Anunnatsiri, S. Chetchotisakd, P. |
2023 |
Journal of the Medical Association of Thailand 4 (104), pp. S12-S18 |
||||||||
| 140. | Virological outcomes and metabolic effects after switching from ritonavir-boosted protease inhibitors to a dolutegravir-based regimen in virologically suppressed patients living with HIV | Sribenjalux, W. Nuntawit, T. Meesing, A. Chetchotisakd, P. |
2023 |
International Journal of STD and AIDS 2 (34), pp. 98-107 |
||||||||
| 141. | Statin Use and Reduced Risk of Pneumonia in Patients with Melioidosis A Lung-Specific Statin Association | Coston, T.D. Wright, S.W. Phunpang, R. Dulsuk, A. Thiansukhon, E. Chaisuksant, S. Tanwisaid, K. Chuananont, S. Morakot, C. Sangsa, N. Chayangsu, S. Silakun, W. Buasi, N. Chetchotisakd, P. |
2024 |
Annals of the American Thoracic Society 2 (21), pp. 228-234 |
||||||||
| 142. | Risk of severe bacterial infections including TB before and after immediate or deferred antiretroviral therapy: A multicenter, prospective, cohort study | Jensen, T.O. Sharma, S. Avihingsanon, A. Lutaakome, J. Brar, I. Burman, W. Chetchotisakd, P. de Castro, N. Galán-Herrera, J.F. Kumarasamy, N. Paredes, R. Ridzon, R. Sciaudone, M. Singh, K. Uriel, A. Lundgren, J. Reilly, C. Matthews, G. |
2025 |
International Journal of Infectious Diseases (156), pp. |
||||||||
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Rhinocerebral mucormycosis: a report of eleven cases. | Chetchotisakd, P Boonma, P Sookpranee, M Pairojkul, C |
1991 |
The Southeast Asian journal of tropical medicine and public health 2 (22), pp. 268-73 |
|
| 2. | Hospital acquired Janthinobacterium lividum septicemia in Srinagarind Hospital. | Patijanasoontorn, B Boonma, P Wilailackana, C Sitthikesorn, J Lumbiganon, P Chetchotisakd, P Noppawinyoowong, C Simajareuk, K |
1992 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet (75), pp. 6-10 |
|
| 3. | Human pythiosis in Srinagarind Hospital: one year's experience. | Chetchotisakd, P Pairojkul, C Porntaveevudhi, O Sathapatayavongs, B Mairiang, P Nuntirooj, K Patjanasoontorn, B Saew, OT Chaiprasert, AK Haswell-Elkins, MR |
1992 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 4 (75), pp. 248-54 |
|
| 4. | Assessment of bacterial cross-transmission as a cause of infections in patients in intensive care units. | Chetchotisakd, P Phelps, CL Hartstein, AI |
1994 |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 6 (18), pp. 929-37 |
|
| 5. | Typing of sequential bacterial isolates by pulsed-field gel electrophoresis. | Hartstein, AI Chetchotisakd, P Phelps, CL LeMonte, AM |
1995 |
Diagnostic microbiology and infectious disease 4 (22), pp. 309-14 |
|
| 6. | Pulmonary infections in HIV infected patients. | Mootsikapun, P Chetchotisakd, P Intarapoka, B |
1996 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 8 (79), pp. 477-85 |
|
| 7. | Sweet's syndrome associated with non-tuberculous mycobacterial infection: a report of five cases. | Choonhakarn, C Chetchotisakd, P Jirarattanapochai, K Mootsikapun, P |
1998 |
The British journal of dermatology 1 (139), pp. 107-10 |
|
| 8. | Cefoperazone/sulbactam + co-trimoxazole vs ceftazidime + co-trimoxazole in the treatment of severe melioidosis: a randomized, double-blind, controlled study. | Thamprajamchit, S Chetchotisakd, P Thinkhamrop, B |
1998 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 4 (81), pp. 265-71 |
|
| 9. | Risk factors for melioidosis and bacteremic melioidosis. | Suputtamongkol, Y Chaowagul, W Chetchotisakd, P Lertpatanasuwun, N Intaranongpai, S Ruchutrakool, T Budhsarawong, D Mootsikapun, P Wuthiekanun, V Teerawatasook, N Lulitanond, A |
1999 |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2 (29), pp. 408-13 |
|
| 10. | Efficacy and safety of twice daily administration of cefpirome in the empiric treatment of sepsis. | Suwangool, P Suttinont, C Bowonwatanuwong, C Rajanuwong, A Kulpradist, SA Dusitnanond, V Chayakul, P Chetchotisakd, P Leelasupasri, S Aswapokee, N |
1999 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 7 (82), pp. 648-53 |
|
| 11. | Antilipopolysaccharide II: an antibody protective against fatal melioidosis. | Charuchaimontri, C Suputtamongkol, Y Nilakul, C Chaowagul, W Chetchotisakd, P Lertpatanasuwun, N Intaranongpai, S Brett, PJ Woods, DE |
1999 |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 4 (29), pp. 813-8 |
|
| 12. | Factors associated with severe manifestations of histoplasmosis in AIDS. | Wheat, LJ Chetchotisakd, P Williams, B Connolly, P Shutt, K Hajjeh, R |
2000 |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 6 (30), pp. 877-81 |
|
| 13. | Disseminated infection due to rapidly growing mycobacteria in immunocompetent hosts presenting with chronic lymphadenopathy: a previously unrecognized clinical entity. | Chetchotisakd, P Mootsikapun, P Anunnatsiri, S Jirarattanapochai, K Choonhakarn, C Chaiprasert, A Ubol, PN Wheat, LJ Davis, TE |
2000 |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1 (30), pp. 29-34 |
|
| 14. | Comparison between the antimicrobial susceptibility of Burkholderia pseudomallei to trimethoprim-sulfamethoxazole by standard disk diffusion method and by minimal inhibitory concentration determination. | Lumbiganon, P Tattawasatra, U Chetchotisakd, P Wongratanacheewin, S Thinkhamrop, B |
2000 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 8 (83), pp. 856-60 |
|
| 15. | Randomized, double-blind, controlled study of cefoperazone-sulbactam plus cotrimoxazole versus ceftazidime plus cotrimoxazole for the treatment of severe melioidosis. | Chetchotisakd, P Porramatikul, S Mootsikapun, P Anunnatsiri, S Thinkhamrop, B |
2001 |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1 (33), pp. 29-34 |
|
| 16. | Clinical outcome of native valve infective endocarditis in Khon Kaen: 1990-1999. | Pachirat, O Klungboonkrong, V Tantisirin, C Taweesangsuksakul, P Tasanavivat, P Chetchotisakd, P Limwattananon, S |
2002 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 2 (85), pp. 139-46 |
|
| 17. | A randomized, open-label, comparative trial of BID and TID dosing of saquinavir enhanced oral formulation as part of a triple therapy for advanced AIDS patients. | Chetchotisakd, P Anunnatsiri, S Wankun, J Mootsikapun, P Boonyaprawit, P |
2002 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 5 (85), pp. 590-6 |
|
| 18. | Infective endocarditis: prevalence, characteristics and mortality in Khon Kaen, 1990-1999. | Pachirat, O Chetchotisakd, P Klungboonkrong, V Taweesangsuksakul, P Tantisirin, C Loapiboon, M |
2002 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 1 (85), pp. 1-10 |
|
| 19. | Efavirenz-based regimen as treatment of advanced AIDS with cryptococcal meningitis. | Sungkanuparph, S Vibhagool, A Mootsikapun, P Chetchotisakd, P Tansuphaswaswadikul, S Bowonwatanuwong, C Chantratita, W |
2003 |
Journal of acquired immune deficiency syndromes (1999) 1 (33), pp. 118-9 |
|
| 20. | Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study. | Vibhagool, A Sungkanuparph, S Mootsikapun, P Chetchotisakd, P Tansuphaswaswadikul, S Bowonwatanuwong, C Ingsathit, A |
2003 |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 10 (36), pp. 1329-31 |
|
| 21. | Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial. | Ananworanich, J Nuesch, R Le Braz, M Chetchotisakd, P Vibhagool, A Wicharuk, S Ruxrungtham, K Furrer, H Cooper, D Hirschel, B Bernasconi, E Cavassini, M Ebnöther, C Fagard, C Genné, D Khanna, N Perrin, L Phanupak, P Ubolyam, S Vernazza, P Yerly, S , |
2003 |
AIDS (London, England) 15 (17), pp. F33-7 |
|
| 22. | The efficacy of fluconazole 600 mg/day versus itraconazole 600 mg/day as consolidation therapy of cryptococcal meningitis in AIDS patients. | Mootsikapun, P Chetchotisakd, P Anunnatsiri, S Choksawadphinyo, K |
2003 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 4 (86), pp. 293-8 |
|
| 23. | Opportunistic infections after the initiation of highly active antiretroviral therapy in advanced AIDS patients in an area with a high prevalence of tuberculosis. | Sungkanuparph, S Vibhagool, A Mootsikapun, P Chetchotisakd, P Tansuphaswaswadikul, S Bowonwatanuwong, C |
2003 |
AIDS (London, England) 14 (17), pp. 2129-31 |
|
| 24. | A multicentre, randomized, double-blind, placebo-controlled trial of primary cryptococcal meningitis prophylaxis in HIV-infected patients with severe immune deficiency. | Chetchotisakd, P Sungkanuparph, S Thinkhamrop, B Mootsikapun, P Boonyaprawit, P |
2004 |
HIV medicine 3 (5), pp. 140-3 |
|
| 25. | Two randomized controlled trials of ceftazidime alone versus ceftazidime in combination with trimethoprim-sulfamethoxazole for the treatment of severe melioidosis. | Chierakul, W Anunnatsiri, S Short, JM Maharjan, B Mootsikapun, P Simpson, AJ Limmathurotsakul, D Cheng, AC Stepniewska, K Newton, PN Chaowagul, W White, NJ Peacock, SJ Day, NP Chetchotisakd, P |
2005 |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 8 (41), pp. 1105-13 |
|
| 26. | Efficacy and safety of indinavir/ritonavir 400/100 mg twice daily plus two nucleoside analogues in treatment-naive HIV-1-infected patients with CD4+ T-cell counts <200 cells/mm3: 96-week outcomes. | Mootsikapun, P Chetchotisakd, P Anunnatsiri, S Boonyaprawit, P |
2005 |
Antiviral therapy 8 (10), pp. 911-6 |
|
| 27. | Effect of changes in diagnosis and management of active infective endocarditis on the clinical outcome at Srinagarind Hospital. | Pachirat, O Kiatchoosakun, S Chetchotisakd, P Tantisirin, C Limwattananon, S Limwattananon, J |
2005 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 4 (88), pp. 498-504 |
|
| 28. | Factors associated with treatment outcomes in pulmonary tuberculosis in northeastern Thailand. | Anunnatsiri, S Chetchotisakd, P Wanke, C |
2005 |
The Southeast Asian journal of tropical medicine and public health 2 (36), pp. 324-30 |
|
| 29. | A prospective study of efficacy and safety of once-daily saquinavir/ritonavir plus two nucleoside reverse transcriptase inhibitors in treatment-naive Thai patients. | Ananworanich, J Hill, A Siangphoe, U Ruxrungtham, K Prasithsirikul, W Chetchotisakd, P Kiertiburanakul, S Munsakul, W Raksakulkarn, P Tansuphasawadikul, S Nuesch, R Cooper, DA Hirschel, B , |
2005 |
Antiviral therapy 6 (10), pp. 761-7 |
|
| 30. | Body composition in adults infected with human immunodeficiency virus in Khon Kaen, Thailand. | Ludy, MJ Hendricks, K Houser, R Chetchotisakd, P Mootsikapun, P Anunnatsiri, S Price, E Wanke, CA |
2005 |
The American journal of tropical medicine and hygiene 4 (73), pp. 815-9 |
|
| 31. | Absence of resistance mutations in antiretroviral-naive patients treated with ritonavir-boosted saquinavir. | Ananworanich, J Hirschel, B Sirivichayakul, S Ubolyam, S Jupimai, T Prasithsirikul, W Chetchotisakd, P Kiertiburanakul, S Munsakul, W Raksakulkarn, P Tansuphasawadikul, S Schutz, M Snowden, W Ruxrungtham, K , |
2006 |
Antiviral therapy 5 (11), pp. 631-5 |
|
| 32. | Clinical and epidemiological analyses of human pythiosis in Thailand. | Krajaejun, T Sathapatayavongs, B Pracharktam, R Nitiyanant, P Leelachaikul, P Wanachiwanawin, W Chaiprasert, A Assanasen, P Saipetch, M Mootsikapun, P Chetchotisakd, P Lekhakula, A Mitarnun, W Kalnauwakul, S Supparatpinyo, K Chaiwarith, R Chiewchanvit, S Tananuvat, N Srisiri, S Suankratay, C Kulwichit, W Wongsaisuwan, M Somkaew, S |
2006 |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 5 (43), pp. 569-76 |
|
| 33. | CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial. | Ananworanich, J Gayet-Ageron, A Le Braz, M Prasithsirikul, W Chetchotisakd, P Kiertiburanakul, S Munsakul, W Raksakulkarn, P Tansuphasawasdikul, S Sirivichayakul, S Cavassini, M Karrer, U Genné, D Nüesch, R Vernazza, P Bernasconi, E Leduc, D Satchell, C Yerly, S Perrin, L Hill, A Perneger, T Phanuphak, P Furrer, H Cooper, D Ruxrungtham, K Hirschel, B , , |
2006 |
Lancet (London, England) 9534 (368), pp. 459-65 |
|
| 34. | High rate multiple drug resistances in HIV-infected patients failing nonnucleoside reverse transcriptase inhibitor regimens in Thailand, where subtype A/E is predominant. | Chetchotisakd, P Anunnatsiri, S Kiertiburanakul, S Sutthent, R Anekthananon, T Bowonwatanuwong, C Kowadisaiburana, B Supparatpinyo, K Horsakulthai, M Chasombat, S Ruxrungtham, K , , , , , , , , |
2006 |
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 4 (5), pp. 152-6 |
|
| 35. | Disseminated nontuberculous mycobacterial infection in patients who are not infected with HIV in Thailand. | Chetchotisakd, P Kiertiburanakul, S Mootsikapun, P Assanasen, S Chaiwarith, R Anunnatsiri, S |
2007 |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 4 (45), pp. 421-7 |
|
| 36. | Addition of trimethoprim-sulfamethoxazole to ceftazidime during parenteral treatment of melioidosis is not associated with a long-term outcome benefit. | Chierakul, W Anunnatsiri, S Chaowagul, W Peacock, SJ Chetchotisakd, P Day, NP |
2007 |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 4 (45), pp. 521-3 |
|
| 37. | Efficacy and tolerability of a double boosted protease inhibitor (lopinavir + saquinavir/ritonavir) regimen in HIV-infected patients who failed treatment with nonnucleoside reverse transcriptase inhibitors. | Chetchotisakd, P Anunnatsiri, S Mootsikapun, P Kiertiburanakul, S Anekthananon, T Bowonwatanuwong, C Kowadisaiburana, B Supparatpinyo, K Ruxrungtham, K , , , , , , , , |
2007 |
HIV medicine 8 (8), pp. 529-35 |
|
| 38. | A rapidly fatal case of Panton-valentine leukocidin positive Staphylococcus aureus necrotizing pneumonia in an HIV-infected patient. | Chetchotisakd, P Anunnatsiri, S Puapermpoonsiri, S Prariyachatgul, C Chumpol, J |
2007 |
The Southeast Asian journal of tropical medicine and public health 4 (38), pp. 690-4 |
|
| 39. | No change in calculated creatinine clearance after tenofovir initiation among Thai patients. | Gayet-Ageron, A Ananworanich, J Jupimai, T Chetchotisakd, P Prasithsirikul, W Ubolyam, S Le Braz, M Ruxrungtham, K Rooney, JF Hirschel, B , |
2007 |
The Journal of antimicrobial chemotherapy 5 (59), pp. 1034-7 |
|
| 40. | Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial. | Kuse, ER Chetchotisakd, P da Cunha, CA Ruhnke, M Barrios, C Raghunadharao, D Sekhon, JS Freire, A Ramasubramanian, V Demeyer, I Nucci, M Leelarasamee, A Jacobs, F Decruyenaere, J Pittet, D Ullmann, AJ Ostrosky-Zeichner, L Lortholary, O Koblinger, S Diekmann-Berndt, H Cornely, OA , |
2007 |
Lancet (London, England) 9572 (369), pp. 1519-27 |
|
| 41. | Interruptions of tenofovir/emtricitabine-based antiretroviral therapy in patients with HIV/hepatitis B virus co-infection. | Nüesch, R Ananworanich, J Srasuebkul, P Chetchotisakd, P Prasithsirikul, W Klinbuayam, W Mahanontharit, A Jupimai, T Ruxrungtham, K Hirschel, B |
2008 |
AIDS (London, England) 1 (22), pp. 152-4 |
|
| 42. | Mycotic aneurysm in Northeast Thailand: the importance of Burkholderia pseudomallei as a causative pathogen. | Anunnatsiri, S Chetchotisakd, P Kularbkaew, C |
2008 |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 11 (47), pp. 1436-9 |
|
| 43. | Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study. | Molina, JM Andrade-Villanueva, J Echevarria, J Chetchotisakd, P Corral, J David, N Moyle, G Mancini, M Percival, L Yang, R Thiry, A McGrath, D , |
2008 |
Lancet (London, England) 9639 (372), pp. 646-55 |
|
| 44. | Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents: the recommendations of the Thai AIDS Society (TAS) 2008. | Sungkanuparph, S Anekthananon, T Hiransuthikul, N Bowonwatanuwong, C Supparatpinyo, K Mootsikapun, P Chetchotisakd, P Kiertiburanakul, S Tansuphaswadikul, S Buppanharun, W Manosuthi, W Techasathit, W Ratanasuwan, W Tantisiriwat, W Suwanagool, S Leechawengwongs, M Ruxrungtham, K , |
2008 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 12 (91), pp. 1925-35 |
|
| 45. | Consensus guidelines for dosing of amoxicillin-clavulanate in melioidosis. | Cheng, AC Chierakul, W Chaowagul, W Chetchotisakd, P Limmathurotsakul, D Dance, DA Peacock, SJ Currie, BJ |
2008 |
The American journal of tropical medicine and hygiene 2 (78), pp. 208-9 |
|
| 46. | Long-term efficacy and safety of first-line therapy with once-daily saquinavir/ritonavir. | Ananworanich, J Gayet-Ageron, A Ruxrungtham, K Chetchotisakd, P Prasithsirikul, W Kiertiburanakul, S Munsakul, W Raksakulkarn, P Tansuphasawadikul, S LeBraz, M Jupimai, T Ubolyam, S Schutz, M Hirschel, B , |
2008 |
Antiviral therapy 3 (13), pp. 375-80 |
|
| 47. | Low-dose, once-daily atazanavir/ritonavir (200/100): an effective treatment for HIV-infected patients in Thailand. | Chetchotisakd, P Anunnatsiri, S |
2008 |
Journal of acquired immune deficiency syndromes (1999) 2 (49), pp. 230-1 |
|
| 48. | Use of a low-dose steroid as an adjunct in the treatment, in mice, of severe sepsis caused by Burkholderia pseudomallei. | Panomket, P Chetchotisakd, P Sermswan, RW Pannengpetch, P Wongratanacheewin, S |
2009 |
Annals of tropical medicine and parasitology 7 (103), pp. 635-46 |
|
| 49. | The CASTLE study: atazanavir/r versus lopinavir/r in antiretroviral-naive patients. | Chetchotisakd, P | 2009 |
Expert review of anti-infective therapy 7 (7), pp. 801-5 |
|
| 50. | Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study. | Sungkanuparph, S Filler, SG Chetchotisakd, P Pappas, PG Nolen, TL Manosuthi, W Anekthananon, T Morris, MI Supparatpinyo, K Kopetskie, H Kendrick, AS Johnson, PC Sobel, JD Larsen, RA |
2009 |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 6 (49), pp. 931-4 |
|
| 51. | Effect of high-dose fluconazole on QT interval in patients with human immunodeficiency virus (HIV)-associated cryptococcal meningitis. | Manosuthi, W Sungkanuparph, S Anekthananon, T Supparatpinyo, K Nolen, TL Zimmer, LO Pappas, PG Larsen, RA Filler, SG Chetchotisakd, P , |
2009 |
International journal of antimicrobial agents 5 (34), pp. 494-6 |
|
| 52. | The impact of combination antiretroviral therapy and its interruption on anxiety, stress, depression and quality of life in Thai patients. | Nüesch, R Gayet-Ageron, A Chetchotisakd, P Prasithsirikul, W Kiertiburanakul, S Munsakul, W Raksakulkarn, P Tansuphasawasdikul, S Chautrakarn, S Ruxrungtham, K Hirschel, B Anaworanich, J , |
2009 |
The open AIDS journal (3), pp. 38-45 |
|
| 53. | A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis. | Pappas, PG Chetchotisakd, P Larsen, RA Manosuthi, W Morris, MI Anekthananon, T Sungkanuparph, S Supparatpinyo, K Nolen, TL Zimmer, LO Kendrick, AS Johnson, P Sobel, JD Filler, SG |
2009 |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 12 (48), pp. 1775-83 |
|
| 54. | Fungemia in non-HIV-infected patients: a five-year review. | Anunnatsiri, S Chetchotisakd, P Mootsikapun, P |
2009 |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 1 (13), pp. 90-6 |
|
| 55. | Phenotypic and functional characterization of human memory T cell responses to Burkholderia pseudomallei. | Tippayawat, P Saenwongsa, W Mahawantung, J Suwannasaen, D Chetchotisakd, P Limmathurotsakul, D Peacock, SJ Felgner, PL Atkins, HS Titball, RW Bancroft, GJ Lertmemongkolchai, G |
2009 |
PLoS neglected tropical diseases 4 (3), pp. e407 |
|
| 56. | Melioidosis pericarditis mimicking tuberculous pericarditis. | Chetchotisakd, P Anunnatsiri, S Kiatchoosakun, S Kularbkaew, C |
2010 |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 5 (51), pp. e46-9 |
|
| 57. | Once-daily atazanavir/ritonavir compared with twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 96-week efficacy and safety results of the CASTLE study. | Molina, JM Andrade-Villanueva, J Echevarria, J Chetchotisakd, P Corral, J David, N Moyle, G Mancini, M Percival, L Yang, R Wirtz, V Lataillade, M Absalon, J McGrath, D , |
2010 |
Journal of acquired immune deficiency syndromes (1999) 3 (53), pp. 323-32 |
|
| 58. | Monitoring and impact of fluconazole serum and cerebrospinal fluid concentration in HIV-associated cryptococcal meningitis-infected patients. | Manosuthi, W Chetchotisakd, P Nolen, TL Wallace, D Sungkanuparph, S Anekthananon, T Supparatpinyo, K Pappas, PG Larsen, RA Filler, SG Andes, D , |
2010 |
HIV medicine 4 (11), pp. 276-81 |
|
| 59. | International collaboration between US and Thailand on a clinical trial of treatment for HIV-associated cryptococcal meningitis. | Zimmer, LO Nolen, TL Pramanpol, S Wallace, D Walker, ME Pappas, P Chetchotisakd, P |
2010 |
Contemporary clinical trials 1 (31), pp. 34-43 |
|
| 60. | Increasing incidence of human melioidosis in Northeast Thailand. | Limmathurotsakul, D Wongratanacheewin, S Teerawattanasook, N Wongsuvan, G Chaisuksant, S Chetchotisakd, P Chaowagul, W Day, NP Peacock, SJ |
2010 |
The American journal of tropical medicine and hygiene 6 (82), pp. 1113-7 |
|
| 61. | Predictors of poor clinical outcome of cryptococcal meningitis in HIV-infected patients. | Anekthananon, T Manosuthi, W Chetchotisakd, P Kiertiburanakul, S Supparatpinyo, K Ratanasuwan, W Pappas, PG Filler, SG Kopetskie, HA Nolen, TL Kendrick, AS Larsen, RA , |
2011 |
International journal of STD & AIDS 11 (22), pp. 665-70 |
|
| 62. | Etravirine and rilpivirine resistance in HIV-1 subtype CRF01_AE-infected adults failing non-nucleoside reverse transcriptase inhibitor-based regimens. | Bunupuradah, T Ananworanich, J Chetchotisakd, P Kantipong, P Jirajariyavej, S Sirivichayakul, S Munsakul, W Prasithsirikul, W Sungkanuparph, S Bowonwattanuwong, C Klinbuayaem, V Petoumenos, K Hirschel, B Bhakeecheep, S Ruxrungtham, K |
2011 |
Antiviral therapy 7 (16), pp. 1113-21 |
|
| 63. | Assessing adherence in Thai patients taking combination antiretroviral therapy. | Kerr, SJ Avihingsanon, A Putcharoen, O Chetchotisakd, P Layton, M Ubolyam, S Ruxrungtham, K Cooper, DA Phanuphak, P Duncombe, C |
2012 |
International journal of STD & AIDS 3 (23), pp. 160-5 |
|
| 64. | Emergence of NDM-1- and IMP-14a-producing Enterobacteriaceae in Thailand. | Rimrang, B Chanawong, A Lulitanond, A Wilailuckana, C Charoensri, N Sribenjalux, P Phumsrikaew, W Wonglakorn, L Kerdsin, A Chetchotisakd, P |
2012 |
The Journal of antimicrobial chemotherapy 11 (67), pp. 2626-30 |
|
| 65. | Adult-onset immunodeficiency in Thailand and Taiwan. | Browne, SK Burbelo, PD Chetchotisakd, P Suputtamongkol, Y Kiertiburanakul, S Shaw, PA Kirk, JL Jutivorakool, K Zaman, R Ding, L Hsu, AP Patel, SY Olivier, KN Lulitanond, V Mootsikapun, P Anunnatsiri, S Angkasekwinai, N Sathapatayavongs, B Hsueh, PR Shieh, CC Brown, MR Thongnoppakhun, W Claypool, R Sampaio, EP Thepthai, C Waywa, D Dacombe, C Reizes, Y Zelazny, AM Saleeb, P Rosen, LB Mo, A Iadarola, M Holland, SM |
2012 |
The New England journal of medicine 8 (367), pp. 725-34 |
|
| 66. | Neurocognitive impairment in patients randomized to second-line lopinavir/ritonavir-based antiretroviral therapy vs. lopinavir/ritonavir monotherapy. | Bunupuradah, T Chetchotisakd, P Jirajariyavej, S Valcour, V Bowonwattanuwong, C Munsakul, W Klinbuayaem, V Prasithsirikul, W Sophonphan, J Mahanontharit, A Hirschel, B Bhakeecheep, S Ruxrungtham, K Ananworanich, J , |
2012 |
Journal of neurovirology 6 (18), pp. 479-87 |
|
| 67. | A randomized comparison of second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir in patients failing NNRTI regimens: the HIV STAR study. | Bunupuradah, T Chetchotisakd, P Ananworanich, J Munsakul, W Jirajariyavej, S Kantipong, P Prasithsirikul, W Sungkanuparph, S Bowonwatanuwong, C Klinbuayaem, V Kerr, SJ Sophonphan, J Bhakeecheep, S Hirschel, B Ruxrungtham, K , |
2012 |
Antiviral therapy 7 (17), pp. 1351-61 |
|
| 68. | Cobicistat versus ritonavir as a pharmacoenhancer of atazanavir plus emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV type 1-infected patients: week 48 results. | Gallant, JE Koenig, E Andrade-Villanueva, J Chetchotisakd, P DeJesus, E Antunes, F Arastéh, K Moyle, G Rizzardini, G Fehr, J Liu, Y Zhong, L Callebaut, C Szwarcberg, J Rhee, MS Cheng, AK |
2013 |
The Journal of infectious diseases 1 (208), pp. 32-9 |
|
| 69. | Week 96 efficacy and safety of rilpivirine in treatment-naive, HIV-1 patients in two Phase III randomized trials. | Cohen, CJ Molina, JM Cassetti, I Chetchotisakd, P Lazzarin, A Orkin, C Rhame, F Stellbrink, HJ Li, T Crauwels, H Rimsky, L Vanveggel, S Williams, P Boven, K , |
2013 |
AIDS (London, England) 6 (27), pp. 939-50 |
|
| 70. | Ergotism in Thailand caused by increased access to antiretroviral drugs: a global warning. | Avihingsanon, A Ramautarsing, RA Suwanpimolkul, G Chetchotisakd, P Bowonwatanuwong, C Jirajariyavej, S Kantipong, P Tantipong, H Ohata, JP Suankratay, C Ruxrungtham, K Burger, DM |
2014 |
Topics in antiviral medicine 5 (21), pp. 165-8 |
|
| 71. | Linezolid in the treatment of disseminated nontuberculous mycobacterial infection in anti-interferon-gamma autoantibody-positive patients. | Chetchotisakd, P Anunnatsiri, S |
2014 |
The Southeast Asian journal of tropical medicine and public health 5 (45), pp. 1125-31 |
|
| 72. | Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial. | Chetchotisakd, P Chierakul, W Chaowagul, W Anunnatsiri, S Phimda, K Mootsikapun, P Chaisuksant, S Pilaikul, J Thinkhamrop, B Phiphitaporn, S Susaengrat, W Toondee, C Wongrattanacheewin, S Wuthiekanun, V Chantratita, N Thaipadungpanit, J Day, NP Limmathurotsakul, D Peacock, SJ |
2014 |
Lancet (London, England) 9919 (383), pp. 807-14 |
|
| 73. | Cost-effectiveness analysis of parenteral antimicrobials for acute melioidosis in Thailand. | Hantrakun, V Chierakul, W Chetchotisakd, P Anunnatsiri, S Currie, BJ Peacock, SJ Day, NP Cheah, P Limmathurotsakul, D Lubell, Y |
2015 |
Transactions of the Royal Society of Tropical Medicine and Hygiene 6 (109), pp. 416-8 |
|
| 74. | Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2014, Thailand. | Manosuthi, W Ongwandee, S Bhakeecheep, S Leechawengwongs, M Ruxrungtham, K Phanuphak, P Hiransuthikul, N Ratanasuwan, W Chetchotisakd, P Tantisiriwat, W Kiertiburanakul, S Avihingsanon, A Sukkul, A Anekthananon, T , , , , , , , , |
2015 |
AIDS research and therapy (12), pp. 12 |
|
| 75. | Cerebrospinal fluid exposure of efavirenz and its major metabolites when dosed at 400 mg and 600 mg once daily: a randomized controlled trial. | Winston, A Amin, J Clarke, A Else, L Amara, A Owen, A Barber, T Jessen, H Avihingsanon, A Avinghsanon, A Chetchotisakd, P Khoo, S Cooper, DA Emery, S Puls, R , , , , , , , , , , , , , , , , , , , , , , , , |
2015 |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 7 (60), pp. 1026-32 |
|
| 76. | Brief Report: Cobicistat Compared With Ritonavir as a Pharmacoenhancer for Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate: Week 144 Results. | Gallant, JE Koenig, E Andrade-Villanueva, JF Chetchotisakd, P DeJesus, E Antunes, F Arastéh, K Rizzardini, G Fehr, J Liu, HC Abram, ME Cao, H Szwarcberg, J |
2015 |
Journal of acquired immune deficiency syndromes (1999) 3 (69), pp. 338-40 |
|
| 77. | Pilot study of a non-return catheter valve for reducing catheter-associated urinary tract infections in critically ill patients. | Panitchote, A Charoensri, S Chetchotisakd, P Hurst, C |
2015 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 2 (98), pp. 150-5 |
|
| 78. | Serological diagnosis of pulmonary Mycobacterium tuberculosis infection by LIPS using a multiple antigen mixture. | Burbelo, PD Keller, J Wagner, J Klimavicz, JS Bayat, A Rhodes, CS Diarra, B Chetchotisakd, P Suputtamongkol, Y Kiertiburanakul, S Holland, SM Browne, SK Siddiqui, S Kovacs, JA |
2015 |
BMC microbiology 1 (15), pp. 205 |
|
| 79. | Cost-effectiveness analysis of parenteral antimicrobials for acute melioidosis in Thailand. | Hantrakun, V Chierakul, W Chetchotisakd, P Anunnatsiri, S Currie, BJ Peacock, SJ Day, NP Cheah, PY Limmathurotsakul, D Lubell, Y |
2015 |
Transactions of the Royal Society of Tropical Medicine and Hygiene 12 (109), pp. 803 |
|
| 80. | A qualitative assessment of barriers and facilitators to antiretroviral adherence in Thai patients. | Phuphanich, M Rattanamahattana, M Avihingsanon, A Chetchotisakd, P Putcharoen, O Gandhi, M Sohn, AH Imrie, J Phanuphak, P Kerr, SJ |
2016 |
Journal of virus eradication 1 (2), pp. 22-7 |
|
| 81. | Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): a randomised, open-label, non-inferiority trial. | Bunupuradah, T Kiertiburanakul, S Avihingsanon, A Chetchotisakd, P Techapornroong, M Leerattanapetch, N Kantipong, P Bowonwatanuwong, C Banchongkit, S Klinbuayaem, V Mekviwattanawong, S Nimitvilai, S Jirajariyavej, S Prasithsirikul, W Munsakul, W Bhakeecheep, S Chaivooth, S Phanuphak, P Cooper, DA Apornpong, T Kerr, SJ Emery, S Ruxrungtham, K , |
2016 |
The lancet. HIV 8 (3), pp. e343-50 |
|
| 82. | Antiretroviral Resistance After First-Line Antiretroviral Therapy Failure in Diverse HIV-1 Subtypes in the SECOND-LINE Study. | Lam, EP Moore, CL Gotuzzo, E Nwizu, C Kamarulzaman, AB Chetchotisakd, P van Wyk, J Teppler, H Kumarasamy, N Molina, JM Emery, S Cooper, DA Boyd, MA |
2016 |
AIDS research and human retroviruses 9 (32), pp. 841-50 |
|
| 83. | Clinical features and outcomes of Sweet's syndrome associated with non-tuberculous mycobacterial infection and other associated diseases. | Chaowattanapanit, S Choonhakarn, C Chetchotisakd, P Sawanyawisuth, K Julanon, N |
2016 |
The Journal of dermatology 5 (43), pp. 532-6 |
|
| 84. | Anti-IFN-γ autoantibodies are strongly associated with HLA-DR*15:02/16:02 and HLA-DQ*05:01/05:02 across Southeast Asia. | Ku, CL Lin, CH Chang, SW Chan, JF Kong, XF Lee, CH Rosen, EA Ding, JY Lee, WI Bustamante, J Witte, T Shih, HP Kuo, CY Chetchotisakd, P Kiertiburanakul, S Suputtamongkol, Y Yuen, KY Casanova, JL Holland, SM Doffinger, R Browne, SK Chih, CY |
2016 |
The Journal of allergy and clinical immunology 3 (137), pp. 945-948.e8 |
|
| 85. | Comparison of community-onset Staphylococcus argenteus and Staphylococcus aureus sepsis in Thailand: a prospective multicentre observational study. | Chantratita, N Wikraiphat, C Tandhavanant, S Wongsuvan, G Ariyaprasert, P Suntornsut, P Thaipadungpanit, J Teerawattanasook, N Jutrakul, Y Srisurat, N Chaimanee, P Anukunananchai, J Phiphitaporn, S Srisamang, P Chetchotisakd, P West, TE Peacock, SJ |
2016 |
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 5 (22), pp. 458.e11-9 |
|
| 86. | High-level carbapenem-resistant OXA-48-producing Klebsiella pneumoniae with a novel OmpK36 variant and low-level, carbapenem-resistant, non-porin-deficient, OXA-181-producing Escherichia coli from Thailand. | Lunha, K Chanawong, A Lulitanond, A Wilailuckana, C Charoensri, N Wonglakorn, L Saenjamla, P Chaimanee, P Angkititrakul, S Chetchotisakd, P |
2016 |
Diagnostic microbiology and infectious disease 2 (85), pp. 221-6 |
|
| 87. | Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis. | Marty, FM Ostrosky-Zeichner, L Cornely, OA Mullane, KM Perfect, JR Thompson, GR Alangaden, GJ Brown, JM Fredricks, DN Heinz, WJ Herbrecht, R Klimko, N Klyasova, G Maertens, JA Melinkeri, SR Oren, I Pappas, PG Ráčil, Z Rahav, G Santos, R Schwartz, S Vehreschild, JJ Young, JH Chetchotisakd, P Jaruratanasirikul, S Kanj, SS Engelhardt, M Kaufhold, A Ito, M Lee, M Sasse, C Maher, RM Zeiher, B Vehreschild, MJ , |
2016 |
The Lancet. Infectious diseases 7 (16), pp. 828-37 |
|
| 88. | Comparison of community-onset Staphylococcus argenteus and Staphylococcus aureus sepsis in Thailand: a prospective multicentre observational study. | Chantratita, N Wikraiphat, C Tandhavanant, S Wongsuvan, G Ariyaprasert, P Suntornsut, P Thaipadungpanit, J Teerawattanasook, N Jutrakul, Y Srisurat, N Chaimanee, P Anukunananchai, J Phiphitaporn, S Srisamang, P Chetchotisakd, P West, TE Peacock, SJ |
2016 |
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 5 (22), pp. 458.e11-9 |
|
| 89. | Improvement of lipid profiles when switching from efavirenz to rilpivirine in HIV-infected patients with dyslipidemia. | Thamrongwonglert, P Chetchotisakd, P Anunnatsiri, S Mootsikapun, P |
2016 |
HIV clinical trials (), pp. 1-5 |
|
| 90. | Early Antiretroviral Therapy at High CD4 Counts Does Not Improve Arterial Elasticity: A Substudy of the Strategic Timing of AntiRetroviral Treatment (START) Trial. | Baker, JV Hullsiek, KH Engen, NW Nelson, R Chetchotisakd, P Gerstoft, J Jessen, H Losso, M Markowitz, N Munderi, P Papadopoulos, A Shuter, J Rappoport, C Pearson, MT Finley, E Babiker, A Emery, S Duprez, D , |
2016 |
Open forum infectious diseases 4 (3), pp. ofw213 |
|
| 91. | Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study. | Pozniak, A Arribas, JR Gathe, J Gupta, SK Post, FA Bloch, M Avihingsanon, A Crofoot, G Benson, P Lichtenstein, K Ramgopal, M Chetchotisakd, P Custodio, JM Abram, ME Wei, X Cheng, A McCallister, S SenGupta, D Fordyce, MW , |
2016 |
Journal of acquired immune deficiency syndromes (1999) 5 (71), pp. 530-7 |
|
| 92. | TLR4 genetic variation is associated with inflammatory responses in Gram-positive sepsis. | Chantratita, N Tandhavanant, S Seal, S Wikraiphat, C Wongsuvan, G Ariyaprasert, P Suntornsut, P Teerawattanasook, N Jutrakul, Y Srisurat, N Chaimanee, P Mahavanakul, W Srisamang, P Phiphitaporn, S Mokchai, M Anukunananchai, J Wongratanacheewin, S Chetchotisakd, P Emond, MJ Peacock, SJ West, TE |
2017 |
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 1 (23), pp. 47.e1-47.e10 |
|
| 93. | Molecular Characterization of Carbapenemase-Nonproducing Clinical Isolates of Escherichia coli (from a Thai University Hospital) with Reduced Carbapenem Susceptibility. | Nuramrum, S Chanawong, A Lunha, K Lulitanond, A Sangka, A Wilailuckana, C Angkititrakul, S Charoensri, N Wonglakorn, L Chaimanee, P Chetchotisakd, P |
2017 |
Japanese journal of infectious diseases 6 (70), pp. 628-634 |
|
| 94. | Patient Characteristics, Management, and Predictors of Outcome from Severe Community-Onset Staphylococcal Sepsis in Northeast Thailand: A Prospective Multicenter Study. | West, TE Wikraiphat, C Tandhavanant, S Ariyaprasert, P Suntornsut, P Okamoto, S Mahavanakul, W Srisamang, P Phiphitaporn, S Anukunananchai, J Chetchotisakd, P Peacock, SJ Chantratita, N |
2017 |
The American journal of tropical medicine and hygiene 5 (96), pp. 1042-1049 |
|
| 95. | TLR4 genetic variation is associated with inflammatory responses in Gram-positive sepsis. | Chantratita, N Tandhavanant, S Seal, S Wikraiphat, C Wongsuvan, G Ariyaprasert, P Suntornsut, P Teerawattanasook, N Jutrakul, Y Srisurat, N Chaimanee, P Mahavanakul, W Srisamang, P Phiphitaporn, S Mokchai, M Anukunananchai, J Wongratanacheewin, S Chetchotisakd, P Emond, MJ Peacock, SJ West, TE |
2017 |
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 1 (23), pp. 47.e1-47.e10 |
|
| 96. | Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study. | Boyd, MA Amin, J Mallon, PW Kumarasamy, N Lombaard, J Wood, R Chetchotisakd, P Phanuphak, P Mohapi, L Azwa, I Belloso, WH Molina, JM Hoy, J Moore, CL Emery, S Cooper, DA , |
2017 |
The lancet. HIV 1 (4), pp. e13-e20 |
|
| 97. | Cryptococcosis in Anti-Interferon-Gamma Autoantibody-Positive Patients: a Different Clinical Manifestation from HIV-Infected Patients. | Chetchotisakd, P Anunnatsiri, S Nithichanon, A Lertmemongkolchai, G |
2017 |
Japanese journal of infectious diseases 1 (70), pp. 69-74 |
|
| 98. | Immune Control of--Common, High-Frequency T-Cell Responses to a Broad Repertoire of Immunoprevalent Epitopes. | Nithichanon, A Rinchai, D Buddhisa, S Saenmuang, P Kewcharoenwong, C Kessler, B Khaenam, P Chetchotisakd, P Maillere, B Robinson, J Reynolds, CJ Boyton, RJ Altmann, DM Lertmemongkolchai, G |
2018 |
Frontiers in immunology (9), pp. 484 |
|
| 99. | Melioidosis in Thailand: Present and Future. | Hinjoy, S Hantrakun, V Kongyu, S Kaewrakmuk, J Wangrangsimakul, T Jitsuronk, S Saengchun, W Bhengsri, S Akarachotpong, T Thamthitiwat, S Sangwichian, O Anunnatsiri, S Sermswan, RW Lertmemongkolchai, G Tharinjaroen, CS Preechasuth, K Udpaun, R Chuensombut, P Waranyasirikul, N Anudit, C Narenpitak, S Jutrakul, Y Teparrukkul, P Teerawattanasook, N Thanvisej, K Suphan, A Sukbut, P Ploddi, K Sirichotirat, P Chiewchanyon, B Rukseree, K Hongsuwan, M Wongsuwan, G Sunthornsut, P Wuthiekanun, V Sachaphimukh, S Wannapinij, P Chierakul, W Chewapreecha, C Thaipadungpanit, J Chantratita, N Korbsrisate, S Taunyok, A Dunachie, S Palittapongarnpim, P Sirisinha, S Kitphati, R Iamsirithaworn, S Chaowagul, W Chetchotisak, P Whistler, T Wongratanacheewin, S Limmathurotsakul, D |
2018 |
Tropical medicine and infectious disease 2 (3), pp. 38 |
|
| 100. | Epidemiology of and risk factors for extrapulmonary nontuberculous mycobacterial infections in Northeast Thailand. | Kham-Ngam, I Chetchotisakd, P Ananta, P Chaimanee, P Sadee, P Reechaipichitkul, W Faksri, K |
2018 |
PeerJ (6), pp. e5479 |
|
| 101. | Analysis of drug-susceptibility patterns and gene sequences associated with clarithromycin and amikacin resistance in serial Mycobacterium abscessus isolates from clinical specimens from Northeast Thailand. | Ananta, P Kham-Ngam, I Chetchotisakd, P Chaimanee, P Reechaipichitkul, W Namwat, W Lulitanond, V Faksri, K |
2018 |
PloS one 11 (13), pp. e0208053 |
|
| 102. | Differentiation between persistent infection/colonization and re-infection/re-colonization of Mycobacterium abscessus isolated from patients in Northeast Thailand. | Kham-Ngam, I Chetchotisakd, P Ananta, P Chaimanee, P Reechaipichitkul, W Lulitanond, V Namwat, W Faksri, K |
2018 |
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases (68), pp. 35-42 |
|
| 103. | Ocular involvement in melioidosis: a 23-year retrospective review. | Yaisawang, S Asawaphureekorn, S Chetchotisakd, P Wongratanacheewin, S Pakdee, P |
2018 |
Journal of ophthalmic inflammation and infection 1 (8), pp. 5 |
|
| 104. | Influence of and polymorphisms on atazanavir/r concentrations in Thai HIV-infected patients. | Singkham, N Avihingsanon, A Thammajaruk, N Ruxrungtham, K Bunupuradah, T Kiertiburanakul, S Chetchotisakd, P Burger, DM Emery, S Punyawudho, B |
2019 |
Pharmacogenomics 7 (20), pp. 517-527 |
|
| 105. | Switching to Fixed-Dose Bictegravir, Emtricitabine, and Tenofovir Alafenamide (B/F/TAF) in Virologically Suppressed HIV-1 Infected Women: A Randomized, Open-Label, Multicenter, Active-Controlled, Phase 3, Noninferiority Trial. | Kityo, C Hagins, D Koenig, E Avihingsanon, A Chetchotisakd, P Supparatpinyo, K Gankina, N Pokrovsky, V Voronin, E Stephens, JL DeJesus, E Wang, H Acosta, RK Cao, H Quirk, E Martin, H Makadzange, T |
2019 |
Journal of acquired immune deficiency syndromes (1999) 3 (82), pp. 321-328 |
|
| 106. | Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial. | Kullberg, BJ Viscoli, C Pappas, PG Vazquez, J Ostrosky-Zeichner, L Rotstein, C Sobel, JD Herbrecht, R Rahav, G Jaruratanasirikul, S Chetchotisakd, P Van Wijngaerden, E De Waele, J Lademacher, C Engelhardt, M Kovanda, L Croos-Dabrera, R Fredericks, C Thompson, GR |
2019 |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 12 (68), pp. 1981-1989 |
|
| 107. | Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in Asian participants with human immunodeficiency virus 1 infection: A sub-analysis of phase 3 clinical trials. | Kim, YS Oka, S Chetchotisakd, P Clarke, A Supparatpinyo, K Avihingsanon, A Ratanasuwan, W Kiertiburanakul, S Ruxrungtham, K Yang, S Guo, S Liu, Y Das, M Tran, D McColl, D Corales, R Nguyen, C Piontkowsky, D |
2019 |
HIV research & clinical practice (), pp. 1-9 |
|
| 108. | Dolutegravir versus ritonavir-boosted lopinavir both with dual nucleoside reverse transcriptase inhibitor therapy in adults with HIV-1 infection in whom first-line therapy has failed (DAWNING): an open-label, non-inferiority, phase 3b trial. | Aboud, M Kaplan, R Lombaard, J Zhang, F Hidalgo, JA Mamedova, E Losso, MH Chetchotisakd, P Brites, C Sievers, J Brown, D Hopking, J Underwood, M Nascimento, MC Punekar, Y Gartland, M Smith, K |
2019 |
The Lancet. Infectious diseases 3 (19), pp. 253-264 |
|
| 109. | Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15-25 years: A phase IV randomized comparative study. | Folschweiller, N Teixeira, J Joshi, S Goldani, LZ Supparatpinyo, K Basu, P Chotpitayasunondh, T Chetchotisakd, P Ruxrungtham, K Roteli-Martins, C Grinsztejn, B Quintana, SM Kumarasamy, N Poongulali, S Kulkarni, V Lin, L Datta, SK Descamps, D Dodet, M Dubin, G Friel, D Hezareh, M Karkada, N Meric Camilleri, D Poncelet, S Salaun, B Tavares-da-Silva, F Thomas-Jooris, F Struyf, F |
2020 |
EClinicalMedicine (23), pp. 100353 |
|
| 110. | Diagnosis of NTM active infection in lymphadenopathy patients with anti-interferon-gamma auto-antibody using inhibitory ELISA vs. indirect ELISA. | Nithichanon, A Chetchotisakd, P Matsumura, T Takahashi, Y Ato, M Sakagami, T Lertmemongkolchai, G |
2020 |
Scientific reports 1 (10), pp. 8968 |
|
| 111. | Natural History and Evolution of Anti-Interferon-γ Autoantibody-Associated Immunodeficiency Syndrome in Thailand and the United States. | Hong, GH Ortega-Villa, AM Hunsberger, S Chetchotisakd, P Anunnatsiri, S Mootsikapun, P Rosen, LB Zerbe, CS Holland, SM |
2020 |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1 (71), pp. 53-62 |
|
| 112. | Evaluation of plasma anti-GPL-core IgA and IgG for diagnosis of disseminated non-tuberculous mycobacteria infection. | Nithichanon, A Samer, W Chetchotisakd, P Kewcharoenwong, C Ato, M Lertmemongkolchai, G |
2020 |
PloS one 11 (15), pp. e0242598 |
|
| 113. | Pharmacogenetics-based population pharmacokinetic analysis for dose optimization of ritonavir-boosted atazanavir in Thai adult HIV-infected patients. | Singkham, N Avihingsanon, A Brundage, RC Birnbaum, AK Thammajaruk, N Ruxrungtham, K Bunupuradah, T Kiertiburanakul, S Chetchotisakd, P Punyawudho, B , |
2021 |
Expert review of clinical pharmacology (), pp. 1-10 |
|
| 114. | Assessment of in vitro activities of novel modified antimicrobial peptides against clarithromycin resistant Mycobacterium abscessus. | Sudadech, P Roytrakul, S Kaewprasert, O Sirichoat, A Chetchotisakd, P Kanthawong, S Faksri, K |
2021 |
PloS one 11 (16), pp. e0260003 |
|
| 115. | Reducing antibiotic treatment duration for ventilator-associated pneumonia (REGARD-VAP): a trial protocol for a randomised clinical trial. | Mo, Y West, TE MacLaren, G Booraphun, S Li, AY Kayastha, G Lau, YH Chew, YT Chetchotisakd, P Tambyah, PA Limmathurotsakul, D Cooper, B |
2021 |
BMJ open 5 (11), pp. e050105 |
|
| 116. | A Comparison Between 12 Versus 20 Weeks of Trimethoprim-sulfamethoxazole as Oral Eradication Treatment for Melioidosis: An Open-label, Pragmatic, Multicenter, Non-inferiority, Randomized Controlled Trial. | Anunnatsiri, S Chaowagul, W Teparrukkul, P Chetchotisakd, P Tanwisaid, K Khemla, S Narenpitak, S Pattarapongsin, M Kongsawasd, W Pisuttimarn, P Thipmontree, W Mootsikapun, P Chaisuksant, S Chierakul, W Day, NPJ Limmathurotsakul, D |
2021 |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 11 (73), pp. e3627-e3633 |
|
| 117. | Varicella zoster meningitis following COVID-19 vaccination: a report of two cases. | Buranasakda, M Kotruchin, P Phanthachai, K Mootsikapun, P Chetchotisakd, P |
2022 |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases (119), pp. 214-216 |
|
| 118. | High rate of reinfection and possible transmission of complex in Northeast Thailand. | Boonjetsadaruhk, W Kaewprasert, O Nithichanon, A Ananta, P Chaimanee, P Salao, K Phoksawat, W Laohaviroj, M Sirichoat, A Fong, Y Wongwajana, S Namwat, W Lulitanond, V Chetchotisakd, P Faksri, K |
2022 |
One health (Amsterdam, Netherlands) (14), pp. 100374 |
|
| 119. | Virological outcomes and metabolic effects after switching from ritonavir-boosted protease inhibitors to a dolutegravir-based regimen in virologically suppressed patients living with HIV. | Sribenjalux, W Nuntawit, T Meesing, A Chetchotisakd, P |
2022 |
International journal of STD & AIDS (), pp. 9564624221137972 |
|
| 120. | Evaluating anti-GPL-core IgA as a diagnostic tool for non-tuberculous mycobacterial infections in Thai patients with high antibody background. | Manbenmad, V So-Ngern, A Chetchotisakd, P Faksri, K Ato, M Nithichanon, A Lertmemongkolchai, G |
2023 |
Scientific reports 1 (13), pp. 18883 |
|
| 121. | MALDI-TOF MS analysis of Burkholderia pseudomallei and closely related species isolated from soils and water in Khon Kaen, Thailand. | Nithimongkolchai, N Hinwan, Y Kaewseekhao, B Chareonsudjai, P Reungsang, P Kraiklang, R Chareonsudjai, S Wonglakorn, L Chetchotisakd, P Sirichoat, A Nithichanon, A Faksri, K |
2023 |
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases (116), pp. 105532 |
|
| 122. | Treatment Outcomes After Switching to Second-Line Anti-Retroviral Therapy: Results From the Thai National Treatment Program. | Sudsila, P Teeraananchai, S Kiertiburanakul, S Lertpiriyasuwat, C Triamwichanon, R Gatechompol, S Putcharoen, O Chetchotisakd, P Avihingsanon, A Kerr, SJ Ruxrungtham, K |
2023 |
Journal of the International Association of Providers of AIDS Care (22), pp. 23259582231220513 |
|
| 123. | Efficacy and safety of switching to bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed Asian adults living with HIV: A pooled analysis from three international phase III randomized trials. | Avihingsanon, A Chetchotisakd, P Kiertiburanakul, S Ratanasuwan, W Siripassorn, K Supparatpinyo, K Martin, H Wang, H Wong, T Wang, HY |
2023 |
HIV medicine 3 (24), pp. 290-300 |
|
| 124. | Lipid profiles of people with human immunodeficiency virus with dyslipidemia after switching from efavirenz to dolutegravir. | Khemla, S Meesing, A Sribenjalux, W Chetchotisakd, P |
2023 |
Drug target insights (17), pp. 45-53 |
|
| 125. | Analysis of fine-scale phylogeny of Burkholderia pseudomallei in relation to regional geography and drug susceptibility in Thailand. | Hinwan, Y Chareonsudjai, P Reungsang, P Kraiklang, R Chetchotisakd, P Chareonsudjai, S Sirichoat, A Nithichanon, A Wonglakorn, L Sermswan, RW Blair, D Faksri, K |
2024 |
Scientific reports 1 (14), pp. 19961 |
|
| 126. | Individualised, short-course antibiotic treatment versus usual long-course treatment for ventilator-associated pneumonia (REGARD-VAP): a multicentre, individually randomised, open-label, non-inferiority trial. | Mo, Y Booraphun, S Li, AY Domthong, P Kayastha, G Lau, YH Chetchotisakd, P Limmathurotsakul, D Tambyah, PA Cooper, BS , |
2024 |
The Lancet. Respiratory medicine 5 (12), pp. 399-408 |
|
| 127. | Lack of Association of TLR1 and TLR5 Coding Variants with Mortality in a Large Multicenter Cohort of Melioidosis Patients. | Yimthin, T Phunpang, R Wright, SW Thiansukhon, E Chaisuksant, S Chetchotisakd, P Tanwisaid, K Chuananont, S Morakot, C Sangsa, N Silakun, W Chayangsu, S Buasi, N Lertmemongkolchai, G Chantratita, N West, TE |
2024 |
The American journal of tropical medicine and hygiene 5 (110), pp. 994-998 |
|
| 128. | Increased Inflammatory Responses in Patients With Active Disseminated Non-Tuberculous Mycobacterial Infection and High Anti-Interferon-Gamma Autoantibodies. | Srisai, P Hongsa, C Hinwan, Y Manbenmad, V Chetchotisakd, P Anunnatsiri, S Faksri, K Techo, T Salao, K Edwards, SW Nithichanon, A |
2024 |
Immune network 5 (24), pp. e36 |
|
| 129. | Statin Use and Reduced Risk of Pneumonia in Patients with Melioidosis: A Lung-Specific Statin Association. | Coston, TD Wright, SW Phunpang, R Dulsuk, A Thiansukhon, E Chaisuksant, S Tanwisaid, K Chuananont, S Morakot, C Sangsa, N Chayangsu, S Silakun, W Buasi, N Chetchotisakd, P Day, NPJ Lertmemongkolchai, G Chantratita, N West, TE |
2024 |
Annals of the American Thoracic Society 2 (21), pp. 228-234 |
|
| 130. | Whole-genome sequencing analysis of Burkholderia pseudomallei comparing drug-resistant and pan-susceptible isolates reveals novel biomarkers for drug resistance. | Hinwan, Y Nithimongkolchai, N Trisakul, K Kaewseekhao, B Wonglakorn, L Chetchotisakd, P Chareonsudjai, S Sirichoat, A Nithichanon, A Phelan, J Clark, TG Faksri, K |
2025 |
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases (133), pp. 105779 |
|
| 131. | Risk of severe bacterial infections including TB before and after immediate or deferred antiretroviral therapy: a multicenter, prospective, cohort study. | Jensen, TO Sharma, S Avihingsanon, A Lutaakome, J Brar, I Burman, W Chetchotisakd, P de Castro, N Galán-Herrera, JF Kumarasamy, N Paredes, R Ridzon, R Sciaudone, M Singh, K Uriel, A Lundgren, J Reilly, C Matthews, G |
2025 |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases (), pp. 107911 |
|
| 132. | Efficacy and Safety of Long-Acting Subcutaneous Lenacapavir in Heavily Treatment-Experienced People with Multidrug-Resistant HIV-1: Week 104 Results of a Phase 2/3 Trial. | Ogbuagu, O Molina, JM Chetchotisakd, P Ramgopal, MN Sanchez, W Brunetta, J Castelli, F Crofoot, GE Hung, CC Ronot-Bregigeon, S Margot, NA Wang, H Dvory-Sobol, H Rhee, MS Segal-Maurer, S |
2025 |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 3 (80), pp. 566-574 |
|
| 133. | Rapid detection of antibiotic resistance in Burkholderia pseudomallei using MALDI-TOF mass spectrometry. | Nithimongkolchai, N Hinwan, Y Trisakul, K Wonglakorn, L Chetchotisakd, P Sirichoat, A Nithichanon, A Chareonsudjai, S Chareonsudjai, P Phelan, J Clark, TG Faksri, K |
2025 |
Scientific reports 1 (15), pp. 21867 |
|
| 134. | Cause of death in people living with HIV who initiated antiretroviral therapy after enrolling to the Thai National AIDS Program from 2008 to 2021. | Lertpiriyasuwat, C Kerr, SJ Noknoy, S Namahoot, P Punsuwan, N Apornpong, T Sophonphan, J Hiranburana, N Chetchotisakd, P Putcharoen, O Ruxrungtham, K Avihingsanon, A |
2025 |
The Lancet regional health. Southeast Asia (36), pp. 100576 |
|
| 135. | Maintenance therapy of melioidosis with ciprofloxacin plus azithromycin compared with cotrimoxazole plus doxycycline. | Chetchotisakd, P Chaowagul, W Mootsikapun, P Budhsarawong, D Thinkamrop, B |
The American journal of tropical medicine and hygiene 1 (64), pp. 24-7 |
| Title | Authors | Year | Journal title | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total | ||||||
| 1. | Randomized, double-blind, controlled study of cefoperazone-sulbactam plus cotrimoxazole versus ceftazidime plus cotrimoxazole for the treatment of severe melioidosis | P Chetchotisakd S Porramatikul P Mootsikapun S Anunnatsiri B Thinkhamrop |
2001 |
CLINICAL INFECTIOUS DISEASES 1.0 (33.0), pp. 29.0-34.0 |
44 | 0 | 0 | 0 | 0 | 0 | 44 | |
| 2. | The role of cefoperazone-sulbactam for treatment of severe melioidosis - Reply | P Chetchotisakd S Porramatikul P Mootsikapun S Anunnatsiri B Thinkhamrop |
2002 |
CLINICAL INFECTIOUS DISEASES 5.0 (34.0), pp. 722.0-723.0 |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 3. | Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: A prospective, multicenter, randomized study | A Vibhagool S Sungkanuparph P Mootsikapun P Chetchotisakd S Tansuphaswaswadikul C Bowonwatanuwong A Ingsathit |
2003 |
CLINICAL INFECTIOUS DISEASES 10.0 (36.0), pp. 1329.0-1331.0 |
146 | 0 | 0 | 0 | 0 | 0 | 146 | |
| 4. | Efavirenz-based regimen as treatment of advanced AIDS with cryptococcal meningitis | S Sungkanuparph A Vibhagool J Mootsikapun P Chetchotisakd S Tansuphaswaswadikul C Bowonwatanuwong W Chantratita |
2003 |
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 1.0 (33.0), pp. 118.0-119.0 |
12 | 0 | 0 | 0 | 0 | 0 | 12 | |
| 5. | Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial | J Ananworanich R Nuesch M Le Braz P Chetchotisakd A Vibhagool S Wicharuk K Ruxrungtham H Furrer D Cooper B Hirschel |
2003 |
AIDS 15.0 (17.0), pp. F33-F37 |
139 | 0 | 0 | 0 | 0 | 0 | 139 | |
| 6. | Opportunistic infections after the initiation of highly active antiretroviral therapy in advanced AIDS patients in an area with a high prevalence of tuberculosis | S Sungkanuparph A Vibhagool P Mootsikapun P Chetchotisakd S Tansuphaswaswadikul C Bowonwatanuwong |
2003 |
AIDS 14.0 (17.0), pp. 2129.0-2131.0 |
67 | 0 | 0 | 0 | 0 | 0 | 67 | |
| 7. | A multicentre, randomized, double-blind, placebo-controlled trial of primary cryptococcal meningitis prophylaxis in HIV-infected patients with severe immune deficiency | P Chetchotisakd S Sungkanuparph B Thinkhamrop P Mootsikapun P Boonyaprawit |
2004 |
HIV MEDICINE 3.0 (5.0), pp. 140.0-143.0 |
80 | 0 | 0 | 0 | 0 | 0 | 80 | |
| 8. | A prospective study of efficacy and safety of once-daily saquinavir/ritonavir plus two nucleoside reverse transcriptase inhibitors in treatment-naive Thai patients | J Ananworanich A Hill U Siangphoe K Ruxrungtham W Prasithsirikul P Chetchotisakd S Kiertiburanakul W Munsakul P Raksakulkarn S Tansuphasawadikul R Nuesch DA Cooper B Hirschel |
2005 |
ANTIVIRAL THERAPY 6.0 (10.0), pp. 761.0-767.0 |
50 | 0 | 0 | 0 | 0 | 0 | 50 | |
| 9. | Body composition in adults infected with human immunodeficiency virus in Khon Kaen, Thailand | MJ Ludy K Hendricks R Houser P Chetchotisakd P Mootsikapun S Anunnatsiri E Price CA Wanke |
2005 |
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE 4.0 (73.0), pp. 815.0-819.0 |
8 | 0 | 0 | 0 | 0 | 0 | 8 | |
| 10. | Efficacy and safety of indinavir/ritonavir 400/100 mg twice daily plus two nucleoside analogues in treatment-naive HIV-1-infected patients with CD4(+) T-cell counts < 200 cells/mm(3): 96-week outcomes | P Mootsikapun P Chetchotisakd S Anunnatsiri P Boonyaprawit |
2005 |
ANTIVIRAL THERAPY 8.0 (10.0), pp. 911.0-916.0 |
26 | 0 | 0 | 0 | 0 | 0 | 26 | |
| 11. | Two randomized controlled trials of ceftazidime alone versus ceftazidime in combination with trimethoprim-sulfamethoxazole for the treatment of severe melioidosis | W Chierakul S Anunnatsiri JM Short B Maharjan P Mootsikapun AJH Simpson D Limmathurotsakul AC Cheng K Stepniewska PN Newton W Chaowagul NJ White SJ Peacock NP Day P Chetchotisakd |
2005 |
CLINICAL INFECTIOUS DISEASES 8.0 (41.0), pp. 1105.0-1113.0 |
67 | 0 | 0 | 0 | 0 | 0 | 67 | |
| 12. | Absence of resistance mutations in antiretroviral-naive patients treated with ritonavir-boosted saquinavir | Jintanat Ananworanich Bernard Hirschel Sunee Sirivichayakul Sasiwimol Ubolyam Thidarat Jupimai Wisit Prasithsirikul Ploenchan Chetchotisakd Sasisopin Kiertiburanakul Warangkana Munsakul Phitsanu Raksakulkarn Somboon Tansuphasawadikul Malte Schutz Wendy Snowden Kiat Ruxrungtham |
2006 |
ANTIVIRAL THERAPY 5.0 (11.0), pp. 631.0-635.0 |
27 | 0 | 0 | 0 | 0 | 0 | 27 | |
| 13. | CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial | Jintanat Ananworanich Angele Gayet-Ageron Michelle Le Braz Wisit Prasithsirikul Ploenchan Chetchotisakd Sasisopin Kiertiburanakul Warangkana Munsakul Phitsanu Raksakulkarn Somboon Tansuphasawasdikul Sunee Sirivichayakul Matthias Cavassini Urs Karrer Daniel Genne Reto Nueesch Pietro Vernazza Enos Bernasconi Dominic Leduc Claudette Satchell Sabine Yerly Luc Perrin Andrew Hill Thomas Perneger Praphan Phanuphak Hansjakob Furrer David Cooper Kiat Ruxrungtham Bernard Hirschel |
2006 |
LANCET 9534.0 (368.0), pp. 459.0-465.0 |
287 | 0 | 0 | 0 | 0 | 0 | 287 | |
| 14. | Clinical and epidemiological analyses of human pythiosis in Thailand | Theerapong Krajaejun Boonmee Sathapatayavongs Roongnapa Pracharktam Prawat Nitiyanant Paisan Leelachaikul Wanchai Wanachiwanawin Angkana Chaiprasert Paraya Assanasen Marisa Saipetch Piroon Mootsikapun Ploenchan Chetchotisakd Arnuparp Lekhakula Winyou Mitarnun Sineenart Kalnauwakul Khuanchai Supparatpinyo Romanee Chaiwarith Siri Chiewchanvit Napaporn Tananuvat Sawet Srisiri Chusana Suankratay Wanla Kulwichit Mawin Wongsaisuwan Shawarash Somkaew |
2006 |
CLINICAL INFECTIOUS DISEASES 5.0 (43.0), pp. 569.0-576.0 |
179 | 0 | 0 | 0 | 0 | 0 | 179 | |
| 15. | Addition of trimethoprim-sulfamethoxazole to ceftazidime during parenteral treatment of melioidosis is not associated with a long-term outcome benefit | Wirongrong Chierakul Siriluck Anunnatsiri Wipada Chaowagul Sharon J. Peacock Ploenchan Chetchotisakd Nicholas P. Day |
2007 |
CLINICAL INFECTIOUS DISEASES 4.0 (45.0), pp. 521.0-523.0 |
9 | 0 | 0 | 0 | 0 | 0 | 9 | |
| 16. | Disseminated nontuberculous mycobacterial infection in patients who are not infected with HIV in Thailand | Ploenchan Chetchotisakd Sasisopin Kiertiburanakul Piroon Mootsikapun Susun Assanasen Romanee Chaiwarith Siriluck Anunnatsiri |
2007 |
CLINICAL INFECTIOUS DISEASES 4.0 (45.0), pp. 421.0-427.0 |
112 | 0 | 0 | 0 | 0 | 0 | 112 | |
| 17. | Efficacy and tolerability of a double boosted protease inhibitor (lopinavir plus saquinavir/ritonavir) regimen in HIV-infected patients who failed treatment with nonnucleoside reverse transcriptase inhibitors | Ploenchan Chetchotisakd S. Anunnatsiri P. Mootsikapun S. Kiertiburanakul T. Anekthananon C. Bowonwatanuwong B. Kowadisaiburana K. Supparatpinyo K. Ruxrungtham |
2007 |
HIV MEDICINE 8.0 (8.0), pp. 529.0-535.0 |
28 | 0 | 0 | 0 | 0 | 0 | 28 | |
| 18. | Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial | Ernst-Ruediger Kuse Ploenchan Chetchotisakd Clovis Arns da Cunha Markus Ruhnke Carlos Barrios Digumarti Raghunadharao Jagdev Singh Sekhon Antonio Freire Venkatasubramanian Ramasubramanian Ignace Demeyer Marcio Nucci Amorn Leelarasamee Frederique Jacobs Johan Decruyenaere Didier Pittet Andrew J. Ullmann Luis Ostrosky-Zeichner Olivier Lortholary Sonja Koblinger Heike Diekmann-Berndt Oliver A. Cornely |
2007 |
LANCET 9572.0 (369.0), pp. 1519.0-1527.0 |
806 | 0 | 0 | 0 | 0 | 0 | 806 | |
| 19. | No change in calculated creatinine clearance after tenofovir initiation among Thai patients | Angele Gayet-Ageron Jintanat Ananworanich Thidarat Jupimai Ploenchan Chetchotisakd Wisit Prasithsirikul Sasiwimol Ubolyam Michelle Le Braz Kiat Ruxrungtham James F. Rooney Bernard Hirschel |
2007 |
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 5.0 (59.0), pp. 1034.0-1037.0 |
35 | 0 | 0 | 0 | 0 | 0 | 35 | |
| 20. | Predictors of CD4 count change over 8 months of follow up in HIV-1-infected patients with a CD4 count >= 300 cells/mu L who were assigned to 7.5 MIU interleukin-2 | Zoe Fox Andrew N. Phillips Schlomo Staszewski Donald I. Abrams David A. Cooper Janet H. Darbyshire William R. Duncan H. Clifford Lane Jens D. Lundgren James D. Neaton Liliana Aguilar Eleonora Betina Angel Silvia Aquilia Jorge Benetucci Victor Bittar Pedro Cahn Arnaldo Casiro Jorge Contarelli Jorge Corral Lucia Daciuk Daniel David Ines Ferrari Diego Fridman Viviana Galache Graciela Guaragna Silvina Ivalo Hector Laplume Isabel Lanusse Maria B. Lasala Roberta Lattes Jaime Lasovsky Gustavo Lopardo Marcelo Losso Leonardo Lourtau Sergio Lupo Aldo Maranzana Cristina Marson Lucila Massera Marisa del Lujan Sanchez Carla Somenzini Mariel Tocci Sally Algar Jonathan Anderson David Baker Kathy Blavius Mark Bloch Michael Boyle David Bradford Phillip Britton Leah Carrall Andrew Carr John Chuah Michael Curry Clive D'Arcy-Evans Pauline Dobson Nicholas Doong Cari Egan Wendy Ferguson Robert Finlayson Martyn French Anthony Frater Julian Gold Philip Habel Kay Haig Rohan Holland Natalie Hyland Jennifer Hoy Jeff Hudson Robyn James Jenny Leung Kaye Lowe Karen MacRae Marilyn McMurchie Nicholas Medland Samantha Miller Jo Murray Rosie Newman David Orth Julie Patching Ruth Primrose Hugo Ree Robyn Richardson Gary Rogers Janine Roney Norman Roth Jeganathan Sarangapany David Shaw Carol Silberberg Jenny Skett Leah Williams Tuck Meng Soo David Sowden Alan Street Robyn Vale Claudio Villella Alan Walker Ashley Watson Ngaire Wendt Helen Wood David Youds Alexander Aichelburg Armin Rieger Norbert Vetter Nathan Clumeck Stephane De Wit Kabamba Kabeya Elizabeth O'Doherty Cristiane de Sales Amorim Caritas Relva Basso David Salamao Lewi Luiz Carlos Pereira Mariliza da Silva Tamara Newman Lobato Souza Jonathan Angel Pierrette-Rolande Bouchard Fran Clark Jeff Cohen Mimose Dambreville Michele Ellis Stephan Fiset Andrea Foster Christopher Fraser Susan Gagnon Janet Gilmour Richard Guenette Heather Haldane Nanci Hawley-Foss Susan Hyndman Lynn Johnston Nathalie Jubinville Francoise Juneau Lynn Kelleher Lyne LaPointe Judy Latendre-Paquette Adeline Lindemulder Laura Mashinter Eric Lefebvre Nancy McFarland Chantal Morisseau Robert O'Neill Alain Piche Edward Ralph Danielle Rouleau Jean-Pierre Routy Roger Sandre Shelley Schmidt Stephen Shafran Fiona Smaill Dale Stromberg Jean-Marc Trepanier Sylvie Trottier Susanne Veal Sharon Walmsley Karl Weiss Kurt Williams Mavis Young Barbara Zaleschuk Don Zarowny Bente Baadegaard Finn Black Kirsten Boedker Jan Gerstoft Lene Jensen Lars Mathiesen Henrik Nielsen Court Pedersen Dorthe Petersen Jean-Pierre Aboulker Adyb Baakili Nafissa Bengrait Maryse Bensalem Huguette Berthe Martin Bloche Claude Bazin Francois Boue Elisabeth Bouvet Christiane Brancon Catherine Capitant Carole Ceppi Christine Cheneau Anne Coutellier Jean Marie Chennebault Fabienne Coquet Pierre De Truchis Anne-Marie Delavalle Veronique Frixon-Marin Jean-Albert Gastaut Francois Delfraissy Muriel Eliaszeicz Herve Gallais Jean-Albert Gataut Jacques Gilquin Gustavo Gonzalez-Canali Chrisiane Gaudebout Cecile Goujard Bruno Hoen Patricia Honore Bernard Jarousse Jean-Marie Lang Benedict Lefebvre Yves Levy Jocelyne Loison Aline Maignan Jean-Luc Meynard Christophe Michon Martin Mole Laurence Marsal Sophie Matheron Emmanuel Mortier Eric Oksenhendler Sandrine Poirier Catherine Picard-Dahan Isabelle Ravaux Francois Raffi Gilles Raguin Jacque Reynes Willy Rozenbaum Dominique Salmon Anne Simon Gabriella Spiridon Jean-Paul Viard Michele Vidal Laurence Weiss David Zucman Frank Bergmann Norbert Brockmeyer Gerd Faetkenheuer Stefan Fenske Daniela Gey Frank-Detlef Goebel Martina Goetsch Martin Hartmann Hartwig Klinker Gisela Kremer Kathleen Mantzsch Stefan Mauss Juergen Rockstroh Jessica Rotty Ellen Rund Katrin Schneider Dirk Schuermann Schlomo Staszweski Klaus Tilmann Martin Vogel Zvi Bentwich Goldstain Drora Eynat Kedem Ruth Lang Itzic Levi Shlomo Maayan Eli Magen Merav Mamorsky Anat Pilpul Shimon Pollack Zev Sthoeger Hadas Vered Israel Yust Fiona Mulcahy Fernando Auiti Gioacchino Angarano Davide Bertelli Teresa Bini Raffaele Bruno Gian Pietro Cadeo Giampietro Carosi Antonella D'Arminio Monforte Sergio Del Giacco Massimo Di Pietro Roberto Esposito Gaetano Filice Gabriella Gavazzeni Giovanni Guaraldi Francesco Indiveri Adriano Lazzarin Francesco Mazzotta Lorenzo Minolli Maria Montroni Mauro Moroni Silvia Nozza Guiseppe Pastor Guido Poli Enzo Raise Sergio Romagnani Vega Rusconi Paolo Sacchi Fredy Suter Giuseppe Tambussi Umberto Tirelli Helen Fraser Aikichi Iwamoto Yoshida Kikuchi Masahiko Mori Tetsuya Nakamura Takashi Odawara Shinichi Oka Takuma Shirasaka Misao Takano Junichiro To Chisato Ueta W. Blok J. Borleffs B. Bravenboer W. Bronveld F. Claessen Maurice Duurvoort J. Ferwerda P. Frissen Nicolette Hulshoff Job Juttman R. Kauffmann P. Koopmans F. Kroon Selwyn Lowe M. Leemhuis P. Meenhorst Lieselotte Posthuma de Boer Peter Reiss S. Reinders-Folmer C. Richter Rick Santegoets Marijke Schoemaker G. Schrey Herman Sprenger Jacob Ten Veen Judith Tessalaar M. van der Ende H. van der Vall Arne van Eeden Remko van Leeuwen Joost Vermeulen Reinier W. ten Kate Renee van Boxtel Arne van Eden Bernadette van de Ven Piet van der Meulen C. ten Napei R. Vriesendrop Johann Bruun Elzbieta Bakowska Marek Beniowski Anna Boron-Kaczmarska Jacek Gasiorowski Andrzej Gxadysz Andrzej Horban Brygida Knysz Elzbieta Mularska Magdelena Pynka Aleksandra Szymczak Isabel Aldir Francisco Antunes Manuela Doroana Luis Duque Kamal Mansinho Inez Pinto Emilia Valadas Jose Vera Estelle Foo Anushia Panchalingham Poh Lian Lim Nick Paton Bernard Peperstraete Angela Quek Rosario Alcazar-Caballero Julio Arrizabalaga Emilio Bouza Concepcion Cepeda Xabier de Barron Miguel Cervero Jimenez Bonaventura Clotet Luis Cortes Pere Domingo Pompeyo Fernandez Eduardo Fernandez-Cruz Montserrat Fuster Jose Gatell Paloma Gijon Ignacio Gil Juan Gonzales-Lahoz Alicia Gonzalez Manuel Hernandez Jose Iribarren Miguel Jimenez Hernando Knobel Agathe Leon Juan Carlos Lopez Angeles Lozano Paco Lopez Jose Moreno Rosa Munoz Belen Padilla Angeles Parras Antoni Pastor Jose Pedreira Julio Pristo Jose Pena Victor Roca Rafael Rubio Jose Sanchez de Rivera Jesus Sanz Lara Tamargo Rafael Torres Pehr O. Pehrson Eric Sandstrom Enos Bernasconi Vanina Gurtner Lorenzo Magenta Uangarun Ampunpong Chureeratana Bowonwatnuwong Patimoaporn Chanchai Ploenchan Chetchotisakd Thesinee Chuenyam Chris Duncombe Mannassinee Horsakulthai Pacharee Kantipong John Liddy Praphan Phanuphak Vithaya Pongsurachet Kiat Ruxrungtham Samroeng Seekaew Areerat Sonjai Nuramon Subsri Surapol Suwanagool Wichai Techasathit Jaturaporn Wankoon Aderonke Adebiyi Diana Aldam Ian Alexander Tristan Barber Sue Bonnington Chris Care Anne Carroll David Cornforth Oscar Donaldson Laurance Druiff Philippa Easterbrook Beverley Edwards Chris Ellis Ikbale Erradey Kamal El Filali Martin Fisher Ray Fox Brian Gazzard Allan Harrison Sandra Herman Lisa Heald Christopher Higgs Hakima Himmich Isabelle Jendrulek Margaret Johnson Lucy Judges Fatimah Karim George Kinghorn Julie Laurenti Christine Lee Clifford Leen Ken Legg Fiona Lyons Raymond Maw Alisdair MacConachie Sinead McKernan Lorna McLean Andrew McMillan Sifiso Mguni Sheila Morris Fiona Mulchay Dee Mullan Scott Mullaney Maurice Murphy Andrew Nunn Edmund Ong Maxine Owen Adrian Palfreeman Nicky Perry Barry Peters Anton Pozniak Annette Rochford Agnes Ronan Cecilia Skinner Carol Stroud Martin Takawira Norbert Tamm Rachel Thomas Thynn Thynn Yee An Vanthuyne Mark Wansborough-Jones Jonathan Weber David White Ed Wilkins Martin Wiselka Ian Williams Mike Waugh Joyce Wotherspoon Mike Youle Margaret Doyle Roberta Luskin-Hawk Rita Verheggen John Baxter C. Lynn Besch Carroll Child David Cohn Pam Cooper Martha Farrough Evelyn Fisher Luis Fuentes Edward Goodwin Carol Graeber Jay Kostman Kelly Lattanzi Rodger MacArthur Linda Makohon Norman P. Markowitz Diane Mastro-Polak Vinnie Mitchell David Mushatt Kathryn Patterson George Perez Corey Rosmarin Jack R. Rouff Jennifer Saldanha Robert Sawyer James Sullivan Bentley Sweeton Ellen Tedaldi Melanie Thompson Patricia Valencia Gwen Verlinghieri Janice Walker Vicky Watson Bruce Williams Adam Armstrong Susan Banks David Blazes Anthony Barile Linda Coelho Marilyn Dennis Hannah Flaks Joyce Gilcrest Kathleen Gittens Shelia Hopper M. J. Humphries Katherine Spooner Cindy L. Tamminga Jean Vita Scott A. Wegner Glenn Wortmann Nicole Bisby William Blake Sheldon Brown Phillippe Chilliade Teresa Cole Katherine Elliot Christiane Geisler Matthew Goetz Elizabeth Gomez-Perez Fred Gordin Jami Helman Nancy Klimas Ann Labriola Ronald Nahass Dirk LeFlore Barbara Marston Maria Obregon Jennifer Petrolati David L. Pitrak Robert Roland Carol Rosa Barbara Rossman Susan Schlueter Wirtz Suzanne Schuck Tiffany Scretchings Gary Simon Mack Smith Barbara Standridge Kimberley Summers Mary Jo Werhane Roberto Arduino Brian Bell Katherine Breaux Hilda Cuervo Carl Hale Stanley Lewis Mark Mall Fransisco Mora Martine M. Diez Pablo Okhuysen Maria Rodriguez-Barradas Shannon R. Schrader Lynn Healy Chris Kaszubski Michael Kolber Tom Tanner Joann Armstrong Jennifer Dahlke Leonard Johnson Patricia Kaminski Cheryl Shoden Zelalem Temesgen Marcy Urbanich Sharon Valenti Marcus Zervos Rick Davey Bill Barrick Doreen Chaitt Barbara Hahn Cliff Lane Dennis Martell Laura McNay Julia Metcalf April Powers Jorge A. Tavel Karen Loveless Norma Martinez Sue Peterson James Sampson Suzanne Sweek Donald Abrams Helmut Albrecht Nicole Antoine Mary Ellen Kelly Paula Pell Waldo Belloso Jose Maria Gatell Jenny Hoy Court Pederson Frank Rhame Wafaa El-Sadr Liselotte Borup Ulrik Bak Dragsted Anne Fau Greve Karoline Jensen Jens Lundgren David Mollerup Mary Pearson Andrew Phillips Jamila Aboulhab Brian Angus Abdel Babiker Brooke Cordwell Janet Darbyshire Lisa Hack Malcolm Hooker Yolanda Moraes Douglas Newberry Harriet Nuwagaba-Biribonwoha Fionna van Hooff Eileen Denning Leslie Holland Klemme Cate Carey Fonnie Chan David Cooper David Courtney-Rodgers Fraser Drummond Sean Emery Simone Jacoby Matthew Law Morgan Stewart Sarah Pett Zarina Alloo Judy Bebchuk Patty Bollenbeck Alain G. DuChene Lisa Fosdick Merrie Harrison Eric Krum Gregg Larson Alan Lifson Sue Meger James Neaton Ray Nelson Siu-Fun L. Quan Terri Schultz Susan Telke Lisa Thackeray Greg Thompson Deborah Wentworth Nicole Wyman William Duncan Elaine Ferguson Lawrence Fox Nikki Gettinger Janet Herrera Sandra Lehrman Mary Anne Luzar Mieko Maeshiro Ana Martinez Karen Oseekey Greg Baigent William Capra Anne-Marie Duliege Linda Fitzgerald Marthin Kwakkelstein Jean Maral Mary O'Hara David Sahner Claire Weber Christine Adam-Perchec Nigel Barron Mary Louise Bell Sandra Dolan Julie Eckstrand Steven Hicks George McAuley Sharon Beck Shawn Brown Adam Rupert |
2007 |
HIV MEDICINE 2.0 (8.0), pp. 112.0-123.0 |
12 | 0 | 0 | 0 | 0 | 0 | 12 | |
| 21. | Fungemia in Non-HIV-infected Patients: A 5-Year Review | S. Anunnatsiri P. Chetchotisakd P. Mootsikapun |
2008 |
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (12.0), pp. E278-E278 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 22. | IMPACT OF PATIENT-HEALTH CARE PROVIDER COMMUNICATION: THE HIV/AIDS PATIENTS' PERSPECTIVES | M. R. Layton S. J. Kerr P. Chetchotisakd |
2008 |
VALUE IN HEALTH 6.0 (11.0), pp. A442-A443 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 23. | Interruptions of tenofovir/emtricitabine-based antiretroviral therapy in patients with HIV/hepatitis B virus co-infection | Reto Nuesch Jintanat Ananworanich Preeyaporn Srasuebkul Ploenchan Chetchotisakd Wisit Prasithsirikul Wirat Klinbuayam Apicha Mahanontharit Thidarat Jupimai Kiat Ruxrungtham Bernard Hirschel |
2008 |
AIDS 1.0 (22.0), pp. 152.0-154.0 |
33 | 0 | 0 | 0 | 0 | 0 | 33 | |
| 24. | Long-term efficacy and safety of first-line therapy with once-daily saquinavir/ritonavir | Jintanat Ananworanich Angele Gayet-Ageron Kiat Ruxrungtham Ploenchan Chetchotisakd Wisit Prasithsirikul Sasisopin Kiertiburanakul Warangkana Munsakul Phitsanu Rakasakulkarn Somboon Tansuphasawadikul Michelle LeBraz Thidarat Jupimai Sasiwimol Ubolyam Malte Schutz Bernard Hirschel |
2008 |
ANTIVIRAL THERAPY 3.0 (13.0), pp. 375.0-380.0 |
47 | 0 | 0 | 0 | 0 | 0 | 47 | |
| 25. | Low-dose, once-daily atazanavir/ritonavir (200/100): An effective treatment for HIV-infected patients in Thailand | Ploenchan Chetchotisakd Siriluck Anunnatsiri |
2008 |
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 2.0 (49.0), pp. 230.0-231.0 |
22 | 0 | 0 | 0 | 0 | 0 | 22 | |
| 26. | Mycotic Aneurysm in Northeast Thailand: The Importance of Burkholderia pseudomallei as a Causative Pathogen | Siriluck Anunnatsiri Ploenchan Chetchotisakd Churairat Kularbkaew |
2008 |
CLINICAL INFECTIOUS DISEASES 11.0 (47.0), pp. 1436.0-1439.0 |
19 | 0 | 0 | 0 | 0 | 0 | 19 | |
| 27. | Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and erntricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study | Jean-Michel Molina Jaime Andrade-Villanueva Juan Echevarria Ploenchan Chetchotisakd Jorge Corral Neal David Graeme Moyle Marco Mancini Lisa Percival Rong Yang Alexandra Thiry Donnie McGrath |
2008 |
LANCET 9639.0 (372.0), pp. 646.0-655.0 |
548 | 0 | 0 | 0 | 0 | 0 | 548 | |
| 28. | Short report: Consensus guidelines for dosing of amoxicillin-clavulanate in melioidosis | Allen C. Cheng Wirongrong Chierakul Wipada Chaowagul Ploenchan Chetchotisakd Direk Limmathurotsakul David A. B. Dance Sharon J. Peacock Bart J. Currie |
2008 |
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE 2.0 (78.0), pp. 208.0-209.0 |
30 | 0 | 0 | 0 | 0 | 0 | 30 | |
| 29. | A Phase II Randomized Trial of Amphotericin B Alone or Combined with Fluconazole in the Treatment of HIV-Associated Cryptococcal Meningitis | Peter G. Pappas Ploenchan Chetchotisakd Robert A. Larsen Weerawat Manosuthi Michele I. Morris Thomansak Anekthananon Somnuek Sungkanuparph Khauncahi Supparatpinyo Tracy L. Nolen Louise O. Zimmer Amy S. Kendrick Phillip Johnson Jack D. Sobel Scott G. Filler |
2009 |
CLINICAL INFECTIOUS DISEASES 12.0 (48.0), pp. 1775.0-1783.0 |
130 | 0 | 0 | 0 | 0 | 0 | 130 | |
| 30. | Cryptococcal Immune Reconstitution Inflammatory Syndrome after Antiretroviral Therapy in AIDS Patients with Cryptococcal Meningitis: A Prospective Multicenter Study | Somnuek Sungkanuparph Scott G. Filler Ploenchan Chetchotisakd Peter G. Pappas Tracy L. Nolen Weerawat Manosuthi Thanomsak Anekthananon Michele I. Morris Khuanchai Supparatpinyo Heather Kopetskie Amy S. Kendrick Philip C. Johnson Jack D. Sobel Robert A. Larsen |
2009 |
CLINICAL INFECTIOUS DISEASES 6.0 (49.0), pp. 931.0-934.0 |
112 | 0 | 0 | 0 | 0 | 0 | 112 | |
| 31. | Effect of high-dose fluconazole on QT interval in patients with human immunodeficiency virus (HIV)-associated cryptococcal meningitis | Weerawat Manosuthi Somnuek Sungkanuparph Thanomsak Anekthananon Khuanchai Supparatpinyo Tracy L. Nolen Louise O. Zimmer Peter G. Pappas Robert A. Larsen Scott G. Filler Ploenchan Chetchotisakd |
2009 |
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 5.0 (34.0), pp. 494.0-496.0 |
12 | 0 | 0 | 0 | 0 | 0 | 12 | |
| 32. | Fungemia in non-HIV-infected patients: a five-year review | Siriluck Anunnatsiri Ploenchan Chetchotisakd Piroon Mootsikapun |
2009 |
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES 1.0 (13.0), pp. 90.0-96.0 |
25 | 0 | 0 | 0 | 0 | 0 | 25 | |
| 33. | Phenotypic and Functional Characterization of Human Memory T Cell Responses to to Burkholderia pseudomallei | Patcharaporn Tippayawat Wipawee Saenwongsa Jirawan Mahawantung Duangchan Suwannasaen Ploenchan Chetchotisakd Direk Limmathurotsakul Sharon J. Peacock Philip L. Felgner Helen S. Atkins Richard W. Titball Gregory J. Bancroft Ganjana Lertmemongkolchai |
2009 |
PLOS NEGLECTED TROPICAL DISEASES 4.0 (3.0), pp. |
53 | 0 | 0 | 0 | 0 | 0 | 53 | |
| 34. | Use of a low-dose steroid as an adjunct in the treatment, in mice, of severe sepsis caused by Burkholderia pseudomallei | P. Panomket P. Chetchotisakd R. W. Sermswan P. Pannengpetch S. Wongratanacheewin |
2009 |
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY 7.0 (103.0), pp. 635.0-646.0 |
10 | 0 | 0 | 0 | 0 | 0 | 10 | |
| 35. | Increasing Incidence of Human Melioidosis in Northeast Thailand | Direk Limmathurotsakul Surasakdi Wongratanacheewin Nittaya Teerawattanasook Gumphol Wongsuvan Seksan Chaisuksant Ploenchan Chetchotisakd Wipada Chaowagul Nicholas P. J. Day Sharon J. Peacock |
2010 |
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE 6.0 (82.0), pp. 1113.0-1117.0 |
341 | 0 | 0 | 0 | 0 | 0 | 341 | |
| 36. | International collaboration between US and Thailand on a clinical trial of treatment for HIV-associated cryptococcal meningitis | L. O. Zimmer T. L. Nolen S. Pramanpol D. Wallace M. E. Walker P. Pappas P. Chetchotisakd |
2010 |
CONTEMPORARY CLINICAL TRIALS 1.0 (31.0), pp. 34.0-43.0 |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
| 37. | Melioidosis Pericarditis Mimicking Tuberculous Pericarditis | Ploenchan Chetchotisakd Siriluck Anunnatsiri Songsak Kiatchoosakun Churairat Kularbkaew |
2010 |
CLINICAL INFECTIOUS DISEASES 5.0 (51.0), pp. E46-E49 |
11 | 0 | 0 | 0 | 0 | 0 | 11 | |
| 38. | Monitoring and impact of fluconazole serum and cerebrospinal fluid concentration in HIV-associated cryptococcal meningitis-infected patients | W. Manosuthi P. Chetchotisakd T. L. Nolen D. Wallace S. Sungkanuparph T. Anekthananon K. Supparatpinyo P. G. Pappas R. A. Larsen S. G. Filler D. Andes |
2010 |
HIV MEDICINE 4.0 (11.0), pp. 276.0-281.0 |
16 | 0 | 0 | 0 | 0 | 0 | 16 | |
| 39. | Once-Daily Atazanavir/Ritonavir Compared With Twice-Daily Lopinavir/Ritonavir, Each in Combination With Tenofovir and Emtricitabine, for Management of Antiretroviral-Naive HIV-1-Infected Patients: 96-Week Efficacy and Safety Results of the CASTLE Study | Jean-Michel Molina Jaime Andrade-Villanueva Juan Echevarria Ploenchan Chetchotisakd Jorge Corral Neal David Graeme Moyle Marco Mancini Lisa Percival Rong Yang Victoria Wirtz Max Lataillade Judith Absalon Donnie McGrath |
2010 |
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 3.0 (53.0), pp. 323.0-332.0 |
306 | 0 | 0 | 0 | 0 | 0 | 306 | |
| 40. | Etravirine and rilpivirine resistance in HIV-1 subtype CRF01_AE-infected adults failing non-nucleoside reverse transcriptase inhibitor-based regimens | Torsak Bunupuradah Jintanat Ananworanich Ploenchan Chetchotisakd Pacharee Kantipong Supunnee Jirajariyavej Sunee Sirivichayakul Warangkana Munsakul Wisit Prasithsirikul Somnuek Sungkanuparph Chureeratana Bowonwattanuwong Virat Klinbuayaem Kathy Petoumenos Bernard Hirschel Sorakij Bhakeecheep Kiat Ruxrungtham |
2011 |
ANTIVIRAL THERAPY 7.0 (16.0), pp. 1113.0-1121.0 |
33 | 0 | 0 | 0 | 0 | 0 | 33 | |
| 41. | Predictors of poor clinical outcome of cryptococcal meningitis in HIV-infected patients | T. Anekthananon W. Manosuthi P. Chetchotisakd S. Kiertiburanakul K. Supparatpinyo W. Ratanasuwan P. G. Pappas S. G. Filler H. A. Kopetskie T. L. Nolen A. S. Kendrick R. A. Larsen |
2011 |
INTERNATIONAL JOURNAL OF STD & AIDS 11.0 (22.0), pp. 665.0-670.0 |
25 | 0 | 0 | 0 | 0 | 0 | 25 | |
| 42. | Adult-Onset Immunodeficiency in Thailand and Taiwan | Sarah K. Browne Peter D. Burbelo Ploenchan Chetchotisakd Yupin Suputtamongkol Sasisopin Kiertiburanakul Pamela A. Shaw Jennifer L. Kirk Kamonwan Jutivorakool Rifat Zaman Li Ding Amy P. Hsu Smita Y. Patel Kenneth N. Olivier Viraphong Lulitanond Piroon Mootsikapun Siriluck Anunnatsiri Nasikarn Angkasekwinai Boonmee Sathapatayavongs Po-Ren Hsueh Chi-Chang Shieh Margaret R. Brown Wanna Thongnoppakhun Reginald Claypool Elizabeth P. Sampaio Charin Thepthai Duangdao Waywa Camilla Dacombe Yona Reizes Adrian M. Zelazny Paul Saleeb Lindsey B. Rosen Allen Mo Michael Iadarola Steven M. Holland |
2012 |
NEW ENGLAND JOURNAL OF MEDICINE 8.0 (367.0), pp. 725.0-734.0 |
265 | 0 | 0 | 0 | 0 | 0 | 265 | |
| 43. | A randomized comparison of second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir in patients failing NNRTI regimens: the HIV STAR study | Torsak Bunupuradah Ploenchan Chetchotisakd Jintanat Ananworanich Warangkana Munsakul Supunnee Jirajariyavej Pacharee Kantipong Wisit Prasithsirikul Somnuek Sungkanuparph Chureeratana Bowonwatanuwong Virat Klinbuayaem Stephen J. Kerr Jiratchaya Sophonphan Sorakij Bhakeecheep Bernard Hirschel Kiat Ruxrungtham |
2012 |
ANTIVIRAL THERAPY 7.0 (17.0), pp. 1351.0-1361.0 |
55 | 0 | 0 | 0 | 0 | 0 | 55 | |
| 44. | Assessing adherence in Thai patients taking combination antiretroviral therapy | S. J. Kerr A. Avihingsanon O. Putcharoen P. Chetchotisakd M. Layton S. Ubolyam K. Ruxrungtham D. A. Cooper P. Phanuphak C. Duncombe |
2012 |
INTERNATIONAL JOURNAL OF STD & AIDS 3.0 (23.0), pp. 160.0-165.0 |
13 | 0 | 0 | 0 | 0 | 0 | 13 | |
| 45. | Cobicistat versus ritonavir as pharmacoenhancers in combination with atazanavir plus tenofovir disoproxil fumarate/emtricitabine: phase 3 randomized, double blind, active-controlled trial, week 48 results | J. Gallant E. Koenig J. Andrade-Villanueva P. Chetchotisakd E. Dejesus F. Antunes K. Arasteh G. Moyle G. Rizzardini J. Fehr Y-P. Liu L. Zhong C. Callebaut S. Ramanathan J. Szwarcberg M. Rhee A. Cheng |
2012 |
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (15.0), pp. 53.0-53.0 |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 46. | Emergence of NDM-1-and IMP-14a-producing Enterobacteriaceae in Thailand | Benchamas Rimrang Aroonwadee Chanawong Aroonlug Lulitanond Chotechana Wilailuckana Nicha Charoensri Pipat Sribenjalux Waewta Phumsrikaew Lumyai Wonglakorn Anusak Kerdsin Ploenchan Chetchotisakd |
2012 |
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 11.0 (67.0), pp. 2626.0-2630.0 |
63 | 0 | 0 | 0 | 0 | 0 | 63 | |
| 47. | Neurocognitive impairment in patients randomized to second-line lopinavir/ritonavir-based antiretroviral therapy vs. lopinavir/ritonavir monotherapy | Torsak Bunupuradah Ploenchan Chetchotisakd Supunnee Jirajariyavej Victor Valcour Chureeratana Bowonwattanuwong Warangkana Munsakul Virat Klinbuayaem Wisit Prasithsirikul Jiratchaya Sophonphan Apicha Mahanontharit Bernard Hirschel Sorakij Bhakeecheep Kiat Ruxrungtham Jintanat Ananworanich |
2012 |
JOURNAL OF NEUROVIROLOGY 6.0 (18.0), pp. 479.0-487.0 |
17 | 0 | 0 | 0 | 0 | 0 | 17 | |
| 48. | New Delhi metallo-beta-lactamase-1 (NDM-1)-producing Enterobacteriaceae: first report in Thailand | B. Rimrang A. Chanawong A. Lulitanond C. Wilailuckana N. Charoensri P. Sribenjalux W. Phumsrikaew L. Wonglakorn P. Chetchotisakd |
2012 |
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (16.0), pp. E431-E431 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 49. | Pooled Week 96 efficacy and safety results from the double-blind, randomised, Phase III trials comparing rilpivirine (RPV;TMC278) versus efavirenz (EFV) in treatment-naive, HIV-1-infected adults | C. Orkin C. Cohen J-M Molina I. Cassetti P. Chetchotisakd A. Lazzarin F. Rhame H. J. Stellbrink L. Taisheng H. Crauwels L. Rimsky S. Vanveggel P. Williams K. Boven |
2012 |
HIV MEDICINE (13.0), pp. 68.0-69.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 50. | Cobicistat Versus Ritonavir as a Pharmacoenhancer of Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-Naive HIV Type 1-Infected Patients: Week 48 Results | Joel E. Gallant Ellen Koenig Jaime Andrade-Villanueva Ploenchan Chetchotisakd Edwin DeJesus Francisco Antunes Keikawus Arasteh Graeme Moyle Giuliano Rizzardini Jan Fehr Yapei Liu Lijie Zhong Christian Callebaut Javier Szwarcberg Martin S. Rhee Andrew K. Cheng |
2013 |
JOURNAL OF INFECTIOUS DISEASES 1.0 (208.0), pp. 32.0-39.0 |
109 | 0 | 0 | 0 | 0 | 0 | 109 | |
| 51. | Week 96 efficacy and safety of rilpivirine in treatment-naive, HIV-1 patients in two Phase III randomized trials | Calvin J. Cohen Jean-Michel Molina Isabel Cassetti Ploenchan Chetchotisakd Adriano Lazzarin Chloe Orkin Frank Rhame Hans-Juergen Stellbrink Taisheng Li Herta Crauwels Laurence Rimsky Simon Vanveggel Peter Williams Katia Boven |
2013 |
AIDS 6.0 (27.0), pp. 939.0-950.0 |
127 | 0 | 0 | 0 | 0 | 0 | 127 | |
| 52. | LINEZOLID IN THE TREATMENT OF DISSEMINATED NONTUBERCULOUS MYCOBACTERIAL INFECTION IN ANTI-INTERFERON-gamma AUTOANTIBODY-POSITIVE PATIENTS | Ploenchan Chetchotisakd Siriluck Anunnatsiri |
2014 |
SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH 5.0 (45.0), pp. 1125.0-1131.0 |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
| 53. | Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial | Ploenchan Chetchotisakd Wirongrong Chierakul Wipada Chaowagul Siriluck Anunnatsiri Kriangsak Phimda Piroon Mootsikapun Seksan Chaisuksant Jiraporn Pilaikul Bandit Thinkhamrop Sunchai Phiphitaporn Wattanachai Susaengrat Chalongchai Toondee Surasakdi Wongrattanacheewin Vanaporn Wuthiekanun Narisara Chantratita Janjira Thaipadungpanit Nicholas P. Day Direk Limmathurotsakul Sharon J. Peacock |
2014 |
LANCET 9919.0 (383.0), pp. 807.0-814.0 |
89 | 0 | 0 | 0 | 0 | 0 | 89 | |
| 54. | Atazanavir/ritonavir 200/100 mg is non-inferior to atazanavir/ritonavir 300/100 mg in virologic suppressed HIV-infected Thai adults: a multicentre, randomized, open-label trial: LASA | Torsak Bunupuradah Sasisopin Kiertiburanakul Anchalee Avihingsanon Ploenchan Chetchotisakd Malee Techapornroong Niramon Leerattanapetch Pacharee Kantipong Chureeratana Bowonwatanuwong Sukit Banchongkit Virat Klinbuayaem Sripetcharat Mekviwattanawan Sireethorn Nimitvilai Supunnee Jirajariyavej Wisit Prasithsirikul Warangkana Munsakul Sorakij Bhakeecheep Sushada Chaivooth Praphan Phanuphak David A. Cooper Tanakorn Apornpong Stephen J. Kerr Sean Emery Kiat Ruxrungtham |
2015 |
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (18.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 55. | Cerebrospinal Fluid Exposure of Efavirenz and Its Major Metabolites When Dosed at 400 mg and 600 mg Once Daily: A Randomized Controlled Trial | Alan Winston Janaki Amin Amanda Clarke Laura Else Alieu Amara Andrew Owen Tristan Barber Heiko Jessen Anchalee Avinghsanon Ploenchan Chetchotisakd Saye Khoo David A. Cooper Sean Emery Rebekah Puls |
2015 |
CLINICAL INFECTIOUS DISEASES 7.0 (60.0), pp. 1026.0-1032.0 |
38 | 0 | 0 | 0 | 0 | 0 | 38 | |
| 56. | Cobicistat Compared With Ritonavir as a Pharmacoenhancer for Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate: Week 144 Results | Joel E. Gallant Ellen Koenig Jaime F. Andrade-Villanueva Ploenchan Chetchotisakd Edwin DeJesus Francisco Antunes Keikawus Arasteh Giuliano Rizzardini Jan Fehr Hui C. Liu Michael E. Abram Huyen Cao Javier Szwarcberg |
2015 |
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 3.0 (69.0), pp. 338.0-340.0 |
43 | 0 | 0 | 0 | 0 | 0 | 43 | |
| 57. | Cost-effectiveness analysis of parenteral antimicrobials for acute melioidosis in Thailand | Viriya Hantrakun Wirongrong Chierakul Ploenchan Chetchotisakd Siriluck Anunnatsiri Bart J. Currie Sharon J. Peacock Nicholas P. J. Day Phaik Cheah Direk Limmathurotsakul Yoel Lubell |
2015 |
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE 6.0 (109.0), pp. 416.0-418.0 |
5 | 0 | 0 | 0 | 0 | 0 | 5 | |
| 58. | Cost-effectiveness analysis of parenteral antimicrobials for acute melioidosis in Thailand (vol 109, pg 416, 2015) | Viriya Hantrakun Wirongrong Chierakul Ploenchan Chetchotisakd Siriluck Anunnatsiri Bart J. Currie Sharon J. Peacock Nicholas P. J. Day Phaik Yeong Cheah Direk Limmathurotsakul Yoel Lubell |
2015 |
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE 12.0 (109.0), pp. 803.0-803.0 |
5 | 0 | 0 | 0 | 0 | 0 | 5 | |
| 59. | Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study | Stephen Becker Marta Boffi To Chris Duncombe Andrew Hill Tim Read Jim Rooney Kim Schaff Er Cecilia Abela Janaki Amin Anchalee Avihingsanon Mark Boyd Dianne Carey Amanda Clarke Kymme Courtney-Vega Marina Delfi No Anna Donaldson Sean Emery Natalie Espinosa Tanya Johannesen Enmoore Lin Alejandra Moricz Sarah Pett Praphan Phanupak Rebekah Puls Kanitta Pussadee Parinya Sutheerasak Louise Tomlins Sasiwimol Ubolyam Waldo Belloso Raja Iskandar Shah bin Raja Azwa Emiliano Bissio Liliana Calanni Ploenchan Chetchotisakd David Cooper Brenda Crabtree-Ramirez Nicholas Doong Julian Elliott Sharne Foulkes Brian Gazzard Heiko Jessen Mark Kelly Suresh Kumar Hector Laplume Man-Po Lee Marcelo Losso Norma del Carmen Luna Sergio Lupo Oscar Garcia Messina Lerato Mohapi Richard Moore David Nolan Chidi Nwizu Catherine Orrell Carlos Perez Praphan Phanuphak Tim Read Juergen Rockstroh Diane Rowling Eduardo Shahar Khuanchai Supparatpinyo Don Smith Jaime Andrade Villanueva Emanuel Vlahakis Alan Winston Marcelo Wolff Barnaby Young Tony Kelleher Philip Cunningham Kate Merlin Julie Yeung Ansari Shaik Bertha Fsadni Alex Carrera Melanie Lograsso Roy Gulick David Dunn Matthew Dolan |
2015 |
LANCET INFECTIOUS DISEASES 7.0 (15.0), pp. 793.0-802.0 |
86 | 0 | 0 | 0 | 0 | 0 | 86 | |
| 60. | Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2014, Thailand | Weerawat Manosuthi Sumet Ongwandee Sorakij Bhakeecheep Manoon Leechawengwongs Kiat Ruxrungtham Praphan Phanuphak Narin Hiransuthikul Winai Ratanasuwan Ploenchan Chetchotisakd Woraphot Tantisiriwat Sasisopin Kiertiburanakul Anchalee Avihingsanon Akechittra Sukkul Thanomsak Anekthananon |
2015 |
AIDS RESEARCH AND THERAPY (12.0), pp. |
84 | 0 | 0 | 0 | 0 | 0 | 84 | |
| 61. | Safety of tenofovir alafenamide in renal impairment | A. Pozniak J. Arribas S. Gupta F. Post A. Avihingsanon G. Crofoot K. Lichtenstein M. Ramgopa P. Chetchotisakd P. Benn M. W. Fordyce |
2015 |
HIV MEDICINE (16.0), pp. 33.0-33.0 |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
| 62. | Serological diagnosis of pulmonary Mycobacterium tuberculosis infection by LIPS using a multiple antigen mixture | Peter D. Burbelo Jason Keller Jason Wagner James S. Klimavicz Ahmad Bayat Craig S. Rhodes Bassirou Diarra Ploenchan Chetchotisakd Yupin Suputtamongkol Sasisopin Kiertiburanakul Steven M. Holland Sarah K. Browne Sophia Siddiqui Joseph A. Kovacs |
2015 |
BMC MICROBIOLOGY (15.0), pp. |
18 | 0 | 0 | 0 | 0 | 0 | 18 | |
| 63. | Anti-IFN-gamma autoantibodies are strongly associated with HLA-DR*15:02/16:02 and HLA-DQ*05:01/05:02 across Southeast Asia | Cheng-Lung Ku Chia-Hao Lin Su-Wei Chang Chen-Chung Chu Jasper F. W. Chan Xiao-Fei Kong Chen-Hsiang Lee Emily A. Rosen Jing-Ya Ding Wen-I. Lee Jacinta Bustamante Torsten Witte Han-Po Shih Chen-Yen Kuo Ploenchan Chetchotisakd Sasisopin Kiertiburanakul Yupin Suputtamongkol Kwok-Yung Yuen Jean-Laurent Casanova Steven M. Holland Rainer Doffinger Sarah K. Browne Chih-Yu Chi |
2016 |
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 3.0 (137.0), pp. 945.0-948.0 |
36 | 0 | 0 | 0 | 0 | 0 | 36 | |
| 64. | Antiretroviral Resistance After First-Line Antiretroviral Therapy Failure in Diverse HIV-1 Subtypes in the SECOND-LINE Study | Edward P. Lam Cecilia L. Moore Eduardo Gotuzzo Chidi Nwizu Adeeba Kamarulzaman Ploenchan Chetchotisakd Jean van Wyk Hedy Teppler Nagalingeswaran Kumarasamy Jean-Michel Molina Sean Emery David A. Cooper Mark A. Boyd |
2016 |
AIDS RESEARCH AND HUMAN RETROVIRUSES 9.0 (32.0), pp. 841.0-850.0 |
16 | 0 | 0 | 0 | 0 | 0 | 16 | |
| 65. | A qualitative assessment of barriers and facilitators to antiretroviral adherence in Thai patients | Melissa Phuphanich Maneerat Rattanamahattana Anchalee Avihingsanon Ploenchan Chetchotisakd Opass Putcharoen Monica Gandhi Annette H. Sohn John Imrie Praphan Phanuphak Stephen J. Kerr |
2016 |
JOURNAL OF VIRUS ERADICATION 1.0 (2.0), pp. 22.0-27.0 |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 66. | Clinical features and outcomes of Sweet's syndrome associated with non-tuberculous mycobacterial infection and other associated diseases | Suteeraporn Chaowattanapanit Charoen Choonhakarn Ploenchan Chetchotisakd Kittisak Sawanyawisuth Narachai Julanon |
2016 |
JOURNAL OF DERMATOLOGY 5.0 (43.0), pp. 532.0-536.0 |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
| 67. | Comparison of community-onset Staphylococcus argenteus and Staphylococcus aureus sepsis in Thailand: a prospective multicentre observational study | N. Chantratita C. Wikraiphat S. Tandhavanant G. Wongsuvan P. Ariyaprasert P. Suntornsut J. Thaipadungpanit N. Teerawattanasook Y. Jutrakul N. Srisurat P. Chaimanee J. Anukunananchai S. Phiphitaporn P. Srisamang P. Chetchotisakd T. E. West S. J. Peacock |
2016 |
CLINICAL MICROBIOLOGY AND INFECTION 5.0 (22.0), pp. |
66 | 0 | 0 | 0 | 0 | 0 | 66 | |
| 68. | COST-UTILITY ANALYSIS OF ATAZANAVIR/RITONAVIR 200/100 MG VERSUS ATAZANAVIR/RITONAVIR 300/100 MG IN THAI ADULTS WITH VIROLOGIC SUPPRESSION | S. Taychakhoonavudh N. Maneesawangwong T. Bunupuradah S. Kiertiburanakul T. Worrathammasorn P. Hadnorntun A. Avihingsanon P. Chetchotisakd S. Emery K. Ruxrungtham |
2016 |
VALUE IN HEALTH 7.0 (19.0), pp. A912-A912 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 69. | Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in treatment-naive Asian adults | Shinichi Oka Ploenchan Chetchotisakd Amanda Clarke Khuanchai Supparatpinyo Sasisopin Kiertiburanakul Julie Ryu David Piontkowsky Susan Guo Thai Nguyen-Cleary Moupali Das Scott McCallister |
2016 |
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (19.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 70. | High-level carbapenem-resistant OXA-48-producing Klebsiella pneumoniae with a novel OmpK36 variant and low-level, carbapenem-resistant, non-porin-deficient, OXA-181-producing Escherichia coli from Thailand | Kamonwan Lunha Aroonwadee Chanawong Aroonlug Lulitanond Chotechana Wilailuckana Nicha Charoensri Lumyai Wonglakorn Pimjai Saenjamla Prajuab Chaimanee Sunpetch Angkititrakul Ploenchan Chetchotisakd |
2016 |
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE 2.0 (85.0), pp. 221.0-226.0 |
32 | 0 | 0 | 0 | 0 | 0 | 32 | |
| 71. | Improvement of lipid profiles when switching from efavirenz to rilpivirine in HIV-infected patients with dyslipidemia | Pornpimol Thamrongwonglert Ploenchan Chetchotisakd Siriluck Anunnatsiri Piroon Mootsikapun |
2016 |
HIV CLINICAL TRIALS 1.0 (17.0), pp. 12.0-16.0 |
23 | 0 | 0 | 0 | 0 | 0 | 23 | |
| 72. | Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis | Francisco M. Marty Luis Ostrosky-Zeichner Oliver A. Cornely Kathleen M. Mullane John R. Perfect George R. Thompson George J. Alangaden Janice M. Brown David N. Fredricks Werner J. Heinz Raoul Herbrecht Nikolai Klimko Galina Klyasova Johan A. Maertens Sameer R. Melinkeri Ilana Oren Peter G. Pappas Zdenek Racil Galia Rahav Rodrigo Santos Stefan Schwartz J. Janne Vehreschild Jo-Anne H. Young Ploenchan Chetchotisakd Sutep Jaruratanasirikul Souha S. Kanj Marc Engelhardt Achim Kaufh Masanori Ito Misun Lee Carolyn Sasse Rochelle M. Maher Bernhardt Zeiher Maria J. G. T. Vehreschild |
2016 |
LANCET INFECTIOUS DISEASES 7.0 (16.0), pp. 828.0-837.0 |
367 | 0 | 0 | 0 | 0 | 0 | 367 | |
| 73. | Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): a randomised, open-label, non-inferiority trial | Torsak Bunupuradah Sasisopin Kiertiburanakul Anchalee Avihingsanon Ploenchan Chetchotisakd Malee Techapornroong Niramon Leerattanapetch Pacharee Kantipong Chureeratana Bowonwatanuwong Sukit Banchongkit Virat Klinbuayaem Sripetcharat Mekviwattanawong Sireethorn Nimitvilai Supunnee Jirajariyavej Wisit Prasithsirikul Warangkana Munsakul Sorakij Bhakeecheep Suchada Chaivooth Praphan Phanuphak David A. Cooper Tanakorn Apornpong Stephen J. Kerr Sean Emery Kiat Ruxrungtham |
2016 |
LANCET HIV 8.0 (3.0), pp. E343-E350 |
24 | 0 | 0 | 0 | 0 | 0 | 24 | |
| 74. | Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study | Anton Pozniak Jose R. Arribas Joseph Gathe Samir K. Gupta Frank A. Post Mark Bloch Anchalee Avihingsanon Gordon Crofoot Paul Benson Kenneth Lichtenstein Moti Ramgopal Ploenchan Chetchotisakd Joseph M. Custodio Michael E. Abram Xuelian Wei Andrew Cheng Scott McCallister Devi SenGupta Marshall W. Fordyce |
2016 |
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 5.0 (71.0), pp. 530.0-537.0 |
202 | 0 | 0 | 0 | 0 | 0 | 202 | |
| 75. | Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study | Mark A. Boyd Janaki Amin Patrick W. G. Mallon Nagalingeswaran Kumarasamy Johan Lombaard Robin Wood Ploenchan Chetchotisakd Praphan Phanuphak Lerato Mohapi Iskandar Azwa Waldo H. Belloso Jean-Michel Molina Jennifer Hoy Cecilia L. Moore Sean Emery David A. Cooper |
2017 |
LANCET HIV 1.0 (4.0), pp. E13-E20 |
10 | 0 | 0 | 0 | 0 | 0 | 10 | |
| 76. | Cryptococcosis in Anti-Interferon-Gamma Autoantibody-Positive Patients: a Different Clinical Manifestation from HIV-Infected Patients | Ploenchan Chetchotisakd Siriluck Anunnatsiri Arnone Nithichanon Ganjana Lertmemongkolchai |
2017 |
JAPANESE JOURNAL OF INFECTIOUS DISEASES 1.0 (70.0), pp. 69.0-74.0 |
14 | 0 | 0 | 0 | 0 | 0 | 14 | |
| 77. | Imipenem-hydrolyzing beta-lactamase-1 (IMI-1)-producing Enterobacter cloacae isolates from Thailand | K. Lunha A. Chanawong A. Lulitanond C. Wilailuckana N. Charoensri L. Wonglakorn W. Kuvadjanakoon P. Chetchotisakd |
2017 |
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (50.0), pp. S102-S102 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 78. | Molecular Characterization of Carbapenemase-Nonproducing Clinical Isolates of Escherichia coli (from a Thai University Hospital) with Reduced Carbapenem Susceptibility | Sawitree Nuramruna Aroonwadee Chanawong Kamonwan Lunha Aroonlug Lulitanond Arunnee Sangka Chotechana Wilailuckana Sunpetch Angkititrakul Nicha Charoensri Lumyai Wonglakorn Prajuab Chaimanee Ploenchan Chetchotisakd |
2017 |
JAPANESE JOURNAL OF INFECTIOUS DISEASES 6.0 (70.0), pp. 628.0-634.0 |
5 | 0 | 0 | 0 | 0 | 0 | 5 | |
| 79. | Patient Characteristics, Management, and Predictors of Outcome from Severe Community-Onset Staphylococcal Sepsis in Northeast Thailand: A Prospective Multicenter Study | T. Eoin West Chanthiwa Wikraiphat Sarunporn Tandhavanant Pitchayanant Ariyaprasert Pornpan Suntornsut Shawna Okamoto Weera Mahavanakul Pramot Srisamang Sunchai Phiphitaporn Jirasak Anukunananchai Ploenchan Chetchotisakd Sharon J. Peacock Narisara Chantratita |
2017 |
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE 5.0 (96.0), pp. 1042.0-1049.0 |
16 | 0 | 0 | 0 | 0 | 0 | 16 | |
| 80. | Superior efficacy of dolutegravir (DTG) plus 2 nucleoside reverse transcriptase inhibitors (NRTIs) compared with lopinavir/ritonavir (LPV/RTV) plus 2 NRTIs in second-line treatment: interim data from the DAWNING study | M. Aboud R. Kaplan J. Lombaard F. Zhang J. Hidalgo E. Mamedova M. Losso P. Chetchotisakd J. Sievers D. Brown J. Hopking M. Underwood M. C. Nascimento M. Gartland K. Smith |
2017 |
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (20.0), pp. 111.0-111.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 81. | TLR4 genetic variation is associated with inflammatory responses in Gram-positive sepsis | N. Chantratita S. Tandhavanant S. Seal C. Wikraiphat G. Wongsuvan P. Ariyaprasert P. Suntornsut N. Teerawattanasook Y. Jutrakul N. Srisurat P. Chaimanee W. Mahavanakul P. Srisamang S. Phiphitaporn M. Mokchai J. Anukunananchai S. Wongratanacheewin P. Chetchotisakd M. J. Emond S. J. Peacock T. E. West |
2017 |
CLINICAL MICROBIOLOGY AND INFECTION 1.0 (23.0), pp. |
39 | 0 | 0 | 0 | 0 | 0 | 39 | |
| 82. | Analysis of drug-susceptibility patterns and gene sequences associated with clarithromycin and amikacin resistance in serial Mycobacterium abscessus isolates from clinical specimens from Northeast Thailand | Pimjai Ananta Irin Kham-ngam Ploenchan Chetchotisakd Prajuab Chaimanee Wipa Reechaipichitkul Wises Namwat Viraphong Lulitanond Kiatichai Faksri |
2018 |
PLOS ONE 11.0 (13.0), pp. |
25 | 0 | 0 | 0 | 0 | 0 | 25 | |
| 83. | Epidemiology of and risk factors for extrapulmonary nontuberculous mycobacterial infections in Northeast Thailand | Irin Kham-ngam Ploenchan Chetchotisakd Pimjai Ananta Prajaub Chaimanee Phuangphaka Sadee Wipa Reechaipichitkul Kiatichai Faksri |
2018 |
PEERJ (6.0), pp. |
20 | 0 | 0 | 0 | 0 | 0 | 20 | |
| 84. | HAEMOPHILUS INFLUENZAE INFECTED ATRIAL MYXOMA: A CASE REPORT | Thinnakrit Sasiprapha Ploenchan Chetchotisakd |
2018 |
SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH 3.0 (49.0), pp. 465.0-468.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 85. | Immune Control of Burkholderia pseudomallei-Common, High-Frequency T-Cell Responses to a Broad Repertoire of Immunoprevalent Epitopes | Arnone Nithichanon Darawan Rinchai Surachat Buddhisa Pornpun Saenmuang Chidchamai Kewcharoenwong Bianca Kessler Prasong Khaenam Ploenchan Chetchotisakd Bernard Maillere John Robinson Catherine J. Reynolds Rosemary J. Boyton Daniel M. Altmann Ganjana Lertmemongkolchai |
2018 |
FRONTIERS IN IMMUNOLOGY (9.0), pp. |
11 | 0 | 0 | 0 | 0 | 0 | 11 | |
| 86. | Intravenous Cyclophosphamide Therapy for Anti-IFN-Gamma Autoantibody-Associated Mycobacterium abscessus Infection | Ploenchan Chetchotisakd Siriluck Anunnatsiri Ratanavadee Nanagara Arnone Nithichanon Ganjana Lertmemongkolchai |
2018 |
JOURNAL OF IMMUNOLOGY RESEARCH (2018.0), pp. |
29 | 0 | 0 | 0 | 0 | 0 | 29 | |
| 87. | Melioidosis in Thailand: Present and Future | Soawapak Hinjoy Viriya Hantrakun Somkid Kongyu Jedsada Kaewrakmuk Tri Wangrangsimakul Siroj Jitsuronk Weerawut Saengchun Saithip Bhengsri Thantapat Akarachotpong Somsak Thamthitiwat Ornuma Sangwichian Siriluck Anunnatsiri Rasana W. Sermswan Ganjana Lertmemongkolchai Chayada Sitthidet Tharinjaroen Kanya Preechasuth Ratchadaporn Udpaun Poomin Chuensombut Nisarat Waranyasirikul Chanihcha Anudit Surapong Narenpitak Yaowaruk Jutrakul Prapit Teparrukkul Nittaya Teerawattanasook Kittisak Thanvisej Alisa Suphan Punchawee Sukbut Kritchavat Ploddi Poolsri Sirichotirat Bongkoch Chiewchanyon Kamolchanok Rukseree Maliwan Hongsuwan Gumphol Wongsuwan Pornpan Sunthornsut Vanaporn Wuthiekanun Sandy Sachaphimukh Prapass Wannapinij Wirongrong Chierakul Claire Chewapreecha Janjira Thaipadungpanit Narisara Chantratita Sunee Korbsrisate Apichai Taunyok Susanna Dunachie Prasit Palittapongarnpim Stitaya Sirisinha Rungrueng Kitphati Sopon Iamsirithaworn Wipada Chaowagul Ploenchan Chetchotisak Toni Whistler Surasakdi Wongratanacheewin Direk Limmathurotsakul |
2018 |
TROPICAL MEDICINE AND INFECTIOUS DISEASE 2.0 (3.0), pp. |
40 | 0 | 0 | 0 | 0 | 0 | 40 | |
| 88. | Ocular involvement in melioidosis: a 23-year retrospective review | Sasi Yaisawang Somkiat Asawaphureekorn Ploenchan Chetchotisakd Surasakdi Wongratanacheewin Peerapat Pakdee |
2018 |
JOURNAL OF OPHTHALMIC INFLAMMATION AND INFECTION (8.0), pp. |
8 | 0 | 0 | 0 | 0 | 0 | 8 | |
| 89. | Predictive Validity of qSOFA for Sepsis Among Patients with Community-Onset Staphylococcal Infection and SIRS in Northeast Thailand | S. Gupta K. E. Rudd C. Wikraiphat S. Tandhavanant G. Wongsuwan P. Ariyaprasert P. Suntornsut N. Teerawattanasook Y. Jutrakul N. Srisurat P. Chaimanee J. Anukunananchai S. Phiphitaporn P. Srisamang P. Chetchotisakd C. W. Seymour D. C. Angus S. J. Peacock N. Chantratita T. E. West |
2018 |
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (197.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 90. | Differentiation between persistent infection/colonization and re-infection/re-colonization of Mycobacterium abscessus isolated from patients in Northeast Thailand | Irin Kham-ngam Ploenchan Chetchotisakd Pimjai Ananta Prajaub Chaimanee Wipa Reechaipichitkul Viraphong Lulitanond Wises Namwat Kiatichai Faksri |
2019 |
INFECTION GENETICS AND EVOLUTION (68.0), pp. 35.0-42.0 |
3 | 0 | 0 | 0 | 0 | 0 | 3 | |
| 91. | Dolutegravir versus ritonavir-boosted lopinavir both with dual nucleoside reverse transcriptase inhibitor therapy in adults with HIV-1 infection in whom first-line therapy has failed (DAWNING): an open-label, non-inferiority, phase 3b trial | Michael Aboud Richard Kaplan Johannes Lombaard Fujie Zhang Jose A. Hidalgo Elmira Mamedova Marcelo H. Losso Ploenchan Chetchotisakd Carlos Brites Jorg Sievers Dannae Brown Judy Hopking Mark Underwood Maria Claudia Nascimento Yogesh Punekar Martin Gartland Kimberly Smith |
2019 |
LANCET INFECTIOUS DISEASES 3.0 (19.0), pp. 253.0-264.0 |
76 | 0 | 0 | 0 | 0 | 0 | 76 | |
| 92. | Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in Asian participants with human immunodeficiency virus 1 infection: A sub-analysis of phase 3 clinical trials | Yeon-Sook Kim Shinichi Oka Ploenchan Chetchotisakd Amanda Clarke Khuanchai Supparatpinyo Anchalee Avihingsanon Winai Ratanasuwan Sasisopin Kiertiburanakul Kiat Ruxrungtham SangYoun Yang Susan Guo YaPei Liu Moupali Das Do Tran Damian McColl Roberto Corales Chris Nguyen David Piontkowsky |
2019 |
HIV RESEARCH & CLINICAL PRACTICE 3.0 (20.0), pp. 73.0-81.0 |
6 | 0 | 0 | 0 | 0 | 0 | 6 | |
| 93. | Influence of CYP3A5 and SLCO1B1 polymorphisms on atazanavir/r concentrations in Thai HIV-infected patients | Noppaket Singkham Anchalee Avihingsanon Narukjaporn Thammajaruk Kiat Ruxrungtham Torsak Bunupuradah Sasisopin Kiertiburanakul Ploenchan Chetchotisakd David M. Burger Sean Emery Baralee Punyawudho |
2019 |
PHARMACOGENOMICS 7.0 (20.0), pp. 517.0-527.0 |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 94. | Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial | Bart Jan Kullberg Claudio Viscoli Peter G. Pappas Jose Vazquez Luis Ostrosky-Zeichner Coleman Rotstein Jack D. Sobel Raoul Herbrecht Galia Rahav Sutep Jaruratanasirikul Ploenchan Chetchotisakd Eric Van Wijngaerden Jan De Waele Christopher Lademacher Marc Engelhardt Laura Kovanda Rodney Croos-Dabrera Christine Fredericks George R. Thompson |
2019 |
CLINICAL INFECTIOUS DISEASES 12.0 (68.0), pp. 1981.0-1989.0 |
81 | 0 | 0 | 0 | 0 | 0 | 81 | |
| 95. | Longer-term (96-week) efficacy and safety of switching to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in women | C. Kityo D. Hagins E. Koenig A. Avihingsanon P. Chetchotisakd K. Supparatpinyo N. Gankina V. Pokrovsky E. Voronin J. L. Stephens E. DeJesus H. Wang R. Acosta D. Brainard H. Martin T. A. Makadzange |
2019 |
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (22.0), pp. 4.0-4.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 96. | Natural History of Anti-Interferon-gamma Autoantibody-associated Immunodeficiency Syndrome in Thailand | Gloria H. Hong Ploenchan Chetchotisakd Siriluck Anunnatsiri Piroon Mootsikapun Lindsey B. Rosen Christa S. Zerbe Steven M. Holland |
2019 |
JOURNAL OF CLINICAL IMMUNOLOGY (39.0), pp. S51-S51 |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 97. | Predictive Validity of the qSOFA Score for Sepsis in Adults with Community-Onset Staphylococcal Infection in Thailand | Supaksh Gupta Kristina E. Rudd Sarunporn Tandhavanant Pornpan Suntornsut Ploenchan Chetchotisakd Derek C. Angus Sharon J. Peacock Narisara Chantratita Timothy Eoin West |
2019 |
JOURNAL OF CLINICAL MEDICINE 11.0 (8.0), pp. |
3 | 0 | 0 | 0 | 0 | 0 | 3 | |
| 98. | Switching to Fixed-Dose Bictegravir, Emtricitabine, and Tenofovir Alafenamide (B/F/TAF) in Virologically Suppressed HIV-1 Infected Women: A Randomized, Open-Label, Multicenter, Active-Controlled, Phase 3, Noninferiority Trial | Cissy Kityo Debbie Hagins Ellen Koenig Anchalee Avihingsanon Ploenchan Chetchotisakd Khuanchai Supparatpinyo Natalya Gankina Vadim Pokrovsky Evgeny Voronin Jeffrey L. Stephens Edwin DeJesus Hui Wang Rima K. Acosta Huyen Cao Erin Quirk Hal Martin Tariro Makadzange |
2019 |
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 3.0 (82.0), pp. 321.0-328.0 |
20 | 0 | 0 | 0 | 0 | 0 | 20 | |
| 99. | Diagnosis of NTM active infection in lymphadenopathy patients with anti-interferon-gamma auto-antibody using inhibitory ELISA vs. indirect ELISA | Arnone Nithichanon Ploenchan Chetchotisakd Takayuki Matsumura Yoshimasa Takahashi Manabu Ato Takuro Sakagami Ganjana Lertmemongkolchai |
2020 |
SCIENTIFIC REPORTS 1.0 (10.0), pp. |
3 | 0 | 0 | 0 | 0 | 0 | 3 | |
| 100. | Evaluation of plasma anti-GPL-core IgA and IgG for diagnosis of disseminated non-tuberculous mycobacteria infection | Arnone Nithichanon Waraporn Samer Ploenchan Chetchotisakd Chidchamai Kewcharoenwong Manabu Ato Ganjana Lertmemongkolchai |
2020 |
PLOS ONE 11.0 (15.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 101. | Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15-25 years: A phase IV randomized comparative study | Nicolas Folschweiller Julio Teixeira Smita Joshi Luciano Z. Goldani Khuanchai Supparatpinyo Partha Basu Tawee Chotpitayasunondh Ploenchan Chetchotisakd Kiat Ruxrungtham Cecilia Roteli-Martins Beatriz Grinsztejn Silvana Maria Quintana Nagalingeswaran Kumarasamy Selvamuthu Poongulali Vinay Kulkarni Lan Lin Sanjoy K. Datta Dominique Descamps Monique Dodet Gary Dubin Damien Friel Marjan Hezareh Naveen Karkada Dorothee Meric Camilleri Sylviane Poncelet Bruno Salaun Fernanda Tavares-da-Silva Florence Thomas-Jooris Frank Struyf |
2020 |
ECLINICALMEDICINE (23.0), pp. |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 102. | Natural History and Evolution of Anti-Interferon-gamma Autoantibody-Associated Immunodeficiency Syndrome in Thailand and the United States | Gloria H. Hong Ana M. Ortega-Villa Sally Hunsberger Ploenchan Chetchotisakd Siriluck Anunnatsiri Piroon Mootsikapun Lindsey B. Rosen Christa S. Zerbe Steven M. Holland |
2020 |
CLINICAL INFECTIOUS DISEASES 1.0 (71.0), pp. 53.0-62.0 |
11 | 0 | 0 | 0 | 0 | 0 | 11 | |
| 103. | A Comparison Between 12 Versus 20 Weeks of Trimethoprim-sulfamethoxazole as Oral Eradication Treatment for Melioidosis: An Open-label, Pragmatic, Multicenter, Non-inferiority, Randomized Controlled Trial | Siriluck Anunnatsiri Wipada Chaowagul Prapit Teparrukkul Ploenchan Chetchotisakd Kittisak Tanwisaid Supphachoke Khemla Surapong Narenpitak Moragot Pattarapongsin Wirod Kongsawasd Pornrith Pisuttimarn Wilawan Thipmontree Piroon Mootsikapun Seksan Chaisuksant Wirongrong Chierakul Nicholas P. J. Day Direk Limmathurotsakul |
2021 |
CLINICAL INFECTIOUS DISEASES 11.0 (73.0), pp. E3627-E3633 |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 104. | Antibiotic Susceptibility of Clinical Burkholderia pseudomallei Isolates in Northeast Thailand from 2015 to 2018 and the Genomic Characterization of beta-Lactam-Resistant Isolates | Shirley Yi Fen Hii Sarunporn Tandhavanant Rungnapa Phunpang Peeraya Ekchariyawat Natnaree Saiprom Claire Chewapreecha Rathanin Seng Ekkachai Thiansukhon Chumpol Morakot Narongchai Sangsa Sunee Chayangsu Somchai Chuananont Kittisak Tanwisaid Wirayut Silakun Noppol Buasi Seksan Chaisuksant Tanin Hompleum Ploenchan Chetchotisakd Nicholas P. J. Day Wasun Chantratita Ganjana Lertmemongkolchai T. Eoin West Narisara Chantratita |
2021 |
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 5.0 (65.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 105. | Pharmacogenetics-based population pharmacokinetic analysis for dose optimization of ritonavir-boosted atazanavir in Thai adult HIV-infected patients | Noppaket Singkham Anchalee Avihingsanon Richard C. Brundage Angela K. Birnbaum Narukjaporn Thammajaruk Kiat Ruxrungtham Torsak Bunupuradah Sasisopin Kiertiburanakul Ploenchan Chetchotisakd Baralee Punyawudho |
2021 |
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Methicillin – resistant Staphylococcus aureus (MRSA) Outbreaks in Srinagarind Hospital | JANPEN JAROONTUM PLOENCHAN CHETCHOTISAKD NANTAKA KHUNTIKEO PAGAKRONG LUMBIGANON WEERACHAI KOSUWON WIPAWADEE MANMONTRI PUNNIPA SIRIERMPOOL |
1994 |
Srinagarind Medical Journal (9 No 4), pp. 174-177 |
| Title | Authors | NRIIS type | Year | NRIIS Scholarship | ||
|---|---|---|---|---|---|---|
| 1. | ระบาดวิทยาเชิงโมเลกุล และการตรวจทางอณูชีววิทยาของเชื้อมัยโคแบคทีเรียที่ไม่ได้ก่อวัณโรคที่ดื้อต่อยารักษา และก่อให้เกิดโรคติดเชื้อแบบแพร่กระจายในผู้ป่วย ในภาคตะวันออกเฉียงเหนือ |
รศ.ดร. เกียรติไชย ฟักศรี ศ. วิภา รีชัยพิชิตกุล นายประจวบ ชัยมณี นางสาวไอริน คำงาม นางสาวพิมใจ อนันตา รศ.ดร. อังคณา ฉายประเสริฐ ศ. เพลินจันทร์ เชษฐ์โชติศักดิ์ |
โครงการ | 2561 | ทุนงบประมาณแผ่นดินประจำปี 2561 (งบบูรณาการวิจัยและนวัตกรรม) |